id	sid	tid	token	lemma	pos
dti-2347	1	1	dti	dti	PROPN
dti-2347	1	2	drug	drug	PROPN
dti-2347	1	3	target	target	NOUN
dti-2347	1	4	insights	insight	NOUN
dti-2347	1	5	2021	2021	NUM
dti-2347	1	6	;	;	PUNCT
dti-2347	1	7	15	15	NUM
dti-2347	1	8	:	:	SYM
dti-2347	1	9	26	26	NUM
dti-2347	1	10	-	-	SYM
dti-2347	1	11	33	33	NUM
dti-2347	1	12	issn	issn	PROPN
dti-2347	1	13	1177	1177	NUM
dti-2347	1	14	-	-	SYM
dti-2347	1	15	3928	3928	NUM
dti-2347	1	16	|	|	ADV
dti-2347	1	17	doi	doi	NOUN
dti-2347	1	18	:	:	PUNCT
dti-2347	1	19	10.33393	10.33393	NUM
dti-2347	1	20	/	/	SYM
dti-2347	1	21	dti.2021.2347	dti.2021.2347	ADJ
dti-2347	1	22	original	original	ADJ
dti-2347	1	23	research	research	NOUN
dti-2347	1	24	article	article	NOUN
dti-2347	1	25	drug	drug	NOUN
dti-2347	1	26	target	target	NOUN
dti-2347	1	27	insights	insight	NOUN
dti-2347	1	28	issn	issn	VERB
dti-2347	1	29	1177	1177	NUM
dti-2347	1	30	-	-	SYM
dti-2347	1	31	3928	3928	NUM
dti-2347	1	32	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2347	1	33	©	©	PROPN
dti-2347	1	34	2021	2021	NUM
dti-2347	1	35	the	the	DET
dti-2347	1	36	authors	author	NOUN
dti-2347	1	37	.	.	PUNCT
dti-2347	2	1	this	this	DET
dti-2347	2	2	article	article	NOUN
dti-2347	2	3	is	be	AUX
dti-2347	2	4	published	publish	VERB
dti-2347	2	5	by	by	ADP
dti-2347	2	6	aboutscience	aboutscience	NOUN
dti-2347	2	7	and	and	CCONJ
dti-2347	2	8	licensed	license	VERB
dti-2347	2	9	under	under	ADP
dti-2347	2	10	creative	creative	ADJ
dti-2347	2	11	commons	common	NOUN
dti-2347	2	12	attribution	attribution	NOUN
dti-2347	2	13	-	-	PUNCT
dti-2347	2	14	noncommercial	noncommercial	ADJ
dti-2347	2	15	4.0	4.0	NUM
dti-2347	2	16	international	international	NOUN
dti-2347	2	17	(	(	PUNCT
dti-2347	2	18	cc	cc	NOUN
dti-2347	2	19	by	by	ADP
dti-2347	2	20	-	-	PUNCT
dti-2347	2	21	nc	nc	PROPN
dti-2347	2	22	4.0	4.0	NUM
dti-2347	2	23	)	)	PUNCT
dti-2347	2	24	.	.	PUNCT
dti-2347	3	1	commercial	commercial	ADJ
dti-2347	3	2	use	use	NOUN
dti-2347	3	3	is	be	AUX
dti-2347	3	4	not	not	PART
dti-2347	3	5	permitted	permit	VERB
dti-2347	3	6	and	and	CCONJ
dti-2347	3	7	is	be	AUX
dti-2347	3	8	subject	subject	ADJ
dti-2347	3	9	to	to	ADP
dti-2347	3	10	publisher	publisher	NOUN
dti-2347	3	11	’s	’s	PART
dti-2347	3	12	permissions	permission	NOUN
dti-2347	3	13	.	.	PUNCT
dti-2347	4	1	full	full	ADJ
dti-2347	4	2	information	information	NOUN
dti-2347	4	3	is	be	AUX
dti-2347	4	4	available	available	ADJ
dti-2347	4	5	at	at	ADP
dti-2347	4	6	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2347	4	7	hexarelin	hexarelin	PROPN
dti-2347	4	8	modulates	modulate	NOUN
dti-2347	4	9	lung	lung	NOUN
dti-2347	4	10	mechanics	mechanic	NOUN
dti-2347	4	11	,	,	PUNCT
dti-2347	4	12	inflammation	inflammation	NOUN
dti-2347	4	13	,	,	PUNCT
dti-2347	4	14	and	and	CCONJ
dti-2347	4	15	fibrosis	fibrosis	NOUN
dti-2347	4	16	in	in	ADP
dti-2347	4	17	acute	acute	ADJ
dti-2347	4	18	lung	lung	PROPN
dti-2347	4	19	injury	injury	PROPN
dti-2347	4	20	vanessa	vanessa	PROPN
dti-2347	4	21	zambelli1	zambelli1	PROPN
dti-2347	4	22	,	,	PUNCT
dti-2347	4	23	laura	laura	PROPN
dti-2347	4	24	rizzi1	rizzi1	PROPN
dti-2347	4	25	,	,	PUNCT
dti-2347	4	26	paolo	paolo	PROPN
dti-2347	4	27	delvecchio1	delvecchio1	PROPN
dti-2347	4	28	,	,	PUNCT
dti-2347	4	29	elena	elena	PROPN
dti-2347	4	30	bresciani1	bresciani1	PROPN
dti-2347	4	31	,	,	PUNCT
dti-2347	4	32	emanuele	emanuele	PROPN
dti-2347	4	33	rezoagli1	rezoagli1	PROPN
dti-2347	4	34	,	,	PUNCT
dti-2347	4	35	laura	laura	PROPN
dti-2347	4	36	molteni1	molteni1	PROPN
dti-2347	4	37	,	,	PUNCT
dti-2347	4	38	ramona	ramona	PROPN
dti-2347	4	39	meanti1	meanti1	PROPN
dti-2347	4	40	,	,	PUNCT
dti-2347	4	41	maria	maria	PROPN
dti-2347	4	42	serena	serena	PROPN
dti-2347	4	43	cuttin2	cuttin2	PROPN
dti-2347	4	44	,	,	PUNCT
dti-2347	4	45	giorgio	giorgio	PROPN
dti-2347	4	46	bovo2	bovo2	PROPN
dti-2347	4	47	,	,	PUNCT
dti-2347	4	48	silvia	silvia	PROPN
dti-2347	4	49	coco1	coco1	PROPN
dti-2347	4	50	,	,	PUNCT
dti-2347	4	51	robert	robert	PROPN
dti-2347	4	52	j	j	PROPN
dti-2347	4	53	omeljaniuk3	omeljaniuk3	PROPN
dti-2347	4	54	,	,	PUNCT
dti-2347	4	55	vittorio	vittorio	PROPN
dti-2347	4	56	locatelli1	locatelli1	PROPN
dti-2347	4	57	,	,	PUNCT
dti-2347	4	58	giacomo	giacomo	PROPN
dti-2347	4	59	bellani1	bellani1	PROPN
dti-2347	4	60	,	,	PUNCT
dti-2347	4	61	antonio	antonio	PROPN
dti-2347	4	62	torsello1	torsello1	NOUN
dti-2347	5	1	1department	1department	NUM
dti-2347	5	2	of	of	ADP
dti-2347	5	3	medicine	medicine	NOUN
dti-2347	5	4	and	and	CCONJ
dti-2347	5	5	surgery	surgery	NOUN
dti-2347	5	6	,	,	PUNCT
dti-2347	5	7	university	university	NOUN
dti-2347	5	8	of	of	ADP
dti-2347	5	9	milano	milano	PROPN
dti-2347	5	10	-	-	PUNCT
dti-2347	5	11	bicocca	bicocca	PROPN
dti-2347	5	12	,	,	PUNCT
dti-2347	5	13	monza	monza	PROPN
dti-2347	5	14	italy	italy	PROPN
dti-2347	5	15	2asst	2asst	NUM
dti-2347	5	16	vimercate	vimercate	NOUN
dti-2347	5	17	,	,	PUNCT
dti-2347	5	18	vimercate	vimercate	NOUN
dti-2347	5	19	italy	italy	PROPN
dti-2347	6	1	3department	3department	NUM
dti-2347	6	2	of	of	ADP
dti-2347	6	3	biology	biology	NOUN
dti-2347	6	4	,	,	PUNCT
dti-2347	6	5	lakehead	lakehead	PROPN
dti-2347	6	6	university	university	PROPN
dti-2347	6	7	,	,	PUNCT
dti-2347	6	8	thunder	thunder	NOUN
dti-2347	6	9	bay	bay	PROPN
dti-2347	6	10	,	,	PUNCT
dti-2347	6	11	ontario	ontario	PROPN
dti-2347	6	12	canada	canada	PROPN
dti-2347	6	13	vanessa	vanessa	PROPN
dti-2347	6	14	zambelli	zambelli	PROPN
dti-2347	6	15	and	and	CCONJ
dti-2347	6	16	laura	laura	PROPN
dti-2347	6	17	rizzi	rizzi	PROPN
dti-2347	6	18	contributed	contribute	VERB
dti-2347	6	19	equally	equally	ADV
dti-2347	6	20	to	to	ADP
dti-2347	6	21	this	this	DET
dti-2347	6	22	research	research	NOUN
dti-2347	6	23	.	.	PUNCT
dti-2347	7	1	abstract	abstract	ADJ
dti-2347	7	2	introduction	introduction	NOUN
dti-2347	7	3	:	:	PUNCT
dti-2347	7	4	acute	acute	ADJ
dti-2347	7	5	respiratory	respiratory	ADJ
dti-2347	7	6	distress	distress	NOUN
dti-2347	7	7	syndrome	syndrome	NOUN
dti-2347	7	8	(	(	PUNCT
dti-2347	7	9	ards	ard	NOUN
dti-2347	7	10	)	)	PUNCT
dti-2347	7	11	is	be	AUX
dti-2347	7	12	an	an	DET
dti-2347	7	13	acute	acute	ADJ
dti-2347	7	14	form	form	NOUN
dti-2347	7	15	of	of	ADP
dti-2347	7	16	diffuse	diffuse	PROPN
dti-2347	7	17	lung	lung	NOUN
dti-2347	7	18	injury	injury	NOUN
dti-2347	7	19	characterized	characterize	VERB
dti-2347	7	20	by	by	ADP
dti-2347	7	21	(	(	PUNCT
dti-2347	7	22	i	i	NOUN
dti-2347	7	23	)	)	PUNCT
dti-2347	7	24	an	an	DET
dti-2347	7	25	intense	intense	ADJ
dti-2347	7	26	inflammatory	inflammatory	ADJ
dti-2347	7	27	response	response	NOUN
dti-2347	7	28	,	,	PUNCT
dti-2347	7	29	(	(	PUNCT
dti-2347	7	30	ii	ii	NOUN
dti-2347	7	31	)	)	PUNCT
dti-2347	7	32	increased	increase	VERB
dti-2347	7	33	pulmonary	pulmonary	ADJ
dti-2347	7	34	vascular	vascular	NOUN
dti-2347	7	35	permeability	permeability	NOUN
dti-2347	7	36	,	,	PUNCT
dti-2347	7	37	and	and	CCONJ
dti-2347	7	38	(	(	PUNCT
dti-2347	7	39	iii	iii	X
dti-2347	7	40	)	)	PUNCT
dti-2347	7	41	the	the	DET
dti-2347	7	42	loss	loss	NOUN
dti-2347	7	43	of	of	ADP
dti-2347	7	44	respiratory	respiratory	ADJ
dti-2347	7	45	pulmonary	pulmonary	ADJ
dti-2347	7	46	tissue	tissue	NOUN
dti-2347	7	47	.	.	PUNCT
dti-2347	8	1	in	in	ADP
dti-2347	8	2	this	this	DET
dti-2347	8	3	article	article	NOUN
dti-2347	8	4	we	we	PRON
dti-2347	8	5	explore	explore	VERB
dti-2347	8	6	the	the	DET
dti-2347	8	7	therapeutic	therapeutic	ADJ
dti-2347	8	8	potential	potential	NOUN
dti-2347	8	9	of	of	ADP
dti-2347	8	10	hexarelin	hexarelin	PROPN
dti-2347	8	11	,	,	PUNCT
dti-2347	8	12	a	a	DET
dti-2347	8	13	synthetic	synthetic	ADJ
dti-2347	8	14	hexapeptide	hexapeptide	NOUN
dti-2347	8	15	growth	growth	NOUN
dti-2347	8	16	hormone	hormone	NOUN
dti-2347	8	17	secretagogue	secretagogue	NOUN
dti-2347	8	18	(	(	PUNCT
dti-2347	8	19	ghs	ghs	PROPN
dti-2347	8	20	)	)	PUNCT
dti-2347	8	21	,	,	PUNCT
dti-2347	8	22	in	in	ADP
dti-2347	8	23	an	an	DET
dti-2347	8	24	experimental	experimental	ADJ
dti-2347	8	25	model	model	NOUN
dti-2347	8	26	of	of	ADP
dti-2347	8	27	ards	ards	PROPN
dti-2347	8	28	.	.	PUNCT
dti-2347	9	1	hexarelin	hexarelin	PROPN
dti-2347	9	2	has	have	VERB
dti-2347	9	3	anti	anti	ADJ
dti-2347	9	4	-	-	ADJ
dti-2347	9	5	inflammatory	inflammatory	ADJ
dti-2347	9	6	properties	property	NOUN
dti-2347	9	7	and	and	CCONJ
dti-2347	9	8	demonstrates	demonstrate	VERB
dti-2347	9	9	cardiovascular	cardiovascular	ADJ
dti-2347	9	10	-	-	PUNCT
dti-2347	9	11	protective	protective	ADJ
dti-2347	9	12	activities	activity	NOUN
dti-2347	9	13	including	include	VERB
dti-2347	9	14	the	the	DET
dti-2347	9	15	inhibition	inhibition	NOUN
dti-2347	9	16	of	of	ADP
dti-2347	9	17	cardiomyocyte	cardiomyocyte	NOUN
dti-2347	9	18	apoptosis	apoptosis	NOUN
dti-2347	9	19	and	and	CCONJ
dti-2347	9	20	cardiac	cardiac	ADJ
dti-2347	9	21	fibrosis	fibrosis	NOUN
dti-2347	9	22	,	,	PUNCT
dti-2347	9	23	both	both	PRON
dti-2347	9	24	of	of	ADP
dti-2347	9	25	which	which	PRON
dti-2347	9	26	may	may	AUX
dti-2347	9	27	involve	involve	VERB
dti-2347	9	28	the	the	DET
dti-2347	9	29	angiotensin	angiotensin	NOUN
dti-2347	9	30	-	-	PUNCT
dti-2347	9	31	converting	convert	VERB
dti-2347	9	32	enzyme	enzyme	NOUN
dti-2347	9	33	(	(	PUNCT
dti-2347	9	34	ace	ace	NOUN
dti-2347	9	35	)	)	PUNCT
dti-2347	9	36	system	system	NOUN
dti-2347	9	37	.	.	PUNCT
dti-2347	10	1	methods	method	NOUN
dti-2347	10	2	:	:	PUNCT
dti-2347	10	3	in	in	ADP
dti-2347	10	4	our	our	PRON
dti-2347	10	5	experimental	experimental	ADJ
dti-2347	10	6	model	model	NOUN
dti-2347	10	7	,	,	PUNCT
dti-2347	10	8	ards	ard	NOUN
dti-2347	10	9	was	be	AUX
dti-2347	10	10	induced	induce	VERB
dti-2347	10	11	by	by	ADP
dti-2347	10	12	the	the	DET
dti-2347	10	13	instillation	instillation	NOUN
dti-2347	10	14	of	of	ADP
dti-2347	10	15	100	100	NUM
dti-2347	10	16	mm	mm	PROPN
dti-2347	10	17	hcl	hcl	PROPN
dti-2347	10	18	into	into	ADP
dti-2347	10	19	the	the	DET
dti-2347	10	20	right	right	ADJ
dti-2347	10	21	bronchus	bronchu	NOUN
dti-2347	10	22	;	;	PUNCT
dti-2347	10	23	these	these	DET
dti-2347	10	24	mice	mouse	NOUN
dti-2347	10	25	were	be	AUX
dti-2347	10	26	treated	treat	VERB
dti-2347	10	27	with	with	ADP
dti-2347	10	28	hexarelin	hexarelin	PROPN
dti-2347	10	29	(	(	PUNCT
dti-2347	10	30	320	320	NUM
dti-2347	10	31	μg	μg	PROPN
dti-2347	10	32	/	/	SYM
dti-2347	10	33	kg	kg	PROPN
dti-2347	10	34	,	,	PUNCT
dti-2347	10	35	ip	ip	NOUN
dti-2347	10	36	)	)	PUNCT
dti-2347	10	37	before	before	ADP
dti-2347	10	38	(	(	PUNCT
dti-2347	10	39	pre	pre	ADJ
dti-2347	10	40	)	)	PUNCT
dti-2347	10	41	or	or	CCONJ
dti-2347	10	42	after	after	ADP
dti-2347	10	43	(	(	PUNCT
dti-2347	10	44	post	post	NOUN
dti-2347	10	45	)	)	PUNCT
dti-2347	10	46	hcl	hcl	PROPN
dti-2347	10	47	challenge	challenge	NOUN
dti-2347	10	48	,	,	PUNCT
dti-2347	10	49	or	or	CCONJ
dti-2347	10	50	with	with	ADP
dti-2347	10	51	vehicle	vehicle	NOUN
dti-2347	10	52	.	.	PUNCT
dti-2347	11	1	respiratory	respiratory	ADJ
dti-2347	11	2	system	system	NOUN
dti-2347	11	3	compliance	compliance	NOUN
dti-2347	11	4	,	,	PUNCT
dti-2347	11	5	blood	blood	NOUN
dti-2347	11	6	gas	gas	NOUN
dti-2347	11	7	analysis	analysis	NOUN
dti-2347	11	8	,	,	PUNCT
dti-2347	11	9	and	and	CCONJ
dti-2347	11	10	differential	differential	ADJ
dti-2347	11	11	cell	cell	NOUN
dti-2347	11	12	counts	count	NOUN
dti-2347	11	13	in	in	ADP
dti-2347	11	14	a	a	DET
dti-2347	11	15	selective	selective	ADJ
dti-2347	11	16	bronchoalveolar	bronchoalveolar	ADJ
dti-2347	11	17	lavage	lavage	NOUN
dti-2347	11	18	(	(	PUNCT
dti-2347	11	19	bal	bal	ADJ
dti-2347	11	20	)	)	PUNCT
dti-2347	11	21	were	be	AUX
dti-2347	11	22	determined	determine	VERB
dti-2347	11	23	6	6	NUM
dti-2347	11	24	or	or	CCONJ
dti-2347	11	25	24	24	NUM
dti-2347	11	26	hours	hour	NOUN
dti-2347	11	27	after	after	ADP
dti-2347	11	28	hcl	hcl	PROPN
dti-2347	11	29	instillation	instillation	NOUN
dti-2347	11	30	.	.	PUNCT
dti-2347	12	1	in	in	ADP
dti-2347	12	2	an	an	DET
dti-2347	12	3	extended	extended	ADJ
dti-2347	12	4	study	study	NOUN
dti-2347	12	5	,	,	PUNCT
dti-2347	12	6	mice	mouse	NOUN
dti-2347	12	7	were	be	AUX
dti-2347	12	8	observed	observe	VERB
dti-2347	12	9	for	for	ADP
dti-2347	12	10	a	a	DET
dti-2347	12	11	subsequent	subsequent	ADJ
dti-2347	12	12	14	14	NUM
dti-2347	12	13	days	day	NOUN
dti-2347	12	14	in	in	ADP
dti-2347	12	15	order	order	NOUN
dti-2347	12	16	to	to	PART
dti-2347	12	17	assess	assess	VERB
dti-2347	12	18	lung	lung	NOUN
dti-2347	12	19	fibrosis	fibrosis	NOUN
dti-2347	12	20	.	.	PUNCT
dti-2347	13	1	results	result	NOUN
dti-2347	13	2	:	:	PUNCT
dti-2347	13	3	hexarelin	hexarelin	PROPN
dti-2347	13	4	induced	induce	VERB
dti-2347	13	5	a	a	DET
dti-2347	13	6	significant	significant	ADJ
dti-2347	13	7	improvement	improvement	NOUN
dti-2347	13	8	in	in	ADP
dti-2347	13	9	lung	lung	NOUN
dti-2347	13	10	compliance	compliance	NOUN
dti-2347	13	11	and	and	CCONJ
dti-2347	13	12	a	a	DET
dti-2347	13	13	reduction	reduction	NOUN
dti-2347	13	14	of	of	ADP
dti-2347	13	15	the	the	DET
dti-2347	13	16	number	number	NOUN
dti-2347	13	17	of	of	ADP
dti-2347	13	18	total	total	ADJ
dti-2347	13	19	immune	immune	ADJ
dti-2347	13	20	cells	cell	NOUN
dti-2347	13	21	in	in	ADP
dti-2347	13	22	bal	bal	PROPN
dti-2347	13	23	24	24	NUM
dti-2347	13	24	hours	hour	NOUN
dti-2347	13	25	after	after	ADP
dti-2347	13	26	hcl	hcl	PROPN
dti-2347	13	27	instillation	instillation	NOUN
dti-2347	13	28	,	,	PUNCT
dti-2347	13	29	accompanied	accompany	VERB
dti-2347	13	30	with	with	ADP
dti-2347	13	31	a	a	DET
dti-2347	13	32	lower	low	ADJ
dti-2347	13	33	recruitment	recruitment	NOUN
dti-2347	13	34	of	of	ADP
dti-2347	13	35	neutrophils	neutrophil	NOUN
dti-2347	13	36	compared	compare	VERB
dti-2347	13	37	with	with	ADP
dti-2347	13	38	the	the	DET
dti-2347	13	39	vehicle	vehicle	NOUN
dti-2347	13	40	group	group	NOUN
dti-2347	13	41	.	.	PUNCT
dti-2347	14	1	at	at	ADP
dti-2347	14	2	day	day	NOUN
dti-2347	14	3	14	14	NUM
dti-2347	14	4	,	,	PUNCT
dti-2347	14	5	hexarelin	hexarelin	PROPN
dti-2347	14	6	-	-	PUNCT
dti-2347	14	7	treated	treat	VERB
dti-2347	14	8	mice	mouse	NOUN
dti-2347	14	9	presented	present	VERB
dti-2347	14	10	with	with	ADP
dti-2347	14	11	less	less	ADJ
dti-2347	14	12	pulmonary	pulmonary	ADJ
dti-2347	14	13	collagen	collagen	NOUN
dti-2347	14	14	deposition	deposition	NOUN
dti-2347	14	15	compared	compare	VERB
dti-2347	14	16	with	with	ADP
dti-2347	14	17	vehicle	vehicle	NOUN
dti-2347	14	18	-	-	PUNCT
dti-2347	14	19	treated	treat	VERB
dti-2347	14	20	controls	control	NOUN
dti-2347	14	21	.	.	PUNCT
dti-2347	15	1	conclusions	conclusion	NOUN
dti-2347	15	2	:	:	PUNCT
dti-2347	15	3	our	our	PRON
dti-2347	15	4	data	datum	NOUN
dti-2347	15	5	suggest	suggest	VERB
dti-2347	15	6	that	that	SCONJ
dti-2347	15	7	hexarelin	hexarelin	PROPN
dti-2347	15	8	can	can	AUX
dti-2347	15	9	inhibit	inhibit	VERB
dti-2347	15	10	the	the	DET
dti-2347	15	11	early	early	ADJ
dti-2347	15	12	phase	phase	NOUN
dti-2347	15	13	of	of	ADP
dti-2347	15	14	the	the	DET
dti-2347	15	15	inflammatory	inflammatory	ADJ
dti-2347	15	16	response	response	NOUN
dti-2347	15	17	in	in	ADP
dti-2347	15	18	a	a	DET
dti-2347	15	19	murine	murine	ADJ
dti-2347	15	20	model	model	NOUN
dti-2347	15	21	of	of	ADP
dti-2347	15	22	hcl	hcl	PROPN
dti-2347	15	23	-	-	PUNCT
dti-2347	15	24	induced	induce	VERB
dti-2347	15	25	ards	ard	NOUN
dti-2347	15	26	,	,	PUNCT
dti-2347	15	27	thereby	thereby	ADV
dti-2347	15	28	blunting	blunt	VERB
dti-2347	15	29	lung	lung	NOUN
dti-2347	15	30	remodeling	remodeling	NOUN
dti-2347	15	31	processes	process	NOUN
dti-2347	15	32	and	and	CCONJ
dti-2347	15	33	fibrotic	fibrotic	ADJ
dti-2347	15	34	development	development	NOUN
dti-2347	15	35	.	.	PUNCT
dti-2347	16	1	keywords	keyword	NOUN
dti-2347	16	2	:	:	PUNCT
dti-2347	16	3	ards	ard	NOUN
dti-2347	16	4	,	,	PUNCT
dti-2347	16	5	ghs	ghs	PROPN
dti-2347	16	6	(	(	PUNCT
dti-2347	16	7	growth	growth	NOUN
dti-2347	16	8	hormone	hormone	NOUN
dti-2347	16	9	secretagogues	secretagogue	NOUN
dti-2347	16	10	)	)	PUNCT
dti-2347	16	11	,	,	PUNCT
dti-2347	16	12	hexarelin	hexarelin	PROPN
dti-2347	16	13	,	,	PUNCT
dti-2347	16	14	inflammation	inflammation	NOUN
dti-2347	16	15	,	,	PUNCT
dti-2347	16	16	lung	lung	NOUN
dti-2347	16	17	fibrosis	fibrosis	NOUN
dti-2347	16	18	received	receive	VERB
dti-2347	16	19	:	:	PUNCT
dti-2347	16	20	september	september	PROPN
dti-2347	16	21	24	24	NUM
dti-2347	16	22	,	,	PUNCT
dti-2347	16	23	2021	2021	NUM
dti-2347	16	24	accepted	accept	VERB
dti-2347	16	25	:	:	PUNCT
dti-2347	16	26	october	october	PROPN
dti-2347	16	27	20	20	NUM
dti-2347	16	28	,	,	PUNCT
dti-2347	16	29	2021	2021	NUM
dti-2347	16	30	published	publish	VERB
dti-2347	16	31	online	online	ADV
dti-2347	16	32	:	:	PUNCT
dti-2347	16	33	november	november	PROPN
dti-2347	16	34	27	27	NUM
dti-2347	16	35	,	,	PUNCT
dti-2347	16	36	2021	2021	NUM
dti-2347	16	37	corresponding	correspond	VERB
dti-2347	16	38	author	author	NOUN
dti-2347	16	39	:	:	PUNCT
dti-2347	16	40	laura	laura	PROPN
dti-2347	16	41	rizzi	rizzi	PROPN
dti-2347	16	42	school	school	PROPN
dti-2347	16	43	of	of	ADP
dti-2347	16	44	medicine	medicine	NOUN
dti-2347	16	45	and	and	CCONJ
dti-2347	16	46	surgery	surgery	NOUN
dti-2347	16	47	university	university	PROPN
dti-2347	16	48	of	of	ADP
dti-2347	16	49	milano	milano	PROPN
dti-2347	16	50	-	-	PUNCT
dti-2347	16	51	bicocca	bicocca	PROPN
dti-2347	16	52	via	via	ADP
dti-2347	16	53	cadore	cadore	ADJ
dti-2347	16	54	48	48	NUM
dti-2347	16	55	20900	20900	NUM
dti-2347	16	56	monza	monza	NOUN
dti-2347	16	57	(	(	PUNCT
dti-2347	16	58	mb	mb	NOUN
dti-2347	16	59	)	)	PUNCT
dti-2347	16	60	italy	italy	PROPN
dti-2347	16	61	laura.rizzi@unimib.it	laura.rizzi@unimib.it	X
dti-2347	16	62	most	most	ADV
dti-2347	16	63	common	common	ADJ
dti-2347	16	64	morphological	morphological	ADJ
dti-2347	16	65	symptom	symptom	NOUN
dti-2347	16	66	of	of	ADP
dti-2347	16	67	the	the	DET
dti-2347	16	68	acute	acute	ADJ
dti-2347	16	69	phase	phase	NOUN
dti-2347	16	70	of	of	ADP
dti-2347	16	71	ards	ard	NOUN
dti-2347	16	72	,	,	PUNCT
dti-2347	16	73	and	and	CCONJ
dti-2347	16	74	is	be	AUX
dti-2347	16	75	characterized	characterize	VERB
dti-2347	16	76	by	by	ADP
dti-2347	16	77	the	the	DET
dti-2347	16	78	influx	influx	NOUN
dti-2347	16	79	of	of	ADP
dti-2347	16	80	neutrophils	neutrophil	NOUN
dti-2347	16	81	and	and	CCONJ
dti-2347	16	82	macrophages	macrophage	NOUN
dti-2347	16	83	into	into	ADP
dti-2347	16	84	alveoli	alveolus	NOUN
dti-2347	16	85	,	,	PUNCT
dti-2347	16	86	and	and	CCONJ
dti-2347	16	87	alteration	alteration	NOUN
dti-2347	16	88	of	of	ADP
dti-2347	16	89	the	the	DET
dti-2347	16	90	alveolar	alveolar	ADJ
dti-2347	16	91	epithelium	epithelium	NOUN
dti-2347	16	92	(	(	PUNCT
dti-2347	16	93	5	5	NUM
dti-2347	16	94	)	)	PUNCT
dti-2347	16	95	.	.	PUNCT
dti-2347	17	1	these	these	DET
dti-2347	17	2	alterations	alteration	NOUN
dti-2347	17	3	often	often	ADV
dti-2347	17	4	progress	progress	VERB
dti-2347	17	5	to	to	ADP
dti-2347	17	6	fibrotic	fibrotic	ADJ
dti-2347	17	7	development	development	NOUN
dti-2347	17	8	accompanied	accompany	VERB
dti-2347	17	9	by	by	ADP
dti-2347	17	10	a	a	DET
dti-2347	17	11	further	further	ADJ
dti-2347	17	12	decrease	decrease	NOUN
dti-2347	17	13	in	in	ADP
dti-2347	17	14	pulmonary	pulmonary	ADJ
dti-2347	17	15	compliance	compliance	NOUN
dti-2347	17	16	(	(	PUNCT
dti-2347	17	17	6	6	NUM
dti-2347	17	18	)	)	PUNCT
dti-2347	17	19	.	.	PUNCT
dti-2347	18	1	there	there	PRON
dti-2347	18	2	is	be	VERB
dti-2347	18	3	no	no	DET
dti-2347	18	4	documented	document	VERB
dti-2347	18	5	and	and	CCONJ
dti-2347	18	6	approved	approve	VERB
dti-2347	18	7	pharmacologic	pharmacologic	ADJ
dti-2347	18	8	treatment	treatment	NOUN
dti-2347	18	9	for	for	ADP
dti-2347	18	10	ards	ard	NOUN
dti-2347	18	11	.	.	PUNCT
dti-2347	19	1	hexarelin	hexarelin	PROPN
dti-2347	19	2	is	be	AUX
dti-2347	19	3	a	a	DET
dti-2347	19	4	synthetic	synthetic	ADJ
dti-2347	19	5	hexapeptide	hexapeptide	NOUN
dti-2347	19	6	that	that	PRON
dti-2347	19	7	has	have	AUX
dti-2347	19	8	already	already	ADV
dti-2347	19	9	shown	show	VERB
dti-2347	19	10	positive	positive	ADJ
dti-2347	19	11	effects	effect	NOUN
dti-2347	19	12	in	in	ADP
dti-2347	19	13	experimental	experimental	ADJ
dti-2347	19	14	models	model	NOUN
dti-2347	19	15	of	of	ADP
dti-2347	19	16	human	human	ADJ
dti-2347	19	17	pathologies	pathology	NOUN
dti-2347	19	18	such	such	ADJ
dti-2347	19	19	as	as	ADP
dti-2347	19	20	epilepsy	epilepsy	NOUN
dti-2347	19	21	and	and	CCONJ
dti-2347	19	22	cachexia	cachexia	NOUN
dti-2347	19	23	(	(	PUNCT
dti-2347	19	24	7	7	NUM
dti-2347	19	25	-	-	SYM
dti-2347	19	26	11	11	NUM
dti-2347	19	27	)	)	PUNCT
dti-2347	19	28	.	.	PUNCT
dti-2347	20	1	in	in	ADP
dti-2347	20	2	particular	particular	ADJ
dti-2347	20	3	,	,	PUNCT
dti-2347	20	4	hexarelin	hexarelin	PROPN
dti-2347	20	5	reduced	reduce	VERB
dti-2347	20	6	cardiac	cardiac	ADJ
dti-2347	20	7	fibrosis	fibrosis	NOUN
dti-2347	20	8	in	in	ADP
dti-2347	20	9	experimental	experimental	ADJ
dti-2347	20	10	models	model	NOUN
dti-2347	20	11	of	of	ADP
dti-2347	20	12	myocardial	myocardial	ADJ
dti-2347	20	13	infarction	infarction	NOUN
dti-2347	20	14	(	(	PUNCT
dti-2347	20	15	12	12	NUM
dti-2347	20	16	)	)	PUNCT
dti-2347	20	17	.	.	PUNCT
dti-2347	21	1	furthermore	furthermore	ADV
dti-2347	21	2	,	,	PUNCT
dti-2347	21	3	we	we	PRON
dti-2347	21	4	previously	previously	ADV
dti-2347	21	5	demonstrated	demonstrate	VERB
dti-2347	21	6	that	that	SCONJ
dti-2347	21	7	the	the	DET
dti-2347	21	8	protective	protective	ADJ
dti-2347	21	9	effects	effect	NOUN
dti-2347	21	10	of	of	ADP
dti-2347	21	11	hexarelin	hexarelin	PROPN
dti-2347	21	12	on	on	ADP
dti-2347	21	13	the	the	DET
dti-2347	21	14	cardiovascular	cardiovascular	ADJ
dti-2347	21	15	system	system	NOUN
dti-2347	21	16	could	could	AUX
dti-2347	21	17	be	be	AUX
dti-2347	21	18	mediated	mediate	VERB
dti-2347	21	19	by	by	ADP
dti-2347	21	20	its	its	PRON
dti-2347	21	21	interaction	interaction	NOUN
dti-2347	21	22	with	with	ADP
dti-2347	21	23	the	the	DET
dti-2347	21	24	angiotensin	angiotensin	NOUN
dti-2347	21	25	-	-	PUNCT
dti-2347	21	26	converting	convert	VERB
dti-2347	21	27	enzyme	enzyme	NOUN
dti-2347	21	28	(	(	PUNCT
dti-2347	21	29	ace	ace	NOUN
dti-2347	21	30	)	)	PUNCT
dti-2347	21	31	system	system	NOUN
dti-2347	21	32	(	(	PUNCT
dti-2347	21	33	13	13	NUM
dti-2347	21	34	)	)	PUNCT
dti-2347	21	35	.	.	PUNCT
dti-2347	22	1	modulation	modulation	NOUN
dti-2347	22	2	of	of	ADP
dti-2347	22	3	ace	ace	NOUN
dti-2347	22	4	activity	activity	NOUN
dti-2347	22	5	associated	associate	VERB
dti-2347	22	6	with	with	ADP
dti-2347	22	7	the	the	DET
dti-2347	22	8	reduction	reduction	NOUN
dti-2347	22	9	of	of	ADP
dti-2347	22	10	angiotensin	angiotensin	NOUN
dti-2347	22	11	ii	ii	PROPN
dti-2347	22	12	synthesis	synthesis	NOUN
dti-2347	22	13	may	may	AUX
dti-2347	22	14	also	also	ADV
dti-2347	22	15	be	be	AUX
dti-2347	22	16	involved	involve	VERB
dti-2347	22	17	with	with	ADP
dti-2347	22	18	reduced	reduced	ADJ
dti-2347	22	19	fibrosis	fibrosis	NOUN
dti-2347	22	20	development	development	NOUN
dti-2347	22	21	in	in	ADP
dti-2347	22	22	the	the	DET
dti-2347	22	23	lung	lung	NOUN
dti-2347	22	24	(	(	PUNCT
dti-2347	22	25	14	14	NUM
dti-2347	22	26	)	)	PUNCT
dti-2347	22	27	.	.	PUNCT
dti-2347	23	1	in	in	ADP
dti-2347	23	2	this	this	DET
dti-2347	23	3	study	study	NOUN
dti-2347	23	4	we	we	PRON
dti-2347	23	5	have	have	AUX
dti-2347	23	6	applied	apply	VERB
dti-2347	23	7	our	our	PRON
dti-2347	23	8	validated	validate	VERB
dti-2347	23	9	experimental	experimental	ADJ
dti-2347	23	10	model	model	NOUN
dti-2347	23	11	of	of	ADP
dti-2347	23	12	unilateral	unilateral	ADJ
dti-2347	23	13	acid	acid	NOUN
dti-2347	23	14	aspiration	aspiration	NOUN
dti-2347	23	15	lung	lung	NOUN
dti-2347	23	16	injury	injury	NOUN
dti-2347	23	17	(	(	PUNCT
dti-2347	23	18	16	16	NUM
dti-2347	23	19	)	)	PUNCT
dti-2347	23	20	to	to	PART
dti-2347	23	21	test	test	VERB
dti-2347	23	22	specific	specific	ADJ
dti-2347	23	23	growth	growth	NOUN
dti-2347	23	24	hormone	hormone	NOUN
dti-2347	23	25	secretagogues	secretagogue	NOUN
dti-2347	23	26	(	(	PUNCT
dti-2347	23	27	ghs	gh	NOUN
dti-2347	23	28	)	)	PUNCT
dti-2347	23	29	as	as	SCONJ
dti-2347	23	30	potential	potential	ADJ
dti-2347	23	31	introduction	introduction	NOUN
dti-2347	23	32	acute	acute	ADJ
dti-2347	23	33	respiratory	respiratory	ADJ
dti-2347	23	34	distress	distress	NOUN
dti-2347	23	35	syndrome	syndrome	NOUN
dti-2347	23	36	(	(	PUNCT
dti-2347	23	37	ards	ard	NOUN
dti-2347	23	38	)	)	PUNCT
dti-2347	23	39	is	be	AUX
dti-2347	23	40	often	often	ADV
dti-2347	23	41	underrecognized	underrecognized	ADJ
dti-2347	23	42	and	and	CCONJ
dti-2347	23	43	undertreated	undertreate	VERB
dti-2347	23	44	,	,	PUNCT
dti-2347	23	45	thereby	thereby	ADV
dti-2347	23	46	contributing	contribute	VERB
dti-2347	23	47	to	to	ADP
dti-2347	23	48	a	a	DET
dti-2347	23	49	high	high	ADJ
dti-2347	23	50	mortality	mortality	NOUN
dti-2347	23	51	rate	rate	NOUN
dti-2347	23	52	(	(	PUNCT
dti-2347	23	53	1	1	NUM
dti-2347	23	54	-	-	SYM
dti-2347	23	55	3	3	NUM
dti-2347	23	56	)	)	PUNCT
dti-2347	23	57	.	.	PUNCT
dti-2347	24	1	ards	ards	PROPN
dti-2347	24	2	constitutes	constitute	VERB
dti-2347	24	3	an	an	DET
dti-2347	24	4	acute	acute	ADJ
dti-2347	24	5	lung	lung	NOUN
dti-2347	24	6	injury	injury	NOUN
dti-2347	24	7	associated	associate	VERB
dti-2347	24	8	with	with	ADP
dti-2347	24	9	(	(	PUNCT
dti-2347	24	10	i	i	NOUN
dti-2347	24	11	)	)	PUNCT
dti-2347	24	12	an	an	DET
dti-2347	24	13	intense	intense	ADJ
dti-2347	24	14	inflammatory	inflammatory	ADJ
dti-2347	24	15	response	response	NOUN
dti-2347	24	16	,	,	PUNCT
dti-2347	24	17	(	(	PUNCT
dti-2347	24	18	ii	ii	NOUN
dti-2347	24	19	)	)	PUNCT
dti-2347	24	20	increased	increase	VERB
dti-2347	24	21	pulmonary	pulmonary	ADJ
dti-2347	24	22	vascular	vascular	NOUN
dti-2347	24	23	permeability	permeability	NOUN
dti-2347	24	24	,	,	PUNCT
dti-2347	24	25	and	and	CCONJ
dti-2347	24	26	(	(	PUNCT
dti-2347	24	27	iii	iii	X
dti-2347	24	28	)	)	PUNCT
dti-2347	24	29	the	the	DET
dti-2347	24	30	loss	loss	NOUN
dti-2347	24	31	of	of	ADP
dti-2347	24	32	aerated	aerate	VERB
dti-2347	24	33	lung	lung	NOUN
dti-2347	24	34	tissue	tissue	NOUN
dti-2347	24	35	(	(	PUNCT
dti-2347	24	36	4	4	NUM
dti-2347	24	37	)	)	PUNCT
dti-2347	24	38	.	.	PUNCT
dti-2347	25	1	diffuse	diffuse	VERB
dti-2347	25	2	alveolar	alveolar	ADJ
dti-2347	25	3	damage	damage	NOUN
dti-2347	25	4	is	be	AUX
dti-2347	25	5	the	the	DET
dti-2347	25	6	https://doi.org/10.33393/dti.2021.2347	https://doi.org/10.33393/dti.2021.2347	ADJ
dti-2347	25	7	https://creativecommons.org/licenses/by-nc/4.0/legalcode	https://creativecommons.org/licenses/by-nc/4.0/legalcode	NOUN
dti-2347	25	8	mailto:laura.rizzi@unimib.it	mailto:laura.rizzi@unimib.it	PROPN
dti-2347	25	9	zambelli	zambelli	PROPN
dti-2347	25	10	et	et	PROPN
dti-2347	25	11	al	al	PROPN
dti-2347	25	12	drug	drug	PROPN
dti-2347	25	13	target	target	NOUN
dti-2347	25	14	insights	insight	NOUN
dti-2347	25	15	2021	2021	NUM
dti-2347	25	16	;	;	PUNCT
dti-2347	25	17	15	15	NUM
dti-2347	25	18	:	:	SYM
dti-2347	25	19	27	27	NUM
dti-2347	25	20	©	©	PROPN
dti-2347	25	21	2021	2021	NUM
dti-2347	25	22	the	the	DET
dti-2347	25	23	authors	author	NOUN
dti-2347	25	24	.	.	PUNCT
dti-2347	26	1	published	publish	VERB
dti-2347	26	2	by	by	ADP
dti-2347	26	3	aboutscience	aboutscience	NOUN
dti-2347	26	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2347	26	5	adjunctive	adjunctive	ADJ
dti-2347	26	6	therapeutic	therapeutic	ADJ
dti-2347	26	7	tools	tool	NOUN
dti-2347	26	8	for	for	ADP
dti-2347	26	9	ards	ard	NOUN
dti-2347	26	10	.	.	PUNCT
dti-2347	27	1	among	among	ADP
dti-2347	27	2	ghs	ghs	PROPN
dti-2347	27	3	,	,	PUNCT
dti-2347	27	4	ghrelin	ghrelin	NOUN
dti-2347	27	5	has	have	AUX
dti-2347	27	6	demonstrated	demonstrate	VERB
dti-2347	27	7	anti	anti	ADJ
dti-2347	27	8	-	-	ADJ
dti-2347	27	9	inflammatory	inflammatory	ADJ
dti-2347	27	10	properties	property	NOUN
dti-2347	27	11	including	include	VERB
dti-2347	27	12	inhibition	inhibition	NOUN
dti-2347	27	13	of	of	ADP
dti-2347	27	14	cardiac	cardiac	ADJ
dti-2347	27	15	fibrosis	fibrosis	NOUN
dti-2347	27	16	(	(	PUNCT
dti-2347	27	17	15	15	NUM
dti-2347	27	18	)	)	PUNCT
dti-2347	27	19	.	.	PUNCT
dti-2347	28	1	consequently	consequently	ADV
dti-2347	28	2	,	,	PUNCT
dti-2347	28	3	this	this	DET
dti-2347	28	4	study	study	NOUN
dti-2347	28	5	examined	examine	VERB
dti-2347	28	6	the	the	DET
dti-2347	28	7	potential	potential	ADJ
dti-2347	28	8	utility	utility	NOUN
dti-2347	28	9	of	of	ADP
dti-2347	28	10	hexarelin	hexarelin	PROPN
dti-2347	28	11	in	in	ADP
dti-2347	28	12	the	the	DET
dti-2347	28	13	treatment	treatment	NOUN
dti-2347	28	14	of	of	ADP
dti-2347	28	15	ards	ard	NOUN
dti-2347	28	16	in	in	ADP
dti-2347	28	17	our	our	PRON
dti-2347	28	18	murine	murine	ADJ
dti-2347	28	19	model	model	NOUN
dti-2347	28	20	.	.	PUNCT
dti-2347	29	1	the	the	DET
dti-2347	29	2	aim	aim	NOUN
dti-2347	29	3	of	of	ADP
dti-2347	29	4	this	this	DET
dti-2347	29	5	research	research	NOUN
dti-2347	29	6	was	be	AUX
dti-2347	29	7	to	to	PART
dti-2347	29	8	ascertain	ascertain	VERB
dti-2347	29	9	whether	whether	SCONJ
dti-2347	29	10	hexarelin	hexarelin	PROPN
dti-2347	29	11	could	could	AUX
dti-2347	29	12	have	have	VERB
dti-2347	29	13	a	a	DET
dti-2347	29	14	potential	potential	ADJ
dti-2347	29	15	therapeutic	therapeutic	ADJ
dti-2347	29	16	use	use	NOUN
dti-2347	29	17	to	to	PART
dti-2347	29	18	antagonize	antagonize	VERB
dti-2347	29	19	the	the	DET
dti-2347	29	20	inflammatory	inflammatory	ADJ
dti-2347	29	21	response	response	NOUN
dti-2347	29	22	and	and	CCONJ
dti-2347	29	23	the	the	DET
dti-2347	29	24	lung	lung	NOUN
dti-2347	29	25	fibrosis	fibrosis	NOUN
dti-2347	29	26	induced	induce	VERB
dti-2347	29	27	by	by	ADP
dti-2347	29	28	unilateral	unilateral	ADJ
dti-2347	29	29	acid	acid	NOUN
dti-2347	29	30	aspiration	aspiration	NOUN
dti-2347	29	31	in	in	ADP
dti-2347	29	32	mice	mouse	NOUN
dti-2347	29	33	.	.	PUNCT
dti-2347	30	1	the	the	DET
dti-2347	30	2	results	result	NOUN
dti-2347	30	3	of	of	ADP
dti-2347	30	4	the	the	DET
dti-2347	30	5	present	present	ADJ
dti-2347	30	6	research	research	NOUN
dti-2347	30	7	demonstrate	demonstrate	VERB
dti-2347	30	8	that	that	SCONJ
dti-2347	30	9	hexarelin	hexarelin	PROPN
dti-2347	30	10	treatment	treatment	NOUN
dti-2347	30	11	reduces	reduce	VERB
dti-2347	30	12	the	the	DET
dti-2347	30	13	development	development	NOUN
dti-2347	30	14	of	of	ADP
dti-2347	30	15	lung	lung	NOUN
dti-2347	30	16	fibrosis	fibrosis	NOUN
dti-2347	30	17	and	and	CCONJ
dti-2347	30	18	further	far	ADV
dti-2347	30	19	suggests	suggest	VERB
dti-2347	30	20	that	that	SCONJ
dti-2347	30	21	specific	specific	ADJ
dti-2347	30	22	synthetic	synthetic	ADJ
dti-2347	30	23	ghs	gh	NOUN
dti-2347	30	24	could	could	AUX
dti-2347	30	25	be	be	AUX
dti-2347	30	26	developed	develop	VERB
dti-2347	30	27	in	in	ADP
dti-2347	30	28	order	order	NOUN
dti-2347	30	29	to	to	PART
dti-2347	30	30	modulate	modulate	VERB
dti-2347	30	31	lung	lung	NOUN
dti-2347	30	32	and	and	CCONJ
dti-2347	30	33	cardiac	cardiac	ADJ
dti-2347	30	34	fibrosis	fibrosis	NOUN
dti-2347	30	35	such	such	ADJ
dti-2347	30	36	as	as	ADP
dti-2347	30	37	those	those	PRON
dti-2347	30	38	associated	associate	VERB
dti-2347	30	39	with	with	ADP
dti-2347	30	40	covid-19	covid-19	PROPN
dti-2347	30	41	infections	infection	NOUN
dti-2347	30	42	.	.	PUNCT
dti-2347	31	1	materials	material	NOUN
dti-2347	31	2	and	and	CCONJ
dti-2347	31	3	methods	method	NOUN
dti-2347	31	4	animals	animal	NOUN
dti-2347	31	5	male	male	ADJ
dti-2347	31	6	c57	c57	NOUN
dti-2347	31	7	/	/	SYM
dti-2347	31	8	bl6j	bl6j	NOUN
dti-2347	31	9	mice	mouse	NOUN
dti-2347	31	10	(	(	PUNCT
dti-2347	31	11	23	23	NUM
dti-2347	31	12	-	-	SYM
dti-2347	31	13	25	25	NUM
dti-2347	31	14	g	g	NOUN
dti-2347	31	15	;	;	PUNCT
dti-2347	31	16	harlan	harlan	PROPN
dti-2347	31	17	laboratories	laboratories	PROPN
dti-2347	31	18	,	,	PUNCT
dti-2347	31	19	udine	udine	PROPN
dti-2347	31	20	,	,	PUNCT
dti-2347	31	21	italy	italy	PROPN
dti-2347	31	22	)	)	PUNCT
dti-2347	31	23	were	be	AUX
dti-2347	31	24	used	use	VERB
dti-2347	31	25	in	in	ADP
dti-2347	31	26	this	this	DET
dti-2347	31	27	experimental	experimental	ADJ
dti-2347	31	28	study	study	NOUN
dti-2347	31	29	.	.	PUNCT
dti-2347	32	1	animals	animal	NOUN
dti-2347	32	2	were	be	AUX
dti-2347	32	3	housed	house	VERB
dti-2347	32	4	five	five	NUM
dti-2347	32	5	per	per	ADP
dti-2347	32	6	cage	cage	NOUN
dti-2347	32	7	in	in	ADP
dti-2347	32	8	a	a	DET
dti-2347	32	9	limited	limited	ADJ
dti-2347	32	10	access	access	NOUN
dti-2347	32	11	animal	animal	NOUN
dti-2347	32	12	facility	facility	NOUN
dti-2347	32	13	,	,	PUNCT
dti-2347	32	14	with	with	ADP
dti-2347	32	15	the	the	DET
dti-2347	32	16	room	room	NOUN
dti-2347	32	17	temperature	temperature	NOUN
dti-2347	32	18	at	at	ADP
dti-2347	32	19	20	20	NUM
dti-2347	32	20	±	±	NUM
dti-2347	32	21	2	2	NUM
dti-2347	32	22	°	°	ADP
dti-2347	32	23	c	c	NOUN
dti-2347	32	24	and	and	CCONJ
dti-2347	32	25	the	the	DET
dti-2347	32	26	relative	relative	ADJ
dti-2347	32	27	humidity	humidity	NOUN
dti-2347	32	28	set	set	VERB
dti-2347	32	29	at	at	ADP
dti-2347	32	30	55	55	NUM
dti-2347	32	31	±	±	NUM
dti-2347	32	32	10	10	NUM
dti-2347	32	33	%	%	NOUN
dti-2347	32	34	.	.	PUNCT
dti-2347	33	1	artificial	artificial	ADJ
dti-2347	33	2	lighting	lighting	NOUN
dti-2347	33	3	provided	provide	VERB
dti-2347	33	4	a	a	DET
dti-2347	33	5	12	12	NUM
dti-2347	33	6	h	h	NOUN
dti-2347	33	7	light/12	light/12	PROPN
dti-2347	33	8	h	h	NOUN
dti-2347	34	1	dark	dark	ADJ
dti-2347	34	2	(	(	PUNCT
dti-2347	34	3	7	7	NUM
dti-2347	34	4	am	am	NOUN
dti-2347	34	5	to	to	ADP
dti-2347	34	6	7	7	NUM
dti-2347	34	7	pm	pm	NOUN
dti-2347	34	8	)	)	PUNCT
dti-2347	34	9	cycle	cycle	NOUN
dti-2347	34	10	.	.	PUNCT
dti-2347	35	1	the	the	DET
dti-2347	35	2	general	general	ADJ
dti-2347	35	3	condition	condition	NOUN
dti-2347	35	4	of	of	ADP
dti-2347	35	5	the	the	DET
dti-2347	35	6	animals	animal	NOUN
dti-2347	35	7	before	before	SCONJ
dti-2347	35	8	the	the	DET
dti-2347	35	9	experiment	experiment	NOUN
dti-2347	35	10	was	be	AUX
dti-2347	35	11	assessed	assess	VERB
dti-2347	35	12	daily	daily	ADV
dti-2347	35	13	.	.	PUNCT
dti-2347	36	1	the	the	DET
dti-2347	36	2	care	care	NOUN
dti-2347	36	3	and	and	CCONJ
dti-2347	36	4	husbandry	husbandry	NOUN
dti-2347	36	5	of	of	ADP
dti-2347	36	6	animals	animal	NOUN
dti-2347	36	7	were	be	AUX
dti-2347	36	8	in	in	ADP
dti-2347	36	9	conformity	conformity	NOUN
dti-2347	36	10	with	with	ADP
dti-2347	36	11	the	the	DET
dti-2347	36	12	institutional	institutional	ADJ
dti-2347	36	13	guidelines	guideline	NOUN
dti-2347	36	14	in	in	ADP
dti-2347	36	15	compliance	compliance	NOUN
dti-2347	36	16	with	with	ADP
dti-2347	36	17	italian	italian	ADJ
dti-2347	36	18	and	and	CCONJ
dti-2347	36	19	european	european	ADJ
dti-2347	36	20	laws	law	NOUN
dti-2347	36	21	and	and	CCONJ
dti-2347	36	22	policies	policy	NOUN
dti-2347	36	23	.	.	PUNCT
dti-2347	37	1	the	the	DET
dti-2347	37	2	animal	animal	NOUN
dti-2347	37	3	study	study	NOUN
dti-2347	37	4	was	be	AUX
dti-2347	37	5	reviewed	review	VERB
dti-2347	37	6	and	and	CCONJ
dti-2347	37	7	approved	approve	VERB
dti-2347	37	8	by	by	ADP
dti-2347	37	9	the	the	DET
dti-2347	37	10	italian	italian	PROPN
dti-2347	37	11	ministry	ministry	PROPN
dti-2347	37	12	of	of	ADP
dti-2347	37	13	health	health	PROPN
dti-2347	37	14	(	(	PUNCT
dti-2347	37	15	591/2017	591/2017	NUM
dti-2347	37	16	-	-	PUNCT
dti-2347	37	17	pr	pr	NOUN
dti-2347	37	18	)	)	PUNCT
dti-2347	37	19	and	and	CCONJ
dti-2347	37	20	by	by	ADP
dti-2347	37	21	the	the	DET
dti-2347	37	22	animal	animal	NOUN
dti-2347	37	23	care	care	NOUN
dti-2347	37	24	unit	unit	NOUN
dti-2347	37	25	of	of	ADP
dti-2347	37	26	the	the	DET
dti-2347	37	27	university	university	PROPN
dti-2347	37	28	of	of	ADP
dti-2347	37	29	milano	milano	PROPN
dti-2347	37	30	-	-	PUNCT
dti-2347	37	31	bicocca	bicocca	PROPN
dti-2347	37	32	,	,	PUNCT
dti-2347	37	33	monza	monza	PROPN
dti-2347	37	34	,	,	PUNCT
dti-2347	37	35	italy	italy	PROPN
dti-2347	37	36	.	.	PUNCT
dti-2347	38	1	in	in	ADP
dti-2347	38	2	full	full	ADJ
dti-2347	38	3	respect	respect	NOUN
dti-2347	38	4	of	of	ADP
dti-2347	38	5	the	the	DET
dti-2347	38	6	reduction	reduction	NOUN
dti-2347	38	7	principle	principle	NOUN
dti-2347	38	8	of	of	ADP
dti-2347	38	9	the	the	DET
dti-2347	38	10	3rs	3rs	NOUN
dti-2347	38	11	,	,	PUNCT
dti-2347	38	12	the	the	DET
dti-2347	38	13	number	number	NOUN
dti-2347	38	14	of	of	ADP
dti-2347	38	15	animals	animal	NOUN
dti-2347	38	16	/	/	SYM
dti-2347	38	17	groups	group	NOUN
dti-2347	38	18	selected	select	VERB
dti-2347	38	19	was	be	AUX
dti-2347	38	20	to	to	PART
dti-2347	38	21	obtain	obtain	VERB
dti-2347	38	22	reliable	reliable	ADJ
dti-2347	38	23	results	result	NOUN
dti-2347	38	24	and	and	CCONJ
dti-2347	38	25	enough	enough	ADJ
dti-2347	38	26	biological	biological	ADJ
dti-2347	38	27	samples	sample	NOUN
dti-2347	38	28	to	to	PART
dti-2347	38	29	perform	perform	VERB
dti-2347	38	30	the	the	DET
dti-2347	38	31	analysis	analysis	NOUN
dti-2347	38	32	planned	plan	VERB
dti-2347	38	33	.	.	PUNCT
dti-2347	39	1	chemicals	chemical	NOUN
dti-2347	39	2	hexarelin	hexarelin	PROPN
dti-2347	39	3	(	(	PUNCT
dti-2347	39	4	his	his	PRON
dti-2347	39	5	/	/	SYM
dti-2347	39	6	d-2	d-2	NOUN
dti-2347	39	7	-	-	PUNCT
dti-2347	39	8	methyl	methyl	NOUN
dti-2347	39	9	-	-	PUNCT
dti-2347	39	10	trp	trp	PROPN
dti-2347	39	11	/	/	SYM
dti-2347	39	12	ala	ala	PROPN
dti-2347	39	13	/	/	SYM
dti-2347	39	14	trp	trp	PROPN
dti-2347	39	15	/	/	SYM
dti-2347	39	16	d	d	PROPN
dti-2347	39	17	-	-	PUNCT
dti-2347	39	18	phe	phe	NOUN
dti-2347	39	19	/	/	SYM
dti-2347	39	20	lys	lys	PROPN
dti-2347	39	21	-	-	PUNCT
dti-2347	39	22	nh2	nh2	NOUN
dti-2347	39	23	)	)	PUNCT
dti-2347	39	24	(	(	PUNCT
dti-2347	39	25	sigma	sigma	PROPN
dti-2347	39	26	-	-	PUNCT
dti-2347	39	27	aldrich	aldrich	NOUN
dti-2347	39	28	)	)	PUNCT
dti-2347	39	29	was	be	AUX
dti-2347	39	30	given	give	VERB
dti-2347	39	31	at	at	ADP
dti-2347	39	32	a	a	DET
dti-2347	39	33	dose	dose	NOUN
dti-2347	39	34	of	of	ADP
dti-2347	39	35	320	320	NUM
dti-2347	39	36	μg	μg	PROPN
dti-2347	39	37	/	/	SYM
dti-2347	39	38	kg	kg	PROPN
dti-2347	39	39	body	body	NOUN
dti-2347	39	40	weight	weight	NOUN
dti-2347	39	41	,	,	PUNCT
dti-2347	39	42	according	accord	VERB
dti-2347	39	43	to	to	ADP
dti-2347	39	44	the	the	DET
dti-2347	39	45	assigned	assign	VERB
dti-2347	39	46	treatment	treatment	NOUN
dti-2347	39	47	group	group	NOUN
dti-2347	39	48	(	(	PUNCT
dti-2347	39	49	see	see	VERB
dti-2347	39	50	below	below	ADV
dti-2347	39	51	)	)	PUNCT
dti-2347	39	52	.	.	PUNCT
dti-2347	40	1	experimental	experimental	ADJ
dti-2347	40	2	protocol	protocol	NOUN
dti-2347	40	3	mice	mouse	NOUN
dti-2347	40	4	were	be	AUX
dti-2347	40	5	anesthetized	anesthetize	VERB
dti-2347	40	6	with	with	ADP
dti-2347	40	7	ketamine	ketamine	PROPN
dti-2347	40	8	(	(	PUNCT
dti-2347	40	9	80	80	NUM
dti-2347	40	10	mg	mg	PROPN
dti-2347	40	11	/	/	SYM
dti-2347	40	12	kg	kg	PROPN
dti-2347	40	13	,	,	PUNCT
dti-2347	40	14	ip	ip	NOUN
dti-2347	40	15	)	)	PUNCT
dti-2347	40	16	(	(	PUNCT
dti-2347	40	17	ketavet	ketavet	NOUN
dti-2347	40	18	100	100	NUM
dti-2347	40	19	;	;	PUNCT
dti-2347	40	20	intervet	intervet	NOUN
dti-2347	40	21	productions	production	NOUN
dti-2347	40	22	)	)	PUNCT
dti-2347	40	23	and	and	CCONJ
dti-2347	40	24	xylazine	xylazine	NOUN
dti-2347	40	25	(	(	PUNCT
dti-2347	40	26	4	4	NUM
dti-2347	40	27	mg	mg	NUM
dti-2347	40	28	/	/	SYM
dti-2347	40	29	kg	kg	PROPN
dti-2347	40	30	,	,	PUNCT
dti-2347	40	31	ip	ip	NOUN
dti-2347	40	32	)	)	PUNCT
dti-2347	40	33	(	(	PUNCT
dti-2347	40	34	rompun	rompun	NOUN
dti-2347	40	35	2	2	NUM
dti-2347	40	36	%	%	NOUN
dti-2347	40	37	;	;	PUNCT
dti-2347	40	38	bayer	bayer	NOUN
dti-2347	40	39	)	)	PUNCT
dti-2347	40	40	and	and	CCONJ
dti-2347	40	41	orotracheally	orotracheally	ADV
dti-2347	40	42	intubated	intubate	VERB
dti-2347	40	43	.	.	PUNCT
dti-2347	41	1	then	then	ADV
dti-2347	41	2	,	,	PUNCT
dti-2347	41	3	lung	lung	NOUN
dti-2347	41	4	injury	injury	NOUN
dti-2347	41	5	was	be	AUX
dti-2347	41	6	induced	induce	VERB
dti-2347	41	7	in	in	ADP
dti-2347	41	8	the	the	DET
dti-2347	41	9	right	right	ADJ
dti-2347	41	10	lung	lung	NOUN
dti-2347	41	11	as	as	SCONJ
dti-2347	41	12	described	describe	VERB
dti-2347	41	13	in	in	ADP
dti-2347	41	14	amigoni	amigoni	NOUN
dti-2347	41	15	et	et	PROPN
dti-2347	41	16	al	al	PROPN
dti-2347	41	17	(	(	PUNCT
dti-2347	41	18	16	16	NUM
dti-2347	41	19	)	)	PUNCT
dti-2347	41	20	.	.	PUNCT
dti-2347	42	1	the	the	DET
dti-2347	42	2	experimental	experimental	ADJ
dti-2347	42	3	protocol	protocol	NOUN
dti-2347	42	4	was	be	AUX
dti-2347	42	5	divided	divide	VERB
dti-2347	42	6	into	into	ADP
dti-2347	42	7	two	two	NUM
dti-2347	42	8	time	time	NOUN
dti-2347	42	9	points	point	NOUN
dti-2347	42	10	including	include	VERB
dti-2347	42	11	(	(	PUNCT
dti-2347	42	12	i	i	NOUN
dti-2347	42	13	)	)	PUNCT
dti-2347	42	14	the	the	DET
dti-2347	42	15	acute	acute	PROPN
dti-2347	42	16	ards	ard	NOUN
dti-2347	42	17	study	study	NOUN
dti-2347	42	18	,	,	PUNCT
dti-2347	42	19	in	in	ADP
dti-2347	42	20	which	which	PRON
dti-2347	42	21	animals	animal	NOUN
dti-2347	42	22	were	be	AUX
dti-2347	42	23	sacrificed	sacrifice	VERB
dti-2347	42	24	after	after	ADP
dti-2347	42	25	6	6	NUM
dti-2347	42	26	or	or	CCONJ
dti-2347	42	27	24	24	NUM
dti-2347	42	28	hours	hour	NOUN
dti-2347	42	29	following	follow	VERB
dti-2347	42	30	hcl	hcl	PROPN
dti-2347	42	31	instillation	instillation	NOUN
dti-2347	42	32	,	,	PUNCT
dti-2347	42	33	and	and	CCONJ
dti-2347	42	34	(	(	PUNCT
dti-2347	42	35	ii	ii	NOUN
dti-2347	42	36	)	)	PUNCT
dti-2347	42	37	the	the	DET
dti-2347	42	38	late	late	ADJ
dti-2347	42	39	ards	ard	NOUN
dti-2347	42	40	study	study	PROPN
dti-2347	42	41	,	,	PUNCT
dti-2347	42	42	with	with	ADP
dti-2347	42	43	sacrifice	sacrifice	NOUN
dti-2347	42	44	performed	perform	VERB
dti-2347	42	45	14	14	NUM
dti-2347	42	46	days	day	NOUN
dti-2347	42	47	after	after	ADP
dti-2347	42	48	hcl	hcl	PROPN
dti-2347	42	49	instillation	instillation	NOUN
dti-2347	42	50	.	.	PUNCT
dti-2347	43	1	in	in	ADP
dti-2347	43	2	the	the	DET
dti-2347	43	3	acute	acute	ADJ
dti-2347	43	4	ards	ard	NOUN
dti-2347	43	5	study	study	PROPN
dti-2347	43	6	,	,	PUNCT
dti-2347	43	7	mice	mouse	NOUN
dti-2347	43	8	were	be	AUX
dti-2347	43	9	assorted	assort	VERB
dti-2347	43	10	into	into	ADP
dti-2347	43	11	three	three	NUM
dti-2347	43	12	treatment	treatment	NOUN
dti-2347	43	13	groups	group	NOUN
dti-2347	43	14	:	:	PUNCT
dti-2347	43	15	–	–	PUNCT
dti-2347	43	16	vehicle	vehicle	NOUN
dti-2347	43	17	:	:	PUNCT
dti-2347	43	18	mice	mouse	NOUN
dti-2347	43	19	received	receive	VERB
dti-2347	43	20	sterile	sterile	ADJ
dti-2347	43	21	physiological	physiological	ADJ
dti-2347	43	22	saline	saline	NOUN
dti-2347	43	23	treatment	treatment	NOUN
dti-2347	43	24	(	(	PUNCT
dti-2347	43	25	100	100	NUM
dti-2347	43	26	µl	µl	ADP
dti-2347	43	27	,	,	PUNCT
dti-2347	43	28	ip	ip	NOUN
dti-2347	43	29	)	)	PUNCT
dti-2347	43	30	,	,	PUNCT
dti-2347	43	31	immediately	immediately	ADV
dti-2347	43	32	after	after	ADP
dti-2347	43	33	hcl	hcl	PROPN
dti-2347	43	34	challenge	challenge	NOUN
dti-2347	43	35	;	;	PUNCT
dti-2347	43	36	–	–	PUNCT
dti-2347	43	37	post	post	ADJ
dti-2347	43	38	-	-	ADJ
dti-2347	43	39	hex	hex	ADJ
dti-2347	43	40	:	:	PUNCT
dti-2347	43	41	mice	mouse	NOUN
dti-2347	43	42	received	receive	VERB
dti-2347	43	43	hexarelin	hexarelin	PROPN
dti-2347	43	44	(	(	PUNCT
dti-2347	43	45	320	320	NUM
dti-2347	43	46	μg	μg	PROPN
dti-2347	43	47	/	/	SYM
dti-2347	43	48	kg	kg	PROPN
dti-2347	43	49	,	,	PUNCT
dti-2347	43	50	ip	ip	ADJ
dti-2347	43	51	,	,	PUNCT
dti-2347	43	52	100	100	NUM
dti-2347	43	53	µl	µl	NOUN
dti-2347	43	54	)	)	PUNCT
dti-2347	43	55	,	,	PUNCT
dti-2347	43	56	immediately	immediately	ADV
dti-2347	43	57	after	after	ADP
dti-2347	43	58	hcl	hcl	PROPN
dti-2347	43	59	challenge	challenge	NOUN
dti-2347	43	60	;	;	PUNCT
dti-2347	43	61	–	–	PUNCT
dti-2347	43	62	pre	pre	ADJ
dti-2347	43	63	-	-	ADJ
dti-2347	43	64	hex	hex	ADJ
dti-2347	43	65	:	:	PUNCT
dti-2347	43	66	mice	mouse	NOUN
dti-2347	43	67	received	receive	VERB
dti-2347	43	68	hexarelin	hexarelin	PROPN
dti-2347	43	69	(	(	PUNCT
dti-2347	43	70	320	320	NUM
dti-2347	43	71	μg	μg	NOUN
dti-2347	43	72	/	/	SYM
dti-2347	43	73	kg	kg	PROPN
dti-2347	43	74	ip	ip	NOUN
dti-2347	43	75	,	,	PUNCT
dti-2347	43	76	100	100	NUM
dti-2347	43	77	µl	µl	NOUN
dti-2347	43	78	)	)	PUNCT
dti-2347	43	79	2	2	NUM
dti-2347	43	80	and	and	CCONJ
dti-2347	43	81	1	1	NUM
dti-2347	43	82	day	day	NOUN
dti-2347	43	83	before	before	ADV
dti-2347	43	84	and	and	CCONJ
dti-2347	43	85	immediately	immediately	ADV
dti-2347	43	86	after	after	ADP
dti-2347	43	87	hcl	hcl	PROPN
dti-2347	43	88	challenge	challenge	NOUN
dti-2347	43	89	.	.	PUNCT
dti-2347	44	1	in	in	ADP
dti-2347	44	2	the	the	DET
dti-2347	44	3	late	late	ADJ
dti-2347	44	4	ards	ard	NOUN
dti-2347	44	5	study	study	PROPN
dti-2347	44	6	,	,	PUNCT
dti-2347	44	7	mice	mouse	NOUN
dti-2347	44	8	were	be	AUX
dti-2347	44	9	assorted	assort	VERB
dti-2347	44	10	into	into	ADP
dti-2347	44	11	two	two	NUM
dti-2347	44	12	treatment	treatment	NOUN
dti-2347	44	13	groups	group	NOUN
dti-2347	44	14	:	:	PUNCT
dti-2347	44	15	–	–	PUNCT
dti-2347	44	16	vehicle	vehicle	NOUN
dti-2347	44	17	:	:	PUNCT
dti-2347	44	18	mice	mouse	NOUN
dti-2347	44	19	received	receive	VERB
dti-2347	44	20	sterile	sterile	ADJ
dti-2347	44	21	physiological	physiological	ADJ
dti-2347	44	22	saline	saline	NOUN
dti-2347	44	23	(	(	PUNCT
dti-2347	44	24	100	100	NUM
dti-2347	44	25	µl	µl	ADP
dti-2347	44	26	,	,	PUNCT
dti-2347	44	27	ip	ip	NOUN
dti-2347	44	28	)	)	PUNCT
dti-2347	44	29	,	,	PUNCT
dti-2347	44	30	immediately	immediately	ADV
dti-2347	44	31	after	after	ADP
dti-2347	44	32	hcl	hcl	PROPN
dti-2347	44	33	challenge	challenge	NOUN
dti-2347	44	34	and	and	CCONJ
dti-2347	44	35	twice	twice	ADV
dti-2347	44	36	daily	daily	ADV
dti-2347	44	37	in	in	ADP
dti-2347	44	38	the	the	DET
dti-2347	44	39	following	follow	VERB
dti-2347	44	40	4	4	NUM
dti-2347	44	41	days	day	NOUN
dti-2347	44	42	;	;	PUNCT
dti-2347	44	43	–	–	PUNCT
dti-2347	44	44	hexarelin	hexarelin	NUM
dti-2347	44	45	:	:	PUNCT
dti-2347	44	46	mice	mouse	NOUN
dti-2347	44	47	received	receive	VERB
dti-2347	44	48	hexarelin	hexarelin	PROPN
dti-2347	44	49	treatment	treatment	NOUN
dti-2347	44	50	immediately	immediately	ADV
dti-2347	44	51	after	after	SCONJ
dti-2347	44	52	hcl	hcl	PROPN
dti-2347	44	53	challenge	challenge	NOUN
dti-2347	44	54	(	(	PUNCT
dti-2347	44	55	entire	entire	ADJ
dti-2347	44	56	dose	dose	NOUN
dti-2347	44	57	,	,	PUNCT
dti-2347	44	58	320	320	NUM
dti-2347	44	59	μg	μg	PROPN
dti-2347	44	60	/	/	SYM
dti-2347	44	61	kg	kg	PROPN
dti-2347	44	62	ip	ip	NOUN
dti-2347	44	63	,	,	PUNCT
dti-2347	44	64	100	100	NUM
dti-2347	44	65	µl	µl	NOUN
dti-2347	44	66	)	)	PUNCT
dti-2347	44	67	and	and	CCONJ
dti-2347	44	68	twice	twice	ADV
dti-2347	44	69	daily	daily	ADV
dti-2347	44	70	in	in	ADP
dti-2347	44	71	the	the	DET
dti-2347	44	72	following	follow	VERB
dti-2347	44	73	4	4	NUM
dti-2347	44	74	days	day	NOUN
dti-2347	44	75	(	(	PUNCT
dti-2347	44	76	two	two	NUM
dti-2347	44	77	half	half	ADJ
dti-2347	44	78	doses	dose	NOUN
dti-2347	44	79	,	,	PUNCT
dti-2347	44	80	160	160	NUM
dti-2347	44	81	μg	μg	PROPN
dti-2347	44	82	/	/	SYM
dti-2347	44	83	kg	kg	PROPN
dti-2347	44	84	ip	ip	NOUN
dti-2347	44	85	,	,	PUNCT
dti-2347	44	86	100	100	NUM
dti-2347	44	87	µl	µl	NOUN
dti-2347	44	88	)	)	PUNCT
dti-2347	44	89	.	.	PUNCT
dti-2347	45	1	a	a	DET
dti-2347	45	2	group	group	NOUN
dti-2347	45	3	of	of	ADP
dti-2347	45	4	healthy	healthy	ADJ
dti-2347	45	5	mice	mouse	NOUN
dti-2347	45	6	(	(	PUNCT
dti-2347	45	7	n	n	NOUN
dti-2347	45	8	=	=	SYM
dti-2347	45	9	5	5	NUM
dti-2347	45	10	)	)	PUNCT
dti-2347	45	11	did	do	AUX
dti-2347	45	12	not	not	PART
dti-2347	45	13	undergo	undergo	VERB
dti-2347	45	14	any	any	PRON
dti-2347	45	15	of	of	ADP
dti-2347	45	16	the	the	DET
dti-2347	45	17	surgical	surgical	ADJ
dti-2347	45	18	interventions	intervention	NOUN
dti-2347	45	19	and	and	CCONJ
dti-2347	45	20	was	be	AUX
dti-2347	45	21	sacrificed	sacrifice	VERB
dti-2347	45	22	(	(	PUNCT
dti-2347	45	23	healthy	healthy	ADJ
dti-2347	45	24	mice	mouse	NOUN
dti-2347	45	25	)	)	PUNCT
dti-2347	45	26	.	.	PUNCT
dti-2347	46	1	when	when	SCONJ
dti-2347	46	2	,	,	PUNCT
dti-2347	46	3	at	at	ADP
dti-2347	46	4	the	the	DET
dti-2347	46	5	moment	moment	NOUN
dti-2347	46	6	of	of	ADP
dti-2347	46	7	the	the	DET
dti-2347	46	8	sacrifice	sacrifice	NOUN
dti-2347	46	9	,	,	PUNCT
dti-2347	46	10	we	we	PRON
dti-2347	46	11	identified	identify	VERB
dti-2347	46	12	that	that	SCONJ
dti-2347	46	13	hcl	hcl	PROPN
dti-2347	46	14	instillation	instillation	NOUN
dti-2347	46	15	involved	involve	VERB
dti-2347	46	16	the	the	DET
dti-2347	46	17	contralateral	contralateral	ADJ
dti-2347	46	18	lung	lung	NOUN
dti-2347	46	19	(	(	PUNCT
dti-2347	46	20	the	the	DET
dti-2347	46	21	left	left	ADJ
dti-2347	46	22	one	one	NUM
dti-2347	46	23	)	)	PUNCT
dti-2347	46	24	through	through	ADP
dti-2347	46	25	a	a	DET
dti-2347	46	26	macroscopic	macroscopic	ADJ
dti-2347	46	27	lung	lung	NOUN
dti-2347	46	28	evaluation	evaluation	NOUN
dti-2347	46	29	,	,	PUNCT
dti-2347	46	30	the	the	DET
dti-2347	46	31	animals	animal	NOUN
dti-2347	46	32	were	be	AUX
dti-2347	46	33	euthanized	euthanize	VERB
dti-2347	46	34	and	and	CCONJ
dti-2347	46	35	excluded	exclude	VERB
dti-2347	46	36	from	from	ADP
dti-2347	46	37	analysis	analysis	NOUN
dti-2347	46	38	(	(	PUNCT
dti-2347	46	39	approximately	approximately	ADV
dti-2347	46	40	2	2	NUM
dti-2347	46	41	%	%	NOUN
dti-2347	46	42	)	)	PUNCT
dti-2347	46	43	.	.	PUNCT
dti-2347	47	1	for	for	ADP
dti-2347	47	2	some	some	DET
dti-2347	47	3	parameters	parameter	NOUN
dti-2347	47	4	(	(	PUNCT
dti-2347	47	5	alveolar	alveolar	ADJ
dti-2347	47	6	inflammatory	inflammatory	ADJ
dti-2347	47	7	cells	cell	NOUN
dti-2347	47	8	count	count	VERB
dti-2347	47	9	,	,	PUNCT
dti-2347	47	10	alveolar	alveolar	ADJ
dti-2347	47	11	protein	protein	NOUN
dti-2347	47	12	content	content	NOUN
dti-2347	47	13	,	,	PUNCT
dti-2347	47	14	and	and	CCONJ
dti-2347	47	15	collagen	collagen	NOUN
dti-2347	47	16	deposition	deposition	NOUN
dti-2347	47	17	)	)	PUNCT
dti-2347	47	18	,	,	PUNCT
dti-2347	47	19	the	the	DET
dti-2347	47	20	two	two	NUM
dti-2347	47	21	lungs	lung	NOUN
dti-2347	47	22	were	be	AUX
dti-2347	47	23	analyzed	analyze	VERB
dti-2347	47	24	separately	separately	ADV
dti-2347	47	25	,	,	PUNCT
dti-2347	47	26	since	since	SCONJ
dti-2347	47	27	the	the	DET
dti-2347	47	28	injury	injury	NOUN
dti-2347	47	29	was	be	AUX
dti-2347	47	30	induced	induce	VERB
dti-2347	47	31	only	only	ADV
dti-2347	47	32	on	on	ADP
dti-2347	47	33	the	the	DET
dti-2347	47	34	right	right	ADJ
dti-2347	47	35	lung	lung	NOUN
dti-2347	47	36	.	.	PUNCT
dti-2347	48	1	the	the	DET
dti-2347	48	2	contralateral	contralateral	ADJ
dti-2347	48	3	(	(	PUNCT
dti-2347	48	4	left	left	ADJ
dti-2347	48	5	)	)	PUNCT
dti-2347	48	6	lung	lung	PROPN
dti-2347	48	7	has	have	AUX
dti-2347	48	8	been	be	AUX
dti-2347	48	9	considered	consider	VERB
dti-2347	48	10	like	like	ADP
dti-2347	48	11	an	an	DET
dti-2347	48	12	internal	internal	ADJ
dti-2347	48	13	control	control	NOUN
dti-2347	48	14	.	.	PUNCT
dti-2347	49	1	pulmonary	pulmonary	ADJ
dti-2347	49	2	function	function	NOUN
dti-2347	49	3	at	at	ADP
dti-2347	49	4	the	the	DET
dti-2347	49	5	time	time	NOUN
dti-2347	49	6	of	of	ADP
dti-2347	49	7	sacrifice	sacrifice	NOUN
dti-2347	49	8	,	,	PUNCT
dti-2347	49	9	mice	mouse	NOUN
dti-2347	49	10	were	be	AUX
dti-2347	49	11	anesthetized	anesthetize	VERB
dti-2347	49	12	with	with	ADP
dti-2347	49	13	ketamine	ketamine	PROPN
dti-2347	49	14	(	(	PUNCT
dti-2347	49	15	100	100	NUM
dti-2347	49	16	mg	mg	PROPN
dti-2347	49	17	/	/	SYM
dti-2347	49	18	kg	kg	NOUN
dti-2347	49	19	)	)	PUNCT
dti-2347	49	20	and	and	CCONJ
dti-2347	49	21	xylazine	xylazine	NOUN
dti-2347	49	22	(	(	PUNCT
dti-2347	49	23	4	4	NUM
dti-2347	49	24	mg	mg	NUM
dti-2347	49	25	/	/	SYM
dti-2347	49	26	kg	kg	PROPN
dti-2347	49	27	)	)	PUNCT
dti-2347	49	28	,	,	PUNCT
dti-2347	49	29	and	and	CCONJ
dti-2347	49	30	mechanically	mechanically	ADV
dti-2347	49	31	ventilated	ventilate	VERB
dti-2347	49	32	.	.	PUNCT
dti-2347	50	1	in	in	ADP
dti-2347	50	2	order	order	NOUN
dti-2347	50	3	to	to	PART
dti-2347	50	4	standardize	standardize	VERB
dti-2347	50	5	lung	lung	NOUN
dti-2347	50	6	recruitment	recruitment	NOUN
dti-2347	50	7	,	,	PUNCT
dti-2347	50	8	a	a	DET
dti-2347	50	9	maneuver	maneuver	NOUN
dti-2347	50	10	(	(	PUNCT
dti-2347	50	11	30	30	NUM
dti-2347	50	12	cm	cm	NOUN
dti-2347	50	13	h2o	h2o	NOUN
dti-2347	50	14	for	for	ADP
dti-2347	50	15	10	10	NUM
dti-2347	50	16	sec	sec	PROPN
dti-2347	50	17	)	)	PUNCT
dti-2347	50	18	was	be	AUX
dti-2347	50	19	performed	perform	VERB
dti-2347	50	20	immediately	immediately	ADV
dti-2347	50	21	after	after	ADP
dti-2347	50	22	intubation	intubation	NOUN
dti-2347	50	23	.	.	PUNCT
dti-2347	51	1	a	a	DET
dti-2347	51	2	pressure	pressure	NOUN
dti-2347	51	3	-	-	PUNCT
dti-2347	51	4	volume	volume	NOUN
dti-2347	51	5	(	(	PUNCT
dti-2347	51	6	pv	pv	NOUN
dti-2347	51	7	)	)	PUNCT
dti-2347	51	8	curve	curve	NOUN
dti-2347	51	9	was	be	AUX
dti-2347	51	10	constructed	construct	VERB
dti-2347	51	11	by	by	ADP
dti-2347	51	12	delivering	deliver	VERB
dti-2347	51	13	five	five	NUM
dti-2347	51	14	steps	step	NOUN
dti-2347	51	15	of	of	ADP
dti-2347	51	16	inspiratory	inspiratory	NOUN
dti-2347	51	17	volume	volume	NOUN
dti-2347	51	18	(	(	PUNCT
dti-2347	51	19	200	200	NUM
dti-2347	51	20	µl	µl	NOUN
dti-2347	51	21	)	)	PUNCT
dti-2347	51	22	from	from	ADP
dti-2347	51	23	functional	functional	ADJ
dti-2347	51	24	residual	residual	ADJ
dti-2347	51	25	capacity	capacity	NOUN
dti-2347	51	26	.	.	PUNCT
dti-2347	52	1	for	for	ADP
dti-2347	52	2	each	each	DET
dti-2347	52	3	step	step	NOUN
dti-2347	52	4	,	,	PUNCT
dti-2347	52	5	the	the	DET
dti-2347	52	6	plateau	plateau	NOUN
dti-2347	52	7	pressure	pressure	NOUN
dti-2347	52	8	was	be	AUX
dti-2347	52	9	recorded	record	VERB
dti-2347	52	10	in	in	ADP
dti-2347	52	11	order	order	NOUN
dti-2347	52	12	to	to	PART
dti-2347	52	13	calculate	calculate	VERB
dti-2347	52	14	the	the	DET
dti-2347	52	15	static	static	ADJ
dti-2347	52	16	compliance	compliance	NOUN
dti-2347	52	17	by	by	ADP
dti-2347	52	18	using	use	VERB
dti-2347	52	19	a	a	DET
dti-2347	52	20	pressure	pressure	NOUN
dti-2347	52	21	transducer	transducer	NOUN
dti-2347	52	22	,	,	PUNCT
dti-2347	52	23	which	which	PRON
dti-2347	52	24	was	be	AUX
dti-2347	52	25	interfaced	interface	VERB
dti-2347	52	26	to	to	ADP
dti-2347	52	27	a	a	DET
dti-2347	52	28	powerlab	powerlab	NOUN
dti-2347	52	29	(	(	PUNCT
dti-2347	52	30	ad	ad	NOUN
dti-2347	52	31	instruments	instrument	NOUN
dti-2347	52	32	)	)	PUNCT
dti-2347	52	33	signal	signal	PROPN
dti-2347	52	34	transduction	transduction	NOUN
dti-2347	52	35	unit	unit	NOUN
dti-2347	52	36	.	.	PUNCT
dti-2347	53	1	a	a	DET
dti-2347	53	2	mean	mean	ADJ
dti-2347	53	3	value	value	NOUN
dti-2347	53	4	was	be	AUX
dti-2347	53	5	calculated	calculate	VERB
dti-2347	53	6	.	.	PUNCT
dti-2347	54	1	after	after	SCONJ
dti-2347	54	2	mechanical	mechanical	ADJ
dti-2347	54	3	properties	property	NOUN
dti-2347	54	4	were	be	AUX
dti-2347	54	5	measured	measure	VERB
dti-2347	54	6	,	,	PUNCT
dti-2347	54	7	the	the	DET
dti-2347	54	8	chest	chest	NOUN
dti-2347	54	9	was	be	AUX
dti-2347	54	10	opened	open	VERB
dti-2347	54	11	and	and	CCONJ
dti-2347	54	12	a	a	DET
dti-2347	54	13	blood	blood	NOUN
dti-2347	54	14	sample	sample	NOUN
dti-2347	54	15	(	(	PUNCT
dti-2347	54	16	0.1	0.1	NUM
dti-2347	54	17	ml	ml	NOUN
dti-2347	54	18	)	)	PUNCT
dti-2347	54	19	was	be	AUX
dti-2347	54	20	withdrawn	withdraw	VERB
dti-2347	54	21	from	from	ADP
dti-2347	54	22	the	the	DET
dti-2347	54	23	left	left	ADJ
dti-2347	54	24	ventricle	ventricle	NOUN
dti-2347	54	25	and	and	CCONJ
dti-2347	54	26	analyzed	analyze	VERB
dti-2347	54	27	with	with	ADP
dti-2347	54	28	an	an	DET
dti-2347	54	29	i	i	NOUN
dti-2347	54	30	-	-	PUNCT
dti-2347	54	31	stat	stat	NOUN
dti-2347	54	32	1	1	NUM
dti-2347	54	33	portable	portable	ADJ
dti-2347	54	34	analyzer	analyzer	NOUN
dti-2347	54	35	to	to	PART
dti-2347	54	36	analyze	analyze	VERB
dti-2347	54	37	oxygenation	oxygenation	NOUN
dti-2347	54	38	value	value	NOUN
dti-2347	54	39	(	(	PUNCT
dti-2347	54	40	pao2	pao2	PROPN
dti-2347	54	41	)	)	PUNCT
dti-2347	55	1	(	(	PUNCT
dti-2347	55	2	oxford	oxford	PROPN
dti-2347	55	3	instruments	instrument	VERB
dti-2347	55	4	s.m	s.m	PROPN
dti-2347	55	5	.	.	PROPN
dti-2347	55	6	,	,	PUNCT
dti-2347	55	7	burke	burke	PROPN
dti-2347	55	8	e	e	PROPN
dti-2347	55	9	burke	burke	PROPN
dti-2347	55	10	)	)	PUNCT
dti-2347	55	11	(	(	PUNCT
dti-2347	55	12	16	16	NUM
dti-2347	55	13	)	)	PUNCT
dti-2347	55	14	.	.	PUNCT
dti-2347	56	1	inflammatory	inflammatory	ADJ
dti-2347	56	2	response	response	NOUN
dti-2347	56	3	an	an	DET
dti-2347	56	4	aliquot	aliquot	NOUN
dti-2347	56	5	of	of	ADP
dti-2347	56	6	each	each	DET
dti-2347	56	7	blood	blood	NOUN
dti-2347	56	8	sample	sample	NOUN
dti-2347	56	9	was	be	AUX
dti-2347	56	10	used	use	VERB
dti-2347	56	11	to	to	PART
dti-2347	56	12	perform	perform	VERB
dti-2347	56	13	peripheral	peripheral	ADJ
dti-2347	56	14	leukocyte	leukocyte	NOUN
dti-2347	56	15	(	(	PUNCT
dti-2347	56	16	wbcs	wbcs	NOUN
dti-2347	56	17	)	)	PUNCT
dti-2347	56	18	counts	count	NOUN
dti-2347	56	19	.	.	PUNCT
dti-2347	57	1	subsequently	subsequently	ADV
dti-2347	57	2	,	,	PUNCT
dti-2347	57	3	bronchoalveolar	bronchoalveolar	ADJ
dti-2347	57	4	lavage	lavage	NOUN
dti-2347	57	5	(	(	PUNCT
dti-2347	57	6	bal	bal	PROPN
dti-2347	57	7	)	)	PUNCT
dti-2347	57	8	was	be	AUX
dti-2347	57	9	performed	perform	VERB
dti-2347	57	10	separately	separately	ADV
dti-2347	57	11	for	for	ADP
dti-2347	57	12	each	each	DET
dti-2347	57	13	lung	lung	NOUN
dti-2347	57	14	,	,	PUNCT
dti-2347	57	15	by	by	ADP
dti-2347	57	16	clamping	clamp	VERB
dti-2347	57	17	alternatively	alternatively	ADV
dti-2347	57	18	the	the	DET
dti-2347	57	19	left	left	ADJ
dti-2347	57	20	and	and	CCONJ
dti-2347	57	21	right	right	ADJ
dti-2347	57	22	bronchus	bronchu	NOUN
dti-2347	57	23	.	.	PUNCT
dti-2347	58	1	lavage	lavage	NOUN
dti-2347	58	2	was	be	AUX
dti-2347	58	3	performed	perform	VERB
dti-2347	58	4	three	three	NUM
dti-2347	58	5	times	time	NOUN
dti-2347	58	6	for	for	ADP
dti-2347	58	7	each	each	DET
dti-2347	58	8	lung	lung	NOUN
dti-2347	58	9	,	,	PUNCT
dti-2347	58	10	with	with	ADP
dti-2347	58	11	600	600	NUM
dti-2347	58	12	or	or	CCONJ
dti-2347	58	13	400	400	NUM
dti-2347	58	14	µl	µl	NOUN
dti-2347	58	15	of	of	ADP
dti-2347	58	16	lavage	lavage	NOUN
dti-2347	58	17	solution	solution	NOUN
dti-2347	58	18	(	(	PUNCT
dti-2347	58	19	0.9	0.9	NUM
dti-2347	58	20	%	%	NOUN
dti-2347	58	21	saline	saline	NOUN
dti-2347	58	22	solution	solution	NOUN
dti-2347	58	23	and	and	CCONJ
dti-2347	58	24	protease	protease	NOUN
dti-2347	58	25	inhibitor	inhibitor	NOUN
dti-2347	58	26	)	)	PUNCT
dti-2347	58	27	respectively	respectively	ADV
dti-2347	58	28	for	for	ADP
dti-2347	58	29	the	the	DET
dti-2347	58	30	right	right	NOUN
dti-2347	58	31	and	and	CCONJ
dti-2347	58	32	the	the	DET
dti-2347	58	33	left	left	ADJ
dti-2347	58	34	one	one	NUM
dti-2347	58	35	.	.	PUNCT
dti-2347	59	1	the	the	DET
dti-2347	59	2	bal	bal	PROPN
dti-2347	59	3	samples	sample	NOUN
dti-2347	59	4	obtained	obtain	VERB
dti-2347	59	5	were	be	AUX
dti-2347	59	6	then	then	ADV
dti-2347	59	7	centrifuged	centrifuge	VERB
dti-2347	59	8	for	for	ADP
dti-2347	59	9	10	10	NUM
dti-2347	59	10	minutes	minute	NOUN
dti-2347	59	11	,	,	PUNCT
dti-2347	59	12	1500	1500	NUM
dti-2347	59	13	rpm	rpm	NOUN
dti-2347	59	14	,	,	PUNCT
dti-2347	59	15	4	4	NUM
dti-2347	59	16	°	°	NOUN
dti-2347	59	17	c	c	NOUN
dti-2347	59	18	;	;	PUNCT
dti-2347	59	19	the	the	DET
dti-2347	59	20	supernatant	supernatant	NOUN
dti-2347	59	21	was	be	AUX
dti-2347	59	22	then	then	ADV
dti-2347	59	23	stored	store	VERB
dti-2347	59	24	at	at	ADP
dti-2347	59	25	–	–	PUNCT
dti-2347	59	26	80	80	NUM
dti-2347	59	27	°	°	NUM
dti-2347	59	28	c	c	NOUN
dti-2347	59	29	for	for	ADP
dti-2347	59	30	subsequent	subsequent	ADJ
dti-2347	59	31	analyses	analysis	NOUN
dti-2347	59	32	.	.	PUNCT
dti-2347	60	1	the	the	DET
dti-2347	60	2	cell	cell	NOUN
dti-2347	60	3	pellet	pellet	NOUN
dti-2347	60	4	was	be	AUX
dti-2347	60	5	resuspended	resuspend	VERB
dti-2347	60	6	in	in	ADP
dti-2347	60	7	500	500	NUM
dti-2347	60	8	µl	µl	ADP
dti-2347	60	9	pbs	pbs	PROPN
dti-2347	60	10	(	(	PUNCT
dti-2347	60	11	dulbecco	dulbecco	NOUN
dti-2347	60	12	’s	’s	PART
dti-2347	60	13	phosphate	phosphate	NOUN
dti-2347	60	14	-	-	PUNCT
dti-2347	60	15	buffered	buffer	VERB
dti-2347	60	16	saline	saline	NOUN
dti-2347	60	17	;	;	PUNCT
dti-2347	60	18	gibco	gibco	NOUN
dti-2347	60	19	)	)	PUNCT
dti-2347	60	20	.	.	PUNCT
dti-2347	61	1	subsequently	subsequently	ADV
dti-2347	61	2	,	,	PUNCT
dti-2347	61	3	a	a	DET
dti-2347	61	4	100	100	NUM
dti-2347	61	5	µl	µl	ADP
dti-2347	61	6	aliquot	aliquot	NOUN
dti-2347	61	7	was	be	AUX
dti-2347	61	8	put	put	VERB
dti-2347	61	9	in	in	ADP
dti-2347	61	10	200	200	NUM
dti-2347	61	11	µl	µl	NOUN
dti-2347	61	12	of	of	ADP
dti-2347	61	13	turk	turk	PROPN
dti-2347	61	14	(	(	PUNCT
dti-2347	61	15	acetic	acetic	ADJ
dti-2347	61	16	acid	acid	NOUN
dti-2347	61	17	gentian	gentian	ADJ
dti-2347	61	18	violet	violet	NOUN
dti-2347	61	19	solution	solution	NOUN
dti-2347	61	20	;	;	PUNCT
dti-2347	61	21	merck	merck	PROPN
dti-2347	61	22	)	)	PUNCT
dti-2347	61	23	for	for	ADP
dti-2347	61	24	total	total	ADJ
dti-2347	61	25	leukocyte	leukocyte	ADJ
dti-2347	61	26	effects	effect	NOUN
dti-2347	61	27	of	of	ADP
dti-2347	61	28	hexarelin	hexarelin	PROPN
dti-2347	61	29	treatment	treatment	NOUN
dti-2347	61	30	on	on	ADP
dti-2347	61	31	acute	acute	ADJ
dti-2347	61	32	lung	lung	NOUN
dti-2347	61	33	injury28	injury28	NOUN
dti-2347	62	1	©	©	PROPN
dti-2347	62	2	2021	2021	NUM
dti-2347	63	1	the	the	DET
dti-2347	63	2	authors	author	NOUN
dti-2347	63	3	.	.	PUNCT
dti-2347	64	1	drug	drug	NOUN
dti-2347	64	2	target	target	NOUN
dti-2347	64	3	insights	insight	NOUN
dti-2347	64	4	issn	issn	VERB
dti-2347	64	5	1177	1177	NUM
dti-2347	64	6	-	-	SYM
dti-2347	64	7	3928	3928	NUM
dti-2347	64	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2347	64	9	count	count	NOUN
dti-2347	64	10	in	in	ADP
dti-2347	64	11	a	a	DET
dti-2347	64	12	burker	burker	NOUN
dti-2347	64	13	chamber	chamber	NOUN
dti-2347	64	14	,	,	PUNCT
dti-2347	64	15	while	while	SCONJ
dti-2347	64	16	another	another	DET
dti-2347	64	17	100	100	NUM
dti-2347	64	18	µl	µl	ADP
dti-2347	64	19	aliquot	aliquot	NOUN
dti-2347	64	20	was	be	AUX
dti-2347	64	21	centrifuged	centrifuge	VERB
dti-2347	64	22	by	by	ADP
dti-2347	64	23	a	a	DET
dti-2347	64	24	cytospin	cytospin	NOUN
dti-2347	64	25	(	(	PUNCT
dti-2347	64	26	centrifuge	centrifuge	NOUN
dti-2347	64	27	,	,	PUNCT
dti-2347	64	28	mpw-351r	mpw-351r	ADJ
dti-2347	64	29	,	,	PUNCT
dti-2347	64	30	mpw	mpw	NOUN
dti-2347	64	31	)	)	PUNCT
dti-2347	64	32	and	and	CCONJ
dti-2347	64	33	then	then	ADV
dti-2347	64	34	stained	stain	VERB
dti-2347	64	35	with	with	ADP
dti-2347	64	36	a	a	DET
dti-2347	64	37	diff	diff	NOUN
dti-2347	64	38	-	-	PUNCT
dti-2347	64	39	quick	quick	ADJ
dti-2347	64	40	kit	kit	NOUN
dti-2347	64	41	(	(	PUNCT
dti-2347	64	42	medion	medion	NOUN
dti-2347	64	43	diagnostics	diagnostic	NOUN
dti-2347	64	44	)	)	PUNCT
dti-2347	64	45	that	that	PRON
dti-2347	64	46	differentially	differentially	ADV
dti-2347	64	47	marks	mark	VERB
dti-2347	64	48	the	the	DET
dti-2347	64	49	nucleus	nucleus	NOUN
dti-2347	64	50	and	and	CCONJ
dti-2347	64	51	cytoplasm	cytoplasm	ADJ
dti-2347	64	52	,	,	PUNCT
dti-2347	64	53	thus	thus	ADV
dti-2347	64	54	facilitating	facilitate	VERB
dti-2347	64	55	a	a	DET
dti-2347	64	56	differential	differential	ADJ
dti-2347	64	57	cell	cell	NOUN
dti-2347	64	58	count	count	NOUN
dti-2347	64	59	(	(	PUNCT
dti-2347	64	60	17	17	NUM
dti-2347	64	61	)	)	PUNCT
dti-2347	64	62	.	.	PUNCT
dti-2347	65	1	protein	protein	NOUN
dti-2347	65	2	contents	content	NOUN
dti-2347	65	3	in	in	ADP
dti-2347	65	4	bal	bal	ADJ
dti-2347	65	5	fluid	fluid	NOUN
dti-2347	65	6	were	be	AUX
dti-2347	65	7	performed	perform	VERB
dti-2347	65	8	by	by	ADP
dti-2347	65	9	the	the	DET
dti-2347	65	10	bca	bca	PROPN
dti-2347	65	11	(	(	PUNCT
dti-2347	65	12	bicinchoninic	bicinchoninic	ADJ
dti-2347	65	13	acid	acid	NOUN
dti-2347	65	14	)	)	PUNCT
dti-2347	65	15	method	method	NOUN
dti-2347	65	16	at	at	ADP
dti-2347	65	17	24	24	NUM
dti-2347	65	18	hours	hour	NOUN
dti-2347	65	19	and	and	CCONJ
dti-2347	65	20	14	14	NUM
dti-2347	65	21	days	day	NOUN
dti-2347	65	22	.	.	PUNCT
dti-2347	66	1	briefly	briefly	NOUN
dti-2347	66	2	,	,	PUNCT
dti-2347	66	3	200	200	NUM
dti-2347	66	4	µl	µl	NOUN
dti-2347	66	5	of	of	ADP
dti-2347	66	6	reagent	reagent	NOUN
dti-2347	66	7	(	(	PUNCT
dti-2347	66	8	composed	compose	VERB
dti-2347	66	9	of	of	ADP
dti-2347	66	10	1:50	1:50	NUM
dti-2347	66	11	bca	bca	PROPN
dti-2347	66	12	and	and	CCONJ
dti-2347	66	13	cuso4	cuso4	PROPN
dti-2347	66	14	;	;	PUNCT
dti-2347	66	15	merck	merck	PROPN
dti-2347	66	16	)	)	PUNCT
dti-2347	66	17	was	be	AUX
dti-2347	66	18	added	add	VERB
dti-2347	66	19	to	to	ADP
dti-2347	66	20	the	the	DET
dti-2347	66	21	samples	sample	NOUN
dti-2347	66	22	.	.	PUNCT
dti-2347	67	1	a	a	DET
dti-2347	67	2	standard	standard	ADJ
dti-2347	67	3	curve	curve	NOUN
dti-2347	67	4	was	be	AUX
dti-2347	67	5	constructed	construct	VERB
dti-2347	67	6	with	with	ADP
dti-2347	67	7	varied	varied	ADJ
dti-2347	67	8	concentrations	concentration	NOUN
dti-2347	67	9	of	of	ADP
dti-2347	67	10	bovine	bovine	ADJ
dti-2347	67	11	serum	serum	NOUN
dti-2347	67	12	albumin	albumin	NOUN
dti-2347	67	13	;	;	PUNCT
dti-2347	67	14	spectrophotometric	spectrophotometric	ADJ
dti-2347	67	15	measurement	measurement	NOUN
dti-2347	67	16	was	be	AUX
dti-2347	67	17	performed	perform	VERB
dti-2347	67	18	at	at	ADP
dti-2347	67	19	570	570	NUM
dti-2347	67	20	nm	nm	NOUN
dti-2347	67	21	with	with	ADP
dti-2347	67	22	a	a	DET
dti-2347	67	23	multilabel	multilabel	NOUN
dti-2347	67	24	spectrophotometer	spectrophotometer	NOUN
dti-2347	67	25	victor3	victor3	PROPN
dti-2347	67	26	(	(	PUNCT
dti-2347	67	27	perkin	perkin	PROPN
dti-2347	67	28	elmer	elmer	PROPN
dti-2347	67	29	)	)	PUNCT
dti-2347	67	30	(	(	PUNCT
dti-2347	67	31	18	18	NUM
dti-2347	67	32	)	)	PUNCT
dti-2347	67	33	.	.	PUNCT
dti-2347	68	1	hydroxyproline	hydroxyproline	PROPN
dti-2347	68	2	(	(	PUNCT
dti-2347	68	3	oh	oh	INTJ
dti-2347	68	4	-	-	PUNCT
dti-2347	68	5	pro	pro	ADJ
dti-2347	68	6	)	)	PUNCT
dti-2347	68	7	assay	assay	VERB
dti-2347	68	8	after	after	ADP
dti-2347	68	9	exsanguination	exsanguination	NOUN
dti-2347	68	10	,	,	PUNCT
dti-2347	68	11	a	a	DET
dti-2347	68	12	macroscopic	macroscopic	ADJ
dti-2347	68	13	observation	observation	NOUN
dti-2347	68	14	of	of	ADP
dti-2347	68	15	the	the	DET
dti-2347	68	16	lungs	lung	NOUN
dti-2347	68	17	allowed	allow	VERB
dti-2347	68	18	identifying	identify	VERB
dti-2347	68	19	the	the	DET
dti-2347	68	20	localization	localization	NOUN
dti-2347	68	21	of	of	ADP
dti-2347	68	22	the	the	DET
dti-2347	68	23	acid	acid	PROPN
dti-2347	68	24	injury	injury	NOUN
dti-2347	68	25	;	;	PUNCT
dti-2347	68	26	lungs	lung	NOUN
dti-2347	68	27	were	be	AUX
dti-2347	68	28	then	then	ADV
dti-2347	68	29	excised	excise	VERB
dti-2347	68	30	and	and	CCONJ
dti-2347	68	31	stored	store	VERB
dti-2347	68	32	at	at	ADP
dti-2347	68	33	−80	−80	PROPN
dti-2347	68	34	°	°	ADP
dti-2347	68	35	c	c	NOUN
dti-2347	68	36	.	.	PUNCT
dti-2347	69	1	collagen	collagen	NOUN
dti-2347	69	2	content	content	NOUN
dti-2347	69	3	was	be	AUX
dti-2347	69	4	measured	measure	VERB
dti-2347	69	5	with	with	ADP
dti-2347	69	6	the	the	DET
dti-2347	69	7	oh	oh	NOUN
dti-2347	69	8	-	-	PUNCT
dti-2347	69	9	pro	pro	NOUN
dti-2347	69	10	assay	assay	NOUN
dti-2347	69	11	.	.	PUNCT
dti-2347	70	1	we	we	PRON
dti-2347	70	2	used	use	VERB
dti-2347	70	3	the	the	DET
dti-2347	70	4	conventional	conventional	ADJ
dti-2347	70	5	method	method	NOUN
dti-2347	70	6	(	(	PUNCT
dti-2347	70	7	19	19	NUM
dti-2347	70	8	)	)	PUNCT
dti-2347	70	9	,	,	PUNCT
dti-2347	70	10	which	which	PRON
dti-2347	70	11	entails	entail	VERB
dti-2347	70	12	lung	lung	NOUN
dti-2347	70	13	tissue	tissue	NOUN
dti-2347	70	14	homogenization	homogenization	NOUN
dti-2347	70	15	and	and	CCONJ
dti-2347	70	16	hydrolysis	hydrolysis	NOUN
dti-2347	70	17	with	with	ADP
dti-2347	70	18	6n	6n	PROPN
dti-2347	70	19	hcl	hcl	PROPN
dti-2347	70	20	at	at	ADP
dti-2347	70	21	120	120	NUM
dti-2347	70	22	°	°	NOUN
dti-2347	70	23	c	c	NOUN
dti-2347	70	24	,	,	PUNCT
dti-2347	70	25	followed	follow	VERB
dti-2347	70	26	by	by	ADP
dti-2347	70	27	chloramine	chloramine	NOUN
dti-2347	70	28	t	t	PROPN
dti-2347	70	29	and	and	CCONJ
dti-2347	70	30	ehrlich	ehrlich	NOUN
dti-2347	70	31	’s	’s	PART
dti-2347	70	32	solution	solution	NOUN
dti-2347	70	33	(	(	PUNCT
dti-2347	70	34	merck	merck	NOUN
dti-2347	70	35	)	)	PUNCT
dti-2347	70	36	addition	addition	NOUN
dti-2347	70	37	to	to	ADP
dti-2347	70	38	samples	sample	NOUN
dti-2347	70	39	for	for	ADP
dti-2347	70	40	the	the	DET
dti-2347	70	41	oh	oh	NUM
dti-2347	70	42	-	-	PUNCT
dti-2347	70	43	proline	proline	NOUN
dti-2347	70	44	oxidation	oxidation	NOUN
dti-2347	70	45	and	and	CCONJ
dti-2347	70	46	a	a	DET
dti-2347	70	47	colorimetric	colorimetric	ADJ
dti-2347	70	48	reaction	reaction	NOUN
dti-2347	70	49	.	.	PUNCT
dti-2347	71	1	finally	finally	ADV
dti-2347	71	2	,	,	PUNCT
dti-2347	71	3	absorbance	absorbance	NOUN
dti-2347	71	4	was	be	AUX
dti-2347	71	5	measured	measure	VERB
dti-2347	71	6	at	at	ADP
dti-2347	71	7	550	550	NUM
dti-2347	71	8	nm	nm	NOUN
dti-2347	71	9	with	with	ADP
dti-2347	71	10	a	a	DET
dti-2347	71	11	multilabel	multilabel	NOUN
dti-2347	71	12	spectrophotometer	spectrophotometer	NOUN
dti-2347	71	13	victor3	victor3	PROPN
dti-2347	71	14	.	.	PUNCT
dti-2347	72	1	histological	histological	ADJ
dti-2347	72	2	analysis	analysis	NOUN
dti-2347	72	3	at	at	ADP
dti-2347	72	4	sacrifice	sacrifice	NOUN
dti-2347	72	5	,	,	PUNCT
dti-2347	72	6	some	some	DET
dti-2347	72	7	mice	mouse	NOUN
dti-2347	72	8	were	be	AUX
dti-2347	72	9	devoted	devote	VERB
dti-2347	72	10	to	to	ADP
dti-2347	72	11	histological	histological	ADJ
dti-2347	72	12	analysis	analysis	NOUN
dti-2347	72	13	.	.	PUNCT
dti-2347	73	1	briefly	briefly	ADV
dti-2347	73	2	,	,	PUNCT
dti-2347	73	3	lung	lung	NOUN
dti-2347	73	4	tissue	tissue	NOUN
dti-2347	73	5	was	be	AUX
dti-2347	73	6	fixed	fix	VERB
dti-2347	73	7	in	in	ADP
dti-2347	73	8	4	4	NUM
dti-2347	73	9	%	%	NOUN
dti-2347	73	10	paraformaldehyde	paraformaldehyde	NOUN
dti-2347	73	11	and	and	CCONJ
dti-2347	73	12	embedded	embed	VERB
dti-2347	73	13	in	in	ADP
dti-2347	73	14	paraffin	paraffin	NOUN
dti-2347	73	15	.	.	PUNCT
dti-2347	74	1	sections	section	NOUN
dti-2347	74	2	were	be	AUX
dti-2347	74	3	stained	stain	VERB
dti-2347	74	4	with	with	ADP
dti-2347	74	5	hematoxylin	hematoxylin	NOUN
dti-2347	74	6	-	-	PUNCT
dti-2347	74	7	eosin	eosin	NOUN
dti-2347	74	8	(	(	PUNCT
dti-2347	74	9	h&e	h&e	PROPN
dti-2347	74	10	)	)	PUNCT
dti-2347	74	11	(	(	PUNCT
dti-2347	74	12	automatic	automatic	ADJ
dti-2347	74	13	stainer	stainer	NOUN
dti-2347	74	14	dako	dako	PROPN
dti-2347	74	15	coverstainer	coverstainer	PROPN
dti-2347	74	16	)	)	PUNCT
dti-2347	74	17	and	and	CCONJ
dti-2347	74	18	masson	masson	PROPN
dti-2347	74	19	’s	’s	PART
dti-2347	74	20	trichrome	trichrome	NOUN
dti-2347	74	21	(	(	PUNCT
dti-2347	74	22	automatic	automatic	ADJ
dti-2347	74	23	stainer	stainer	NOUN
dti-2347	74	24	dako	dako	PROPN
dti-2347	74	25	artisan	artisan	PROPN
dti-2347	74	26	link	link	PROPN
dti-2347	74	27	pro	pro	ADJ
dti-2347	74	28	special	special	ADJ
dti-2347	74	29	staining	stain	VERB
dti-2347	74	30	system	system	NOUN
dti-2347	74	31	)	)	PUNCT
dti-2347	74	32	.	.	PUNCT
dti-2347	75	1	morphological	morphological	ADJ
dti-2347	75	2	changes	change	NOUN
dti-2347	75	3	were	be	AUX
dti-2347	75	4	analyzed	analyze	VERB
dti-2347	75	5	by	by	ADP
dti-2347	75	6	two	two	NUM
dti-2347	75	7	experienced	experienced	ADJ
dti-2347	75	8	pathologists	pathologist	NOUN
dti-2347	75	9	in	in	ADP
dti-2347	75	10	a	a	DET
dti-2347	75	11	blinded	blinded	ADJ
dti-2347	75	12	fashion	fashion	NOUN
dti-2347	75	13	(	(	PUNCT
dti-2347	75	14	light	light	ADJ
dti-2347	75	15	microscope	microscope	NOUN
dti-2347	75	16	leica	leica	PROPN
dti-2347	75	17	dm	dm	PROPN
dti-2347	75	18	2500	2500	NUM
dti-2347	75	19	and	and	CCONJ
dti-2347	75	20	digital	digital	ADJ
dti-2347	75	21	microimaging	microimaging	NOUN
dti-2347	75	22	device	device	PROPN
dti-2347	75	23	leica	leica	PROPN
dti-2347	75	24	dmd108	dmd108	PROPN
dti-2347	75	25	)	)	PUNCT
dti-2347	75	26	.	.	PUNCT
dti-2347	76	1	statistical	statistical	ADJ
dti-2347	76	2	analysis	analysis	NOUN
dti-2347	76	3	data	datum	NOUN
dti-2347	76	4	are	be	AUX
dti-2347	76	5	expressed	express	VERB
dti-2347	76	6	as	as	ADP
dti-2347	76	7	mean	mean	NOUN
dti-2347	76	8	±	±	NUM
dti-2347	76	9	standard	standard	ADJ
dti-2347	76	10	error	error	NOUN
dti-2347	76	11	of	of	ADP
dti-2347	76	12	the	the	DET
dti-2347	76	13	mean	mean	NOUN
dti-2347	76	14	(	(	PUNCT
dti-2347	76	15	sem	sem	NOUN
dti-2347	76	16	)	)	PUNCT
dti-2347	76	17	.	.	PUNCT
dti-2347	77	1	differences	difference	NOUN
dti-2347	77	2	in	in	ADP
dti-2347	77	3	variances	variance	NOUN
dti-2347	77	4	between	between	ADP
dti-2347	77	5	treatment	treatment	NOUN
dti-2347	77	6	groups	group	NOUN
dti-2347	77	7	were	be	AUX
dti-2347	77	8	assessed	assess	VERB
dti-2347	77	9	by	by	ADP
dti-2347	77	10	one	one	NUM
dti-2347	77	11	-	-	PUNCT
dti-2347	77	12	way	way	NOUN
dti-2347	77	13	analysis	analysis	NOUN
dti-2347	77	14	of	of	ADP
dti-2347	77	15	variance	variance	NOUN
dti-2347	77	16	(	(	PUNCT
dti-2347	77	17	anova	anova	PROPN
dti-2347	77	18	)	)	PUNCT
dti-2347	77	19	and	and	CCONJ
dti-2347	77	20	tukey	tukey	PROPN
dti-2347	77	21	post	post	X
dti-2347	77	22	hoc	hoc	X
dti-2347	77	23	test	test	NOUN
dti-2347	77	24	.	.	PUNCT
dti-2347	78	1	p	p	NOUN
dti-2347	78	2	values	value	NOUN
dti-2347	78	3	of	of	ADP
dti-2347	78	4	less	less	ADJ
dti-2347	78	5	than	than	ADP
dti-2347	78	6	0.05	0.05	NUM
dti-2347	78	7	(	(	PUNCT
dti-2347	78	8	two	two	NUM
dti-2347	78	9	-	-	PUNCT
dti-2347	78	10	tailed	tail	VERB
dti-2347	78	11	)	)	PUNCT
dti-2347	78	12	were	be	AUX
dti-2347	78	13	considered	consider	VERB
dti-2347	78	14	as	as	ADP
dti-2347	78	15	statistically	statistically	ADV
dti-2347	78	16	significant	significant	ADJ
dti-2347	78	17	.	.	PUNCT
dti-2347	79	1	in	in	ADP
dti-2347	79	2	the	the	DET
dti-2347	79	3	acute	acute	ADJ
dti-2347	79	4	ards	ard	NOUN
dti-2347	79	5	study	study	PROPN
dti-2347	79	6	,	,	PUNCT
dti-2347	79	7	anova	anova	PROPN
dti-2347	79	8	was	be	AUX
dti-2347	79	9	performed	perform	VERB
dti-2347	79	10	in	in	ADP
dti-2347	79	11	experimental	experimental	ADJ
dti-2347	79	12	groups	group	NOUN
dti-2347	79	13	sacrificed	sacrifice	VERB
dti-2347	79	14	at	at	ADP
dti-2347	79	15	6	6	NUM
dti-2347	79	16	hours	hour	NOUN
dti-2347	79	17	and	and	CCONJ
dti-2347	79	18	at	at	ADP
dti-2347	79	19	24	24	NUM
dti-2347	79	20	hours	hour	NOUN
dti-2347	79	21	separately	separately	ADV
dti-2347	79	22	.	.	PUNCT
dti-2347	80	1	statistical	statistical	ADJ
dti-2347	80	2	analysis	analysis	NOUN
dti-2347	80	3	was	be	AUX
dti-2347	80	4	performed	perform	VERB
dti-2347	80	5	by	by	ADP
dti-2347	80	6	graphpad	graphpad	NOUN
dti-2347	80	7	prism	prism	NOUN
dti-2347	80	8	(	(	PUNCT
dti-2347	80	9	version	version	NOUN
dti-2347	80	10	8.4.2	8.4.2	NUM
dti-2347	80	11	)	)	PUNCT
dti-2347	80	12	.	.	PUNCT
dti-2347	81	1	results	result	VERB
dti-2347	81	2	acute	acute	PROPN
dti-2347	81	3	ards	ard	NOUN
dti-2347	81	4	study	study	VERB
dti-2347	81	5	pulmonary	pulmonary	ADJ
dti-2347	81	6	function	function	NOUN
dti-2347	81	7	acid	acid	NOUN
dti-2347	81	8	instillation	instillation	NOUN
dti-2347	81	9	,	,	PUNCT
dti-2347	81	10	as	as	SCONJ
dti-2347	81	11	expected	expect	VERB
dti-2347	81	12	,	,	PUNCT
dti-2347	81	13	reduced	reduce	VERB
dti-2347	81	14	respiratory	respiratory	ADJ
dti-2347	81	15	compliance	compliance	NOUN
dti-2347	81	16	(	(	PUNCT
dti-2347	81	17	fig	fig	NOUN
dti-2347	81	18	.	.	PUNCT
dti-2347	82	1	1a	1a	NOUN
dti-2347	82	2	)	)	PUNCT
dti-2347	83	1	;	;	PUNCT
dti-2347	83	2	specifically	specifically	ADV
dti-2347	83	3	,	,	PUNCT
dti-2347	83	4	at	at	ADP
dti-2347	83	5	6	6	NUM
dti-2347	83	6	and	and	CCONJ
dti-2347	83	7	24	24	NUM
dti-2347	83	8	hours	hour	NOUN
dti-2347	83	9	post	post	NOUN
dti-2347	83	10	instillation	instillation	NOUN
dti-2347	83	11	respiratory	respiratory	ADJ
dti-2347	83	12	compliance	compliance	NOUN
dti-2347	83	13	was	be	AUX
dti-2347	83	14	significantly	significantly	ADV
dti-2347	83	15	reduced	reduce	VERB
dti-2347	83	16	by	by	ADP
dti-2347	83	17	30	30	NUM
dti-2347	83	18	%	%	NOUN
dti-2347	83	19	(	(	PUNCT
dti-2347	83	20	p<0.01	p<0.01	PROPN
dti-2347	83	21	)	)	PUNCT
dti-2347	83	22	and	and	CCONJ
dti-2347	83	23	21	21	NUM
dti-2347	83	24	%	%	NOUN
dti-2347	83	25	(	(	PUNCT
dti-2347	83	26	p<0.05	p<0.05	NOUN
dti-2347	83	27	)	)	PUNCT
dti-2347	83	28	,	,	PUNCT
dti-2347	83	29	respectively	respectively	ADV
dti-2347	83	30	,	,	PUNCT
dti-2347	83	31	compared	compare	VERB
dti-2347	83	32	with	with	ADP
dti-2347	83	33	healthy	healthy	ADJ
dti-2347	83	34	mice	mouse	NOUN
dti-2347	83	35	.	.	PUNCT
dti-2347	84	1	mice	mouse	NOUN
dti-2347	84	2	presented	present	VERB
dti-2347	84	3	no	no	DET
dti-2347	84	4	apparent	apparent	ADJ
dti-2347	84	5	adverse	adverse	ADJ
dti-2347	84	6	responses	response	NOUN
dti-2347	84	7	to	to	ADP
dti-2347	84	8	hexarelin	hexarelin	PROPN
dti-2347	84	9	pretreatment	pretreatment	NOUN
dti-2347	84	10	or	or	CCONJ
dti-2347	84	11	treatment	treatment	NOUN
dti-2347	84	12	regimes	regime	NOUN
dti-2347	84	13	;	;	PUNCT
dti-2347	84	14	moreover	moreover	ADV
dti-2347	84	15	,	,	PUNCT
dti-2347	84	16	hexarelin	hexarelin	PROPN
dti-2347	84	17	administration	administration	NOUN
dti-2347	84	18	,	,	PUNCT
dti-2347	84	19	in	in	ADP
dti-2347	84	20	both	both	DET
dti-2347	84	21	treatment	treatment	NOUN
dti-2347	84	22	regimes	regime	NOUN
dti-2347	84	23	,	,	PUNCT
dti-2347	84	24	modulated	modulate	VERB
dti-2347	84	25	acid	acid	NOUN
dti-2347	84	26	-	-	PUNCT
dti-2347	84	27	reduced	reduce	VERB
dti-2347	84	28	respiratory	respiratory	ADJ
dti-2347	84	29	compliance	compliance	NOUN
dti-2347	84	30	.	.	PUNCT
dti-2347	85	1	to	to	PART
dti-2347	85	2	illustrate	illustrate	VERB
dti-2347	85	3	,	,	PUNCT
dti-2347	85	4	at	at	ADP
dti-2347	85	5	6	6	NUM
dti-2347	85	6	hours	hour	NOUN
dti-2347	85	7	post	post	ADJ
dti-2347	85	8	-	-	NOUN
dti-2347	85	9	instillation	instillation	NOUN
dti-2347	85	10	the	the	DET
dti-2347	85	11	beneficial	beneficial	ADJ
dti-2347	85	12	effects	effect	NOUN
dti-2347	85	13	of	of	ADP
dti-2347	85	14	hexarelin	hexarelin	PROPN
dti-2347	85	15	were	be	AUX
dti-2347	85	16	slight	slight	ADJ
dti-2347	85	17	but	but	CCONJ
dti-2347	85	18	not	not	PART
dti-2347	85	19	significant	significant	ADJ
dti-2347	85	20	;	;	PUNCT
dti-2347	85	21	by	by	ADP
dti-2347	85	22	contrast	contrast	NOUN
dti-2347	85	23	,	,	PUNCT
dti-2347	85	24	hexarelin	hexarelin	PROPN
dti-2347	85	25	induced	induce	VERB
dti-2347	85	26	a	a	DET
dti-2347	85	27	significant	significant	ADJ
dti-2347	85	28	(	(	PUNCT
dti-2347	85	29	p<0.05	p<0.05	NOUN
dti-2347	85	30	)	)	PUNCT
dti-2347	85	31	improvement	improvement	NOUN
dti-2347	85	32	in	in	ADP
dti-2347	85	33	respiratory	respiratory	ADJ
dti-2347	85	34	compliance	compliance	NOUN
dti-2347	85	35	24	24	NUM
dti-2347	85	36	hours	hour	NOUN
dti-2347	85	37	after	after	ADP
dti-2347	85	38	lung	lung	NOUN
dti-2347	85	39	injury	injury	NOUN
dti-2347	85	40	.	.	PUNCT
dti-2347	86	1	by	by	ADP
dti-2347	86	2	comparison	comparison	NOUN
dti-2347	86	3	,	,	PUNCT
dti-2347	86	4	arterial	arterial	ADJ
dti-2347	86	5	oxygen	oxygen	NOUN
dti-2347	86	6	partial	partial	ADJ
dti-2347	86	7	pressure	pressure	NOUN
dti-2347	86	8	(	(	PUNCT
dti-2347	86	9	pao2	pao2	PROPN
dti-2347	86	10	)	)	PUNCT
dti-2347	86	11	was	be	AUX
dti-2347	86	12	severely	severely	ADV
dti-2347	86	13	and	and	CCONJ
dti-2347	86	14	significantly	significantly	ADV
dti-2347	86	15	decreased	decrease	VERB
dti-2347	86	16	in	in	ADP
dti-2347	86	17	all	all	DET
dti-2347	86	18	acid	acid	NOUN
dti-2347	86	19	-	-	PUNCT
dti-2347	86	20	treated	treat	VERB
dti-2347	86	21	animals	animal	NOUN
dti-2347	86	22	(	(	PUNCT
dti-2347	86	23	p<0.01	p<0.01	PROPN
dti-2347	86	24	)	)	PUNCT
dti-2347	86	25	compared	compare	VERB
dti-2347	86	26	with	with	ADP
dti-2347	86	27	healthy	healthy	ADJ
dti-2347	86	28	mice	mouse	NOUN
dti-2347	86	29	(	(	PUNCT
dti-2347	86	30	fig	fig	NOUN
dti-2347	86	31	.	.	PUNCT
dti-2347	86	32	1b	1b	NUM
dti-2347	86	33	)	)	PUNCT
dti-2347	86	34	.	.	PUNCT
dti-2347	87	1	inflammatory	inflammatory	ADJ
dti-2347	87	2	response	response	NOUN
dti-2347	87	3	total	total	ADJ
dti-2347	87	4	numbers	number	NOUN
dti-2347	87	5	of	of	ADP
dti-2347	87	6	peripheral	peripheral	ADJ
dti-2347	87	7	white	white	ADJ
dti-2347	87	8	blood	blood	NOUN
dti-2347	87	9	cells	cell	NOUN
dti-2347	87	10	,	,	PUNCT
dti-2347	87	11	an	an	DET
dti-2347	87	12	assumed	assumed	ADJ
dti-2347	87	13	index	index	NOUN
dti-2347	87	14	of	of	ADP
dti-2347	87	15	systemic	systemic	ADJ
dti-2347	87	16	inflammation	inflammation	NOUN
dti-2347	87	17	,	,	PUNCT
dti-2347	87	18	increased	increase	VERB
dti-2347	87	19	significantly	significantly	ADV
dti-2347	87	20	6	6	NUM
dti-2347	87	21	hours	hour	NOUN
dti-2347	87	22	after	after	ADP
dti-2347	87	23	acid	acid	NOUN
dti-2347	87	24	instillation	instillation	NOUN
dti-2347	87	25	(	(	PUNCT
dti-2347	87	26	fig	fig	NOUN
dti-2347	87	27	.	.	PUNCT
dti-2347	88	1	2a	2a	NUM
dti-2347	88	2	)	)	PUNCT
dti-2347	89	1	in	in	ADP
dti-2347	89	2	both	both	DET
dti-2347	89	3	vehicle	vehicle	NOUN
dti-2347	89	4	(	(	PUNCT
dti-2347	89	5	p<0.01	p<0.01	PROPN
dti-2347	89	6	)	)	PUNCT
dti-2347	89	7	and	and	CCONJ
dti-2347	89	8	hexarelin	hexarelin	PROPN
dti-2347	89	9	-	-	PUNCT
dti-2347	89	10	treated	treat	VERB
dti-2347	89	11	(	(	PUNCT
dti-2347	89	12	p<0.05	p<0.05	NOUN
dti-2347	89	13	)	)	PUNCT
dti-2347	89	14	groups	group	NOUN
dti-2347	89	15	compared	compare	VERB
dti-2347	89	16	fig	fig	NOUN
dti-2347	89	17	.	.	PUNCT
dti-2347	90	1	1	1	NUM
dti-2347	90	2	respiratory	respiratory	ADJ
dti-2347	90	3	system	system	NOUN
dti-2347	90	4	static	static	ADJ
dti-2347	90	5	compliance	compliance	NOUN
dti-2347	90	6	(	(	PUNCT
dti-2347	90	7	panel	panel	NOUN
dti-2347	90	8	a	a	NOUN
dti-2347	90	9	)	)	PUNCT
dti-2347	90	10	and	and	CCONJ
dti-2347	90	11	oxygenation	oxygenation	NOUN
dti-2347	90	12	(	(	PUNCT
dti-2347	90	13	panel	panel	NOUN
dti-2347	90	14	b	b	NOUN
dti-2347	90	15	)	)	PUNCT
dti-2347	90	16	.	.	PUNCT
dti-2347	91	1	respiratory	respiratory	ADJ
dti-2347	91	2	system	system	NOUN
dti-2347	91	3	static	static	ADJ
dti-2347	91	4	compliance	compliance	NOUN
dti-2347	91	5	derived	derive	VERB
dti-2347	91	6	from	from	ADP
dti-2347	91	7	the	the	DET
dti-2347	91	8	pressure	pressure	NOUN
dti-2347	91	9	-	-	PUNCT
dti-2347	91	10	volume	volume	NOUN
dti-2347	91	11	curve	curve	NOUN
dti-2347	91	12	construction	construction	NOUN
dti-2347	91	13	and	and	CCONJ
dti-2347	91	14	oxygenation	oxygenation	NOUN
dti-2347	91	15	(	(	PUNCT
dti-2347	91	16	pao2	pao2	PROPN
dti-2347	91	17	)	)	PUNCT
dti-2347	91	18	was	be	AUX
dti-2347	91	19	measured	measure	VERB
dti-2347	91	20	by	by	ADP
dti-2347	91	21	arterial	arterial	ADJ
dti-2347	91	22	blood	blood	NOUN
dti-2347	91	23	from	from	ADP
dti-2347	91	24	the	the	DET
dti-2347	91	25	left	left	ADJ
dti-2347	91	26	ventricle	ventricle	NOUN
dti-2347	91	27	.	.	PUNCT
dti-2347	92	1	a	a	DET
dti-2347	92	2	)	)	PUNCT
dti-2347	92	3	analysis	analysis	NOUN
dti-2347	92	4	of	of	ADP
dti-2347	92	5	variance	variance	NOUN
dti-2347	92	6	(	(	PUNCT
dti-2347	92	7	anova	anova	PROPN
dti-2347	92	8	)	)	PUNCT
dti-2347	92	9	in	in	ADP
dti-2347	92	10	sacrifice	sacrifice	NOUN
dti-2347	92	11	6	6	NUM
dti-2347	92	12	h	h	NOUN
dti-2347	92	13	experiment	experiment	NOUN
dti-2347	92	14	p<0.05	p<0.05	NOUN
dti-2347	92	15	,	,	PUNCT
dti-2347	92	16	tukey	tukey	PROPN
dti-2347	92	17	post	post	X
dti-2347	92	18	hoc	hoc	X
dti-2347	92	19	test	test	NOUN
dti-2347	92	20	;	;	PUNCT
dti-2347	92	21	*	*	PUNCT
dti-2347	92	22	p<0.05	p<0.05	NOUN
dti-2347	92	23	vs.	vs.	X
dti-2347	92	24	healthy	healthy	ADJ
dti-2347	92	25	;	;	PUNCT
dti-2347	92	26	anova	anova	X
dti-2347	92	27	in	in	ADP
dti-2347	92	28	sacrifice	sacrifice	NOUN
dti-2347	92	29	24	24	NUM
dti-2347	92	30	h	h	NOUN
dti-2347	92	31	experiment	experiment	NOUN
dti-2347	92	32	p<0.01	p<0.01	PROPN
dti-2347	92	33	,	,	PUNCT
dti-2347	92	34	tukey	tukey	PROPN
dti-2347	92	35	post	post	X
dti-2347	92	36	hoc	hoc	X
dti-2347	92	37	test	test	NOUN
dti-2347	92	38	;	;	PUNCT
dti-2347	92	39	*	*	PUNCT
dti-2347	92	40	p<0.05	p<0.05	NOUN
dti-2347	92	41	vs.	vs.	ADP
dti-2347	92	42	healthy	healthy	ADJ
dti-2347	92	43	,	,	PUNCT
dti-2347	92	44	°	°	PROPN
dti-2347	92	45	p<0.05	p<0.05	NOUN
dti-2347	92	46	vs.	vs.	ADP
dti-2347	92	47	post	post	ADJ
dti-2347	92	48	-	-	ADJ
dti-2347	92	49	hex	hex	ADJ
dti-2347	92	50	,	,	PUNCT
dti-2347	92	51	#	#	NOUN
dti-2347	92	52	p<0.05	p<0.05	NOUN
dti-2347	92	53	vs.	vs.	ADP
dti-2347	92	54	pre	pre	NOUN
dti-2347	92	55	-	-	ADJ
dti-2347	92	56	hex	hex	PROPN
dti-2347	92	57	.	.	PUNCT
dti-2347	93	1	b	b	X
dti-2347	93	2	)	)	PUNCT
dti-2347	93	3	anova	anova	PROPN
dti-2347	93	4	in	in	ADP
dti-2347	93	5	sacrifice	sacrifice	NOUN
dti-2347	93	6	6	6	NUM
dti-2347	93	7	h	h	NOUN
dti-2347	93	8	experiment	experiment	NOUN
dti-2347	93	9	p<0.01	p<0.01	PROPN
dti-2347	93	10	,	,	PUNCT
dti-2347	93	11	tukey	tukey	PROPN
dti-2347	93	12	post	post	X
dti-2347	93	13	hoc	hoc	X
dti-2347	93	14	test	test	NOUN
dti-2347	93	15	;	;	PUNCT
dti-2347	93	16	*	*	PUNCT
dti-2347	93	17	p<0.01	p<0.01	PROPN
dti-2347	93	18	vs.	vs.	ADP
dti-2347	93	19	vehicle	vehicle	NOUN
dti-2347	93	20	,	,	PUNCT
dti-2347	93	21	post	post	ADJ
dti-2347	93	22	-	-	ADJ
dti-2347	93	23	hex	hex	ADJ
dti-2347	93	24	and	and	CCONJ
dti-2347	93	25	pre	pre	ADJ
dti-2347	93	26	-	-	ADJ
dti-2347	93	27	hex	hex	X
dti-2347	93	28	;	;	PUNCT
dti-2347	93	29	anova	anova	X
dti-2347	93	30	in	in	ADP
dti-2347	93	31	sacrifice	sacrifice	NOUN
dti-2347	93	32	24	24	NUM
dti-2347	93	33	h	h	NOUN
dti-2347	93	34	experiment	experiment	NOUN
dti-2347	93	35	p<0.01	p<0.01	PROPN
dti-2347	93	36	,	,	PUNCT
dti-2347	93	37	tukey	tukey	PROPN
dti-2347	93	38	post	post	X
dti-2347	93	39	hoc	hoc	X
dti-2347	93	40	test	test	NOUN
dti-2347	93	41	;	;	PUNCT
dti-2347	93	42	*	*	PUNCT
dti-2347	93	43	p<0.01	p<0.01	PROPN
dti-2347	93	44	vs.	vs.	ADP
dti-2347	93	45	vehicle	vehicle	NOUN
dti-2347	93	46	,	,	PUNCT
dti-2347	93	47	posthex	posthex	PROPN
dti-2347	93	48	,	,	PUNCT
dti-2347	93	49	and	and	CCONJ
dti-2347	93	50	pre	pre	ADJ
dti-2347	93	51	-	-	ADJ
dti-2347	93	52	hex	hex	ADJ
dti-2347	93	53	.	.	PUNCT
dti-2347	94	1	healthy	healthy	ADJ
dti-2347	94	2	:	:	PUNCT
dti-2347	95	1	no	no	DET
dti-2347	95	2	surgical	surgical	ADJ
dti-2347	95	3	interventions	intervention	NOUN
dti-2347	95	4	or	or	CCONJ
dti-2347	95	5	treatment	treatment	NOUN
dti-2347	95	6	(	(	PUNCT
dti-2347	95	7	n	n	NOUN
dti-2347	95	8	=	=	SYM
dti-2347	95	9	5	5	NUM
dti-2347	95	10	)	)	PUNCT
dti-2347	95	11	;	;	PUNCT
dti-2347	95	12	vehicle	vehicle	NOUN
dti-2347	95	13	:	:	PUNCT
dti-2347	95	14	hcl	hcl	PROPN
dti-2347	95	15	instillation	instillation	NOUN
dti-2347	95	16	+	+	CCONJ
dti-2347	95	17	vehicle	vehicle	NOUN
dti-2347	95	18	treatment	treatment	NOUN
dti-2347	95	19	(	(	PUNCT
dti-2347	95	20	n	n	NOUN
dti-2347	95	21	=	=	SYM
dti-2347	95	22	8)	8)	NUM
dti-2347	95	23	;	;	PUNCT
dti-2347	95	24	post	post	ADJ
dti-2347	95	25	-	-	ADJ
dti-2347	95	26	hex	hex	ADJ
dti-2347	95	27	:	:	PUNCT
dti-2347	95	28	hcl	hcl	PROPN
dti-2347	95	29	instillation	instillation	NOUN
dti-2347	95	30	+	+	CCONJ
dti-2347	95	31	hexarelin	hexarelin	PROPN
dti-2347	95	32	treatment	treatment	NOUN
dti-2347	95	33	(	(	PUNCT
dti-2347	95	34	n	n	NOUN
dti-2347	95	35	=	=	SYM
dti-2347	95	36	8)	8)	NUM
dti-2347	95	37	;	;	PUNCT
dti-2347	95	38	pre	pre	ADJ
dti-2347	95	39	-	-	ADJ
dti-2347	95	40	hex	hex	ADJ
dti-2347	95	41	:	:	PUNCT
dti-2347	95	42	hexarelin	hexarelin	PROPN
dti-2347	95	43	pretreatment	pretreatment	NOUN
dti-2347	95	44	+	+	CCONJ
dti-2347	95	45	hcl	hcl	PROPN
dti-2347	95	46	instillation	instillation	NOUN
dti-2347	95	47	(	(	PUNCT
dti-2347	95	48	n	n	NOUN
dti-2347	95	49	=	=	SYM
dti-2347	95	50	8)	8)	NUM
dti-2347	95	51	.	.	PUNCT
dti-2347	95	52	zambelli	zambelli	PROPN
dti-2347	95	53	et	et	PROPN
dti-2347	95	54	al	al	PROPN
dti-2347	95	55	drug	drug	PROPN
dti-2347	95	56	target	target	NOUN
dti-2347	95	57	insights	insight	NOUN
dti-2347	95	58	2021	2021	NUM
dti-2347	95	59	;	;	PUNCT
dti-2347	95	60	15	15	NUM
dti-2347	95	61	:	:	SYM
dti-2347	95	62	29	29	NUM
dti-2347	95	63	©	©	ADP
dti-2347	95	64	2021	2021	NUM
dti-2347	95	65	the	the	DET
dti-2347	95	66	authors	author	NOUN
dti-2347	95	67	.	.	PUNCT
dti-2347	96	1	published	publish	VERB
dti-2347	96	2	by	by	ADP
dti-2347	96	3	aboutscience	aboutscience	NOUN
dti-2347	96	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2347	96	5	with	with	ADP
dti-2347	96	6	healthy	healthy	ADJ
dti-2347	96	7	mice	mouse	NOUN
dti-2347	96	8	.	.	PUNCT
dti-2347	97	1	at	at	ADP
dti-2347	97	2	24	24	NUM
dti-2347	97	3	hours	hour	NOUN
dti-2347	97	4	post	post	ADJ
dti-2347	97	5	-	-	NOUN
dti-2347	97	6	instillation	instillation	NOUN
dti-2347	97	7	,	,	PUNCT
dti-2347	97	8	total	total	ADJ
dti-2347	97	9	cell	cell	NOUN
dti-2347	97	10	numbers	number	NOUN
dti-2347	97	11	decreased	decrease	VERB
dti-2347	97	12	in	in	ADP
dti-2347	97	13	all	all	DET
dti-2347	97	14	groups	group	NOUN
dti-2347	97	15	;	;	PUNCT
dti-2347	97	16	in	in	ADP
dti-2347	97	17	particular	particular	ADJ
dti-2347	97	18	,	,	PUNCT
dti-2347	97	19	cell	cell	NOUN
dti-2347	97	20	numbers	number	NOUN
dti-2347	97	21	returned	return	VERB
dti-2347	97	22	to	to	ADP
dti-2347	97	23	normal	normal	ADJ
dti-2347	97	24	(	(	PUNCT
dti-2347	97	25	healthy	healthy	ADJ
dti-2347	97	26	)	)	PUNCT
dti-2347	97	27	levels	level	NOUN
dti-2347	97	28	in	in	ADP
dti-2347	97	29	hexarelin	hexarelin	PROPN
dti-2347	97	30	-	-	PUNCT
dti-2347	97	31	treated	treat	VERB
dti-2347	97	32	mice	mouse	NOUN
dti-2347	97	33	.	.	PUNCT
dti-2347	98	1	differential	differential	ADJ
dti-2347	98	2	cell	cell	NOUN
dti-2347	98	3	counts	count	NOUN
dti-2347	98	4	of	of	ADP
dti-2347	98	5	bal	bal	ADJ
dti-2347	98	6	fluid	fluid	NOUN
dti-2347	98	7	were	be	AUX
dti-2347	98	8	strongly	strongly	ADV
dti-2347	98	9	influenced	influence	VERB
dti-2347	98	10	both	both	CCONJ
dti-2347	98	11	by	by	ADP
dti-2347	98	12	acid	acid	NOUN
dti-2347	98	13	instillation	instillation	NOUN
dti-2347	98	14	and	and	CCONJ
dti-2347	98	15	by	by	ADP
dti-2347	98	16	hexarelin	hexarelin	PROPN
dti-2347	98	17	(	(	PUNCT
dti-2347	98	18	fig	fig	NOUN
dti-2347	98	19	.	.	PUNCT
dti-2347	99	1	2b	2b	NOUN
dti-2347	99	2	,	,	PUNCT
dti-2347	99	3	c	c	NOUN
dti-2347	99	4	)	)	PUNCT
dti-2347	99	5	.	.	PUNCT
dti-2347	100	1	in	in	ADP
dti-2347	100	2	the	the	DET
dti-2347	100	3	bal	bal	NOUN
dti-2347	100	4	of	of	ADP
dti-2347	100	5	healthy	healthy	ADJ
dti-2347	100	6	mice	mouse	NOUN
dti-2347	100	7	,	,	PUNCT
dti-2347	100	8	polymorphonuclear	polymorphonuclear	NOUN
dti-2347	100	9	(	(	PUNCT
dti-2347	100	10	pmn	pmn	ADJ
dti-2347	100	11	)	)	PUNCT
dti-2347	100	12	cells	cell	NOUN
dti-2347	100	13	represented	represent	VERB
dti-2347	100	14	4	4	NUM
dti-2347	100	15	%	%	NOUN
dti-2347	100	16	of	of	ADP
dti-2347	100	17	total	total	ADJ
dti-2347	100	18	white	white	ADJ
dti-2347	100	19	blood	blood	NOUN
dti-2347	100	20	cells	cell	NOUN
dti-2347	100	21	,	,	PUNCT
dti-2347	100	22	the	the	DET
dti-2347	100	23	balance	balance	NOUN
dti-2347	100	24	of	of	ADP
dti-2347	100	25	which	which	PRON
dti-2347	100	26	(	(	PUNCT
dti-2347	100	27	96	96	NUM
dti-2347	100	28	%	%	NOUN
dti-2347	100	29	)	)	PUNCT
dti-2347	100	30	were	be	AUX
dti-2347	100	31	macrophages	macrophage	NOUN
dti-2347	100	32	.	.	PUNCT
dti-2347	101	1	at	at	ADP
dti-2347	101	2	6	6	NUM
dti-2347	101	3	hours	hour	NOUN
dti-2347	101	4	post	post	ADJ
dti-2347	101	5	-	-	ADJ
dti-2347	101	6	acid	acid	ADJ
dti-2347	101	7	instillation	instillation	NOUN
dti-2347	101	8	,	,	PUNCT
dti-2347	101	9	there	there	PRON
dti-2347	101	10	was	be	VERB
dti-2347	101	11	an	an	DET
dti-2347	101	12	important	important	ADJ
dti-2347	101	13	increase	increase	NOUN
dti-2347	101	14	in	in	ADP
dti-2347	101	15	bal	bal	PROPN
dti-2347	101	16	pmn	pmn	PROPN
dti-2347	101	17	;	;	PUNCT
dti-2347	101	18	notably	notably	ADV
dti-2347	101	19	,	,	PUNCT
dti-2347	101	20	pmn	pmn	NOUN
dti-2347	101	21	in	in	ADP
dti-2347	101	22	the	the	DET
dti-2347	101	23	bal	bal	NOUN
dti-2347	101	24	of	of	ADP
dti-2347	101	25	the	the	DET
dti-2347	101	26	pre	pre	ADJ
dti-2347	101	27	-	-	ADJ
dti-2347	101	28	hexarelin	hexarelin	ADJ
dti-2347	101	29	-	-	PUNCT
dti-2347	101	30	treated	treat	VERB
dti-2347	101	31	group	group	NOUN
dti-2347	101	32	was	be	AUX
dti-2347	101	33	also	also	ADV
dti-2347	101	34	elevated	elevated	ADJ
dti-2347	101	35	and	and	CCONJ
dti-2347	101	36	significantly	significantly	ADV
dti-2347	101	37	(	(	PUNCT
dti-2347	101	38	p	p	X
dti-2347	101	39	=	=	NOUN
dti-2347	101	40	0.010	0.010	NUM
dti-2347	101	41	)	)	PUNCT
dti-2347	101	42	different	different	ADJ
dti-2347	101	43	from	from	ADP
dti-2347	101	44	those	those	PRON
dti-2347	101	45	in	in	ADP
dti-2347	101	46	healthy	healthy	ADJ
dti-2347	101	47	mice	mouse	NOUN
dti-2347	101	48	.	.	PUNCT
dti-2347	102	1	acid	acid	NOUN
dti-2347	102	2	instillation	instillation	NOUN
dti-2347	102	3	increased	increase	VERB
dti-2347	102	4	the	the	DET
dti-2347	102	5	differential	differential	ADJ
dti-2347	102	6	cell	cell	NOUN
dti-2347	102	7	count	count	NOUN
dti-2347	102	8	,	,	PUNCT
dti-2347	102	9	which	which	PRON
dti-2347	102	10	achieved	achieve	VERB
dti-2347	102	11	maximum	maximum	ADJ
dti-2347	102	12	levels	level	NOUN
dti-2347	102	13	at	at	ADP
dti-2347	102	14	24	24	NUM
dti-2347	102	15	hours	hour	NOUN
dti-2347	102	16	post	post	ADJ
dti-2347	102	17	-	-	NOUN
dti-2347	102	18	instillation	instillation	ADJ
dti-2347	102	19	(	(	PUNCT
dti-2347	102	20	fig	fig	NOUN
dti-2347	102	21	.	.	PUNCT
dti-2347	103	1	2b	2b	NOUN
dti-2347	103	2	,	,	PUNCT
dti-2347	103	3	c	c	NOUN
dti-2347	103	4	)	)	PUNCT
dti-2347	103	5	.	.	PUNCT
dti-2347	104	1	at	at	ADP
dti-2347	104	2	this	this	DET
dti-2347	104	3	time	time	NOUN
dti-2347	104	4	,	,	PUNCT
dti-2347	104	5	hexarelin	hexarelin	PROPN
dti-2347	104	6	treatment	treatment	NOUN
dti-2347	104	7	and	and	CCONJ
dti-2347	104	8	especially	especially	ADV
dti-2347	104	9	pretreatment	pretreatment	NOUN
dti-2347	104	10	modulated	modulate	VERB
dti-2347	104	11	pmn	pmn	ADJ
dti-2347	104	12	numbers	number	NOUN
dti-2347	104	13	to	to	ADP
dti-2347	104	14	a	a	DET
dti-2347	104	15	lesser	less	ADJ
dti-2347	104	16	and	and	CCONJ
dti-2347	104	17	greater	great	ADJ
dti-2347	104	18	extent	extent	NOUN
dti-2347	104	19	.	.	PUNCT
dti-2347	105	1	curiously	curiously	ADV
dti-2347	105	2	,	,	PUNCT
dti-2347	105	3	macrophage	macrophage	ADJ
dti-2347	105	4	numbers	number	NOUN
dti-2347	105	5	in	in	ADP
dti-2347	105	6	hexarelin	hexarelin	PROPN
dti-2347	105	7	-	-	PUNCT
dti-2347	105	8	treated	treat	VERB
dti-2347	105	9	mice	mouse	NOUN
dti-2347	105	10	were	be	AUX
dti-2347	105	11	significantly	significantly	ADV
dti-2347	105	12	greater	great	ADJ
dti-2347	105	13	compared	compare	VERB
dti-2347	105	14	with	with	ADP
dti-2347	105	15	other	other	ADJ
dti-2347	105	16	groups	group	NOUN
dti-2347	105	17	in	in	ADP
dti-2347	105	18	both	both	CCONJ
dti-2347	105	19	the	the	DET
dti-2347	105	20	right	right	NOUN
dti-2347	105	21	(	(	PUNCT
dti-2347	105	22	acid	acid	NOUN
dti-2347	105	23	-	-	PUNCT
dti-2347	105	24	instilled	instill	VERB
dti-2347	105	25	)	)	PUNCT
dti-2347	105	26	as	as	ADV
dti-2347	105	27	well	well	ADV
dti-2347	105	28	as	as	ADP
dti-2347	105	29	the	the	DET
dti-2347	105	30	left	left	ADJ
dti-2347	105	31	(	(	PUNCT
dti-2347	105	32	acid	acid	NOUN
dti-2347	105	33	-	-	PUNCT
dti-2347	105	34	naive	naive	ADJ
dti-2347	105	35	)	)	PUNCT
dti-2347	105	36	lungs	lung	NOUN
dti-2347	105	37	.	.	PUNCT
dti-2347	106	1	indices	index	NOUN
dti-2347	106	2	of	of	ADP
dti-2347	106	3	local	local	ADJ
dti-2347	106	4	inflammation	inflammation	NOUN
dti-2347	106	5	included	include	VERB
dti-2347	106	6	the	the	DET
dti-2347	106	7	total	total	ADJ
dti-2347	106	8	protein	protein	NOUN
dti-2347	106	9	contents	content	NOUN
dti-2347	106	10	and	and	CCONJ
dti-2347	106	11	differential	differential	ADJ
dti-2347	106	12	cell	cell	NOUN
dti-2347	106	13	counts	count	NOUN
dti-2347	106	14	of	of	ADP
dti-2347	106	15	bal	bal	PROPN
dti-2347	106	16	.	.	PUNCT
dti-2347	107	1	acid	acid	PROPN
dti-2347	107	2	instillation	instillation	NOUN
dti-2347	107	3	induced	induce	VERB
dti-2347	107	4	a	a	DET
dti-2347	107	5	very	very	ADV
dti-2347	107	6	large	large	ADJ
dti-2347	107	7	protein	protein	NOUN
dti-2347	107	8	extravasation	extravasation	NOUN
dti-2347	107	9	into	into	ADP
dti-2347	107	10	alveoli	alveoli	PRON
dti-2347	107	11	(	(	PUNCT
dti-2347	107	12	tab	tab	NOUN
dti-2347	107	13	.	.	PUNCT
dti-2347	108	1	i	i	PRON
dti-2347	108	2	)	)	PUNCT
dti-2347	108	3	.	.	PUNCT
dti-2347	109	1	hexarelin	hexarelin	PROPN
dti-2347	109	2	treatment	treatment	NOUN
dti-2347	109	3	and	and	CCONJ
dti-2347	109	4	pretreatment	pretreatment	NOUN
dti-2347	109	5	modulated	modulate	VERB
dti-2347	109	6	acidinduced	acidinduced	ADJ
dti-2347	109	7	protein	protein	NOUN
dti-2347	109	8	leakage	leakage	NOUN
dti-2347	109	9	;	;	PUNCT
dti-2347	109	10	in	in	ADP
dti-2347	109	11	fact	fact	NOUN
dti-2347	109	12	,	,	PUNCT
dti-2347	109	13	the	the	DET
dti-2347	109	14	bal	bal	ADJ
dti-2347	109	15	protein	protein	NOUN
dti-2347	109	16	contents	content	NOUN
dti-2347	109	17	in	in	ADP
dti-2347	109	18	both	both	CCONJ
dti-2347	109	19	hexarelin	hexarelin	PROPN
dti-2347	109	20	-	-	PUNCT
dti-2347	109	21	treated	treat	VERB
dti-2347	109	22	groups	group	NOUN
dti-2347	109	23	(	(	PUNCT
dti-2347	109	24	6	6	NUM
dti-2347	109	25	hours	hour	NOUN
dti-2347	109	26	post	post	ADJ
dti-2347	109	27	-	-	NOUN
dti-2347	109	28	instillation	instillation	NOUN
dti-2347	109	29	)	)	PUNCT
dti-2347	109	30	were	be	AUX
dti-2347	109	31	comparable	comparable	ADJ
dti-2347	109	32	with	with	ADP
dti-2347	109	33	those	those	PRON
dti-2347	109	34	of	of	ADP
dti-2347	109	35	healthy	healthy	ADJ
dti-2347	109	36	mice	mouse	NOUN
dti-2347	109	37	and	and	CCONJ
dti-2347	109	38	significantly	significantly	ADV
dti-2347	109	39	smaller	small	ADJ
dti-2347	109	40	(	(	PUNCT
dti-2347	109	41	p<0.01	p<0.01	PROPN
dti-2347	109	42	)	)	PUNCT
dti-2347	109	43	than	than	ADP
dti-2347	109	44	those	those	PRON
dti-2347	109	45	in	in	ADP
dti-2347	109	46	the	the	DET
dti-2347	109	47	acid	acid	NOUN
dti-2347	109	48	-	-	PUNCT
dti-2347	109	49	instilled	instill	VERB
dti-2347	109	50	-	-	PUNCT
dti-2347	109	51	alone	alone	ADV
dti-2347	109	52	group	group	NOUN
dti-2347	109	53	.	.	PUNCT
dti-2347	110	1	table	table	NOUN
dti-2347	110	2	i	i	PRON
dti-2347	110	3	local	local	ADJ
dti-2347	110	4	inflammation	inflammation	NOUN
dti-2347	110	5	:	:	PUNCT
dti-2347	110	6	total	total	ADJ
dti-2347	110	7	protein	protein	NOUN
dti-2347	110	8	bal	bal	PROPN
dti-2347	110	9	content	content	NOUN
dti-2347	110	10	in	in	ADP
dti-2347	110	11	right	right	ADV
dti-2347	110	12	and	and	CCONJ
dti-2347	110	13	left	leave	VERB
dti-2347	110	14	lung	lung	NOUN
dti-2347	110	15	by	by	ADP
dti-2347	110	16	bca	bca	PROPN
dti-2347	110	17	method	method	PROPN
dti-2347	110	18	groups	group	NOUN
dti-2347	110	19	right	right	ADJ
dti-2347	111	1	lung	lung	NOUN
dti-2347	111	2	left	leave	VERB
dti-2347	111	3	lung	lung	PROPN
dti-2347	111	4	healthy	healthy	ADJ
dti-2347	111	5	268	268	NUM
dti-2347	111	6	±	±	NUM
dti-2347	111	7	24	24	NUM
dti-2347	111	8	423	423	NUM
dti-2347	111	9	±	±	NUM
dti-2347	111	10	54	54	NUM
dti-2347	111	11	sacrifice	sacrifice	NOUN
dti-2347	111	12	6	6	NUM
dti-2347	111	13	h	h	NOUN
dti-2347	111	14	vehicle	vehicle	NOUN
dti-2347	111	15	2994	2994	NUM
dti-2347	111	16	±	±	NUM
dti-2347	111	17	496	496	NUM
dti-2347	111	18	*	*	NOUN
dti-2347	111	19	,	,	PUNCT
dti-2347	111	20	°	°	ADP
dti-2347	111	21	1148	1148	NUM
dti-2347	111	22	±	±	NUM
dti-2347	111	23	193	193	NUM
dti-2347	111	24	post	post	ADJ
dti-2347	111	25	-	-	ADJ
dti-2347	111	26	hex	hex	ADJ
dti-2347	111	27	1585	1585	NUM
dti-2347	111	28	±	±	NUM
dti-2347	111	29	316	316	NUM
dti-2347	111	30	1380	1380	NUM
dti-2347	111	31	±	±	NUM
dti-2347	111	32	262	262	NUM
dti-2347	111	33	pre	pre	ADJ
dti-2347	111	34	-	-	ADJ
dti-2347	111	35	hex	hex	ADJ
dti-2347	111	36	1647	1647	NUM
dti-2347	111	37	±315	±315	PROPN
dti-2347	111	38	1013	1013	NUM
dti-2347	111	39	±	±	NUM
dti-2347	111	40	294	294	NUM
dti-2347	111	41	sacrifice	sacrifice	NOUN
dti-2347	111	42	24	24	NUM
dti-2347	111	43	h	h	NOUN
dti-2347	111	44	vehicle	vehicle	NOUN
dti-2347	111	45	2891	2891	NUM
dti-2347	111	46	±	±	NUM
dti-2347	111	47	289	289	NUM
dti-2347	111	48	*	*	PUNCT
dti-2347	111	49	*	*	PUNCT
dti-2347	111	50	773	773	NUM
dti-2347	111	51	±	±	NUM
dti-2347	111	52	103	103	NUM
dti-2347	111	53	post	post	ADJ
dti-2347	111	54	-	-	ADJ
dti-2347	111	55	hex	hex	ADJ
dti-2347	111	56	2145	2145	NUM
dti-2347	111	57	±	±	NUM
dti-2347	111	58	266	266	NUM
dti-2347	111	59	°	°	NOUN
dti-2347	111	60	°	°	ADP
dti-2347	111	61	616	616	NUM
dti-2347	111	62	±	±	NUM
dti-2347	111	63	70	70	NUM
dti-2347	111	64	pre	pre	ADJ
dti-2347	111	65	-	-	ADJ
dti-2347	111	66	hex	hex	ADJ
dti-2347	111	67	2364	2364	NUM
dti-2347	111	68	±	±	NUM
dti-2347	111	69	296	296	NUM
dti-2347	111	70	#	#	NOUN
dti-2347	111	71	521	521	NUM
dti-2347	111	72	±	±	NUM
dti-2347	111	73	90	90	NUM
dti-2347	111	74	in	in	ADP
dti-2347	111	75	the	the	DET
dti-2347	111	76	right	right	ADJ
dti-2347	111	77	lung	lung	NOUN
dti-2347	111	78	:	:	PUNCT
dti-2347	111	79	anova	anova	PROPN
dti-2347	111	80	in	in	ADP
dti-2347	111	81	sacrifice	sacrifice	NOUN
dti-2347	111	82	6	6	NUM
dti-2347	111	83	h	h	NOUN
dti-2347	111	84	experiment	experiment	NOUN
dti-2347	111	85	p<0.01	p<0.01	PROPN
dti-2347	111	86	,	,	PUNCT
dti-2347	111	87	tukey	tukey	PROPN
dti-2347	111	88	post	post	X
dti-2347	111	89	hoc	hoc	X
dti-2347	111	90	test	test	NOUN
dti-2347	111	91	;	;	PUNCT
dti-2347	111	92	*	*	PUNCT
dti-2347	111	93	p<0.01	p<0.01	NOUN
dti-2347	111	94	vs.	vs.	X
dti-2347	111	95	healthy	healthy	ADJ
dti-2347	111	96	,	,	PUNCT
dti-2347	111	97	°	°	PROPN
dti-2347	111	98	p<0.05	p<0.05	NOUN
dti-2347	111	99	vs.	vs.	ADP
dti-2347	111	100	post	post	NOUN
dti-2347	111	101	-	-	ADJ
dti-2347	111	102	hex	hex	X
dti-2347	111	103	;	;	PUNCT
dti-2347	111	104	anova	anova	X
dti-2347	111	105	in	in	ADP
dti-2347	111	106	sacrifice	sacrifice	NOUN
dti-2347	111	107	24	24	NUM
dti-2347	111	108	h	h	NOUN
dti-2347	111	109	experiment	experiment	NOUN
dti-2347	111	110	p<0.01	p<0.01	PROPN
dti-2347	111	111	,	,	PUNCT
dti-2347	111	112	tukey	tukey	PROPN
dti-2347	111	113	post	post	X
dti-2347	111	114	hoc	hoc	X
dti-2347	111	115	test	test	NOUN
dti-2347	111	116	;	;	PUNCT
dti-2347	111	117	*	*	PUNCT
dti-2347	111	118	*	*	PUNCT
dti-2347	111	119	p<0.01	p<0.01	ADJ
dti-2347	111	120	vs.	vs.	X
dti-2347	111	121	healthy	healthy	ADJ
dti-2347	111	122	,	,	PUNCT
dti-2347	111	123	°	°	PROPN
dti-2347	111	124	°	°	NOUN
dti-2347	111	125	p<0.01	p<0.01	PROPN
dti-2347	111	126	vs.	vs.	X
dti-2347	111	127	healthy	healthy	ADJ
dti-2347	111	128	,	,	PUNCT
dti-2347	111	129	#	#	NOUN
dti-2347	111	130	p<0.01	p<0.01	NOUN
dti-2347	111	131	vs.	vs.	X
dti-2347	111	132	healthy	healthy	ADJ
dti-2347	111	133	.	.	PUNCT
dti-2347	112	1	in	in	ADP
dti-2347	112	2	the	the	DET
dti-2347	112	3	left	left	ADJ
dti-2347	112	4	lung	lung	PROPN
dti-2347	112	5	:	:	PUNCT
dti-2347	112	6	anova	anova	PROPN
dti-2347	112	7	p	p	X
dti-2347	112	8	=	=	SYM
dti-2347	112	9	ns	ns	PROPN
dti-2347	112	10	.	.	PROPN
dti-2347	112	11	healthy	healthy	ADJ
dti-2347	112	12	:	:	PUNCT
dti-2347	112	13	no	no	DET
dti-2347	112	14	surgical	surgical	ADJ
dti-2347	112	15	interventions	intervention	NOUN
dti-2347	112	16	or	or	CCONJ
dti-2347	112	17	treatment	treatment	NOUN
dti-2347	112	18	(	(	PUNCT
dti-2347	112	19	n	n	NOUN
dti-2347	112	20	=	=	SYM
dti-2347	112	21	5	5	NUM
dti-2347	112	22	)	)	PUNCT
dti-2347	112	23	;	;	PUNCT
dti-2347	112	24	vehicle	vehicle	NOUN
dti-2347	112	25	:	:	PUNCT
dti-2347	112	26	hcl	hcl	PROPN
dti-2347	112	27	instillation	instillation	NOUN
dti-2347	112	28	+	+	CCONJ
dti-2347	112	29	vehicle	vehicle	NOUN
dti-2347	112	30	treatment	treatment	NOUN
dti-2347	112	31	(	(	PUNCT
dti-2347	112	32	n	n	NOUN
dti-2347	112	33	=	=	SYM
dti-2347	112	34	8)	8)	NUM
dti-2347	112	35	;	;	PUNCT
dti-2347	112	36	post	post	ADJ
dti-2347	112	37	-	-	ADJ
dti-2347	112	38	hex	hex	ADJ
dti-2347	112	39	:	:	PUNCT
dti-2347	112	40	hcl	hcl	PROPN
dti-2347	112	41	instillation	instillation	NOUN
dti-2347	112	42	+	+	CCONJ
dti-2347	112	43	hexarelin	hexarelin	PROPN
dti-2347	112	44	treatment	treatment	NOUN
dti-2347	112	45	(	(	PUNCT
dti-2347	112	46	n	n	NOUN
dti-2347	112	47	=	=	SYM
dti-2347	112	48	8)	8)	NUM
dti-2347	112	49	;	;	PUNCT
dti-2347	112	50	pre	pre	ADJ
dti-2347	112	51	-	-	ADJ
dti-2347	112	52	hex	hex	ADJ
dti-2347	112	53	:	:	PUNCT
dti-2347	112	54	hexarelin	hexarelin	PROPN
dti-2347	112	55	pretreatment	pretreatment	NOUN
dti-2347	112	56	+	+	CCONJ
dti-2347	112	57	hcl	hcl	PROPN
dti-2347	112	58	instillation	instillation	NOUN
dti-2347	112	59	(	(	PUNCT
dti-2347	112	60	n	n	NOUN
dti-2347	112	61	=	=	SYM
dti-2347	112	62	8)	8)	NUM
dti-2347	112	63	.	.	PUNCT
dti-2347	112	64	anova	anova	PROPN
dti-2347	113	1	=	=	PUNCT
dti-2347	113	2	analysis	analysis	NOUN
dti-2347	113	3	of	of	ADP
dti-2347	113	4	variance	variance	NOUN
dti-2347	113	5	;	;	PUNCT
dti-2347	113	6	bal	bal	PROPN
dti-2347	113	7	=	=	PUNCT
dti-2347	113	8	bronchoalveolar	bronchoalveolar	ADJ
dti-2347	113	9	lavage	lavage	NOUN
dti-2347	113	10	;	;	PUNCT
dti-2347	113	11	bca	bca	PROPN
dti-2347	113	12	=	=	PUNCT
dti-2347	113	13	bicinchoninic	bicinchoninic	ADJ
dti-2347	113	14	acid	acid	NOUN
dti-2347	113	15	.	.	PUNCT
dti-2347	114	1	late	late	ADJ
dti-2347	114	2	ards	ards	PROPN
dti-2347	114	3	study	study	PROPN
dti-2347	114	4	body	body	NOUN
dti-2347	114	5	weight	weight	NOUN
dti-2347	114	6	was	be	AUX
dti-2347	114	7	monitored	monitor	VERB
dti-2347	114	8	throughout	throughout	ADP
dti-2347	114	9	the	the	DET
dti-2347	114	10	experiment	experiment	NOUN
dti-2347	114	11	,	,	PUNCT
dti-2347	114	12	since	since	SCONJ
dti-2347	114	13	it	it	PRON
dti-2347	114	14	is	be	AUX
dti-2347	114	15	known	know	VERB
dti-2347	114	16	that	that	SCONJ
dti-2347	114	17	hexarelin	hexarelin	PROPN
dti-2347	114	18	stimulates	stimulate	VERB
dti-2347	114	19	food	food	NOUN
dti-2347	114	20	intake	intake	NOUN
dti-2347	114	21	.	.	PUNCT
dti-2347	115	1	as	as	SCONJ
dti-2347	115	2	expected	expect	VERB
dti-2347	115	3	,	,	PUNCT
dti-2347	115	4	mice	mouse	NOUN
dti-2347	115	5	belonging	belong	VERB
dti-2347	115	6	to	to	ADP
dti-2347	115	7	acid	acid	NOUN
dti-2347	115	8	-	-	PUNCT
dti-2347	115	9	instilled	instill	VERB
dti-2347	115	10	groups	group	NOUN
dti-2347	115	11	showed	show	VERB
dti-2347	115	12	a	a	DET
dti-2347	115	13	significant	significant	ADJ
dti-2347	115	14	(	(	PUNCT
dti-2347	115	15	p<0.01	p<0.01	PROPN
dti-2347	115	16	)	)	PUNCT
dti-2347	115	17	loss	loss	NOUN
dti-2347	115	18	of	of	ADP
dti-2347	115	19	body	body	NOUN
dti-2347	115	20	weight	weight	NOUN
dti-2347	115	21	48	48	NUM
dti-2347	115	22	hours	hour	NOUN
dti-2347	115	23	after	after	ADP
dti-2347	115	24	hcl	hcl	PROPN
dti-2347	115	25	administration	administration	NOUN
dti-2347	115	26	,	,	PUNCT
dti-2347	115	27	compared	compare	VERB
dti-2347	115	28	with	with	ADP
dti-2347	115	29	healthy	healthy	ADJ
dti-2347	115	30	mice	mouse	NOUN
dti-2347	115	31	(	(	PUNCT
dti-2347	115	32	fig	fig	NOUN
dti-2347	115	33	.	.	PUNCT
dti-2347	116	1	3a	3a	NUM
dti-2347	116	2	)	)	PUNCT
dti-2347	116	3	.	.	PUNCT
dti-2347	117	1	fig	fig	NOUN
dti-2347	117	2	.	.	PUNCT
dti-2347	118	1	2	2	NUM
dti-2347	118	2	peripheral	peripheral	ADJ
dti-2347	118	3	and	and	CCONJ
dti-2347	118	4	local	local	ADJ
dti-2347	118	5	inflammation	inflammation	NOUN
dti-2347	118	6	:	:	PUNCT
dti-2347	118	7	total	total	ADJ
dti-2347	118	8	white	white	ADJ
dti-2347	118	9	blood	blood	NOUN
dti-2347	118	10	cells	cell	NOUN
dti-2347	118	11	(	(	PUNCT
dti-2347	118	12	a	a	X
dti-2347	118	13	)	)	PUNCT
dti-2347	118	14	and	and	CCONJ
dti-2347	118	15	cell	cell	NOUN
dti-2347	118	16	count	count	NOUN
dti-2347	118	17	in	in	ADP
dti-2347	118	18	bronchoalveolar	bronchoalveolar	ADJ
dti-2347	118	19	lavage	lavage	NOUN
dti-2347	118	20	(	(	PUNCT
dti-2347	118	21	bal	bal	PROPN
dti-2347	118	22	)	)	PUNCT
dti-2347	118	23	in	in	ADP
dti-2347	118	24	right	right	ADJ
dti-2347	118	25	(	(	PUNCT
dti-2347	118	26	panel	panel	NOUN
dti-2347	118	27	b	b	NOUN
dti-2347	118	28	)	)	PUNCT
dti-2347	118	29	and	and	CCONJ
dti-2347	118	30	left	leave	VERB
dti-2347	118	31	lung	lung	NOUN
dti-2347	118	32	(	(	PUNCT
dti-2347	118	33	panel	panel	NOUN
dti-2347	118	34	c	c	NOUN
dti-2347	118	35	)	)	PUNCT
dti-2347	118	36	.	.	PUNCT
dti-2347	119	1	white	white	ADJ
dti-2347	119	2	blood	blood	NOUN
dti-2347	119	3	cells	cell	NOUN
dti-2347	119	4	were	be	AUX
dti-2347	119	5	collected	collect	VERB
dti-2347	119	6	from	from	ADP
dti-2347	119	7	the	the	DET
dti-2347	119	8	arterial	arterial	ADJ
dti-2347	119	9	blood	blood	NOUN
dti-2347	119	10	and	and	CCONJ
dti-2347	119	11	stained	stain	VERB
dti-2347	119	12	with	with	ADP
dti-2347	119	13	turk	turk	NOUN
dti-2347	119	14	solution	solution	NOUN
dti-2347	119	15	.	.	PUNCT
dti-2347	120	1	alveolar	alveolar	ADJ
dti-2347	120	2	cells	cell	NOUN
dti-2347	120	3	were	be	AUX
dti-2347	120	4	collected	collect	VERB
dti-2347	120	5	by	by	ADP
dti-2347	120	6	performing	perform	VERB
dti-2347	120	7	bal	bal	PROPN
dti-2347	120	8	and	and	CCONJ
dti-2347	120	9	stained	stain	VERB
dti-2347	120	10	with	with	ADP
dti-2347	120	11	diff	diff	NOUN
dti-2347	120	12	-	-	PUNCT
dti-2347	120	13	quik	quik	NOUN
dti-2347	120	14	reagent	reagent	ADJ
dti-2347	120	15	solution	solution	NOUN
dti-2347	120	16	.	.	PUNCT
dti-2347	121	1	a	a	DET
dti-2347	121	2	)	)	PUNCT
dti-2347	121	3	analysis	analysis	NOUN
dti-2347	121	4	of	of	ADP
dti-2347	121	5	variance	variance	NOUN
dti-2347	121	6	(	(	PUNCT
dti-2347	121	7	anova	anova	PROPN
dti-2347	121	8	)	)	PUNCT
dti-2347	121	9	in	in	ADP
dti-2347	121	10	sacrifice	sacrifice	NOUN
dti-2347	121	11	6	6	NUM
dti-2347	121	12	h	h	NOUN
dti-2347	121	13	experiment	experiment	NOUN
dti-2347	121	14	p<0.01	p<0.01	PROPN
dti-2347	121	15	,	,	PUNCT
dti-2347	121	16	tukey	tukey	PROPN
dti-2347	121	17	post	post	X
dti-2347	121	18	hoc	hoc	X
dti-2347	121	19	test	test	NOUN
dti-2347	121	20	;	;	PUNCT
dti-2347	121	21	*	*	PUNCT
dti-2347	121	22	p<0.01	p<0.01	NOUN
dti-2347	121	23	vs.	vs.	X
dti-2347	121	24	healthy	healthy	ADJ
dti-2347	121	25	,	,	PUNCT
dti-2347	121	26	°	°	PROPN
dti-2347	121	27	p<0.05	p<0.05	NOUN
dti-2347	121	28	vs.	vs.	X
dti-2347	121	29	healthy	healthy	ADJ
dti-2347	121	30	;	;	PUNCT
dti-2347	121	31	anova	anova	X
dti-2347	121	32	in	in	ADP
dti-2347	121	33	sacrifice	sacrifice	NOUN
dti-2347	121	34	24	24	NUM
dti-2347	121	35	h	h	NOUN
dti-2347	121	36	experiment	experiment	NOUN
dti-2347	121	37	p<0.05	p<0.05	NOUN
dti-2347	121	38	,	,	PUNCT
dti-2347	121	39	tukey	tukey	PROPN
dti-2347	121	40	post	post	X
dti-2347	121	41	hoc	hoc	X
dti-2347	121	42	test	test	NOUN
dti-2347	121	43	;	;	PUNCT
dti-2347	121	44	#	#	NUM
dti-2347	121	45	p<0.05	p<0.05	NOUN
dti-2347	121	46	vs.	vs.	ADP
dti-2347	121	47	pre	pre	NOUN
dti-2347	121	48	-	-	ADJ
dti-2347	121	49	hex	hex	PROPN
dti-2347	121	50	.	.	PUNCT
dti-2347	121	51	b	b	X
dti-2347	121	52	)	)	PUNCT
dti-2347	121	53	polymorphonuclear	polymorphonuclear	NOUN
dti-2347	121	54	(	(	PUNCT
dti-2347	121	55	pmn	pmn	PROPN
dti-2347	121	56	):	):	PUNCT
dti-2347	121	57	anova	anova	PROPN
dti-2347	121	58	in	in	ADP
dti-2347	121	59	sacrifice	sacrifice	NOUN
dti-2347	121	60	6	6	NUM
dti-2347	121	61	h	h	NOUN
dti-2347	121	62	experiment	experiment	NOUN
dti-2347	121	63	p	p	X
dti-2347	121	64	=	=	PUNCT
dti-2347	121	65	ns	ns	PROPN
dti-2347	121	66	;	;	PUNCT
dti-2347	121	67	anova	anova	X
dti-2347	121	68	in	in	ADP
dti-2347	121	69	sacrifice	sacrifice	NOUN
dti-2347	121	70	24	24	NUM
dti-2347	121	71	h	h	NOUN
dti-2347	121	72	experiment	experiment	NOUN
dti-2347	121	73	p<0.01	p<0.01	PROPN
dti-2347	121	74	,	,	PUNCT
dti-2347	121	75	tukey	tukey	PROPN
dti-2347	121	76	post	post	X
dti-2347	121	77	hoc	hoc	X
dti-2347	121	78	test	test	NOUN
dti-2347	121	79	;	;	PUNCT
dti-2347	121	80	*	*	PUNCT
dti-2347	121	81	p	p	NOUN
dti-2347	121	82	=	=	NOUN
dti-2347	121	83	0.01	0.01	NUM
dti-2347	121	84	vs.	vs.	ADP
dti-2347	121	85	healthy	healthy	ADJ
dti-2347	121	86	,	,	PUNCT
dti-2347	121	87	°	°	PROPN
dti-2347	121	88	p	p	NOUN
dti-2347	121	89	=	=	NOUN
dti-2347	121	90	0.01	0.01	NUM
dti-2347	121	91	vs.	vs.	ADP
dti-2347	121	92	pre	pre	ADJ
dti-2347	121	93	-	-	ADJ
dti-2347	121	94	hex	hex	ADJ
dti-2347	121	95	.	.	PUNCT
dti-2347	121	96	macrophages	macrophage	NOUN
dti-2347	121	97	:	:	PUNCT
dti-2347	121	98	anova	anova	X
dti-2347	121	99	in	in	ADP
dti-2347	121	100	sacrifice	sacrifice	NOUN
dti-2347	121	101	6	6	NUM
dti-2347	121	102	h	h	NOUN
dti-2347	121	103	experiment	experiment	NOUN
dti-2347	121	104	p	p	NOUN
dti-2347	121	105	=	=	NOUN
dti-2347	121	106	0.02	0.02	NUM
dti-2347	121	107	,	,	PUNCT
dti-2347	121	108	tukey	tukey	NOUN
dti-2347	121	109	post	post	X
dti-2347	121	110	hoc	hoc	X
dti-2347	121	111	test	test	NOUN
dti-2347	121	112	;	;	PUNCT
dti-2347	122	1	*	*	PUNCT
dti-2347	122	2	p	p	NOUN
dti-2347	122	3	=	=	NOUN
dti-2347	122	4	0.01	0.01	NUM
dti-2347	122	5	vs.	vs.	ADP
dti-2347	122	6	healthy	healthy	ADJ
dti-2347	122	7	;	;	PUNCT
dti-2347	122	8	anova	anova	X
dti-2347	122	9	in	in	ADP
dti-2347	122	10	sacrifice	sacrifice	NOUN
dti-2347	122	11	24	24	NUM
dti-2347	122	12	h	h	NOUN
dti-2347	122	13	experiment	experiment	NOUN
dti-2347	122	14	p<0.01	p<0.01	PROPN
dti-2347	122	15	,	,	PUNCT
dti-2347	122	16	tukey	tukey	PROPN
dti-2347	122	17	post	post	X
dti-2347	122	18	hoc	hoc	X
dti-2347	122	19	test	test	NOUN
dti-2347	122	20	;	;	PUNCT
dti-2347	122	21	*	*	PUNCT
dti-2347	122	22	*	*	PUNCT
dti-2347	122	23	p<0.01	p<0.01	ADJ
dti-2347	122	24	vs.	vs.	X
dti-2347	122	25	healthy	healthy	ADJ
dti-2347	122	26	,	,	PUNCT
dti-2347	122	27	°	°	NOUN
dti-2347	122	28	°	°	ADJ
dti-2347	122	29	p<0.05	p<0.05	NOUN
dti-2347	122	30	vs.	vs.	ADP
dti-2347	122	31	vehicle	vehicle	NOUN
dti-2347	122	32	,	,	PUNCT
dti-2347	122	33	#	#	NOUN
dti-2347	122	34	p<0.01	p<0.01	PROPN
dti-2347	122	35	vs.	vs.	X
dti-2347	122	36	pre	pre	ADJ
dti-2347	122	37	-	-	ADJ
dti-2347	122	38	hex	hex	ADJ
dti-2347	122	39	.	.	PUNCT
dti-2347	122	40	c	c	X
dti-2347	122	41	)	)	PUNCT
dti-2347	122	42	pmn	pmn	NOUN
dti-2347	122	43	:	:	PUNCT
dti-2347	122	44	anova	anova	X
dti-2347	122	45	in	in	ADP
dti-2347	122	46	sacrifice	sacrifice	NOUN
dti-2347	122	47	6	6	NUM
dti-2347	122	48	h	h	NOUN
dti-2347	122	49	experiment	experiment	NOUN
dti-2347	122	50	p	p	X
dti-2347	122	51	=	=	PUNCT
dti-2347	122	52	ns	ns	PROPN
dti-2347	122	53	;	;	PUNCT
dti-2347	122	54	anova	anova	X
dti-2347	122	55	in	in	ADP
dti-2347	122	56	sacrifice	sacrifice	NOUN
dti-2347	122	57	24	24	NUM
dti-2347	122	58	h	h	NOUN
dti-2347	122	59	experiment	experiment	NOUN
dti-2347	123	1	p	p	NOUN
dti-2347	123	2	=	=	NOUN
dti-2347	123	3	0.01	0.01	NUM
dti-2347	123	4	,	,	PUNCT
dti-2347	123	5	tukey	tukey	NOUN
dti-2347	123	6	post	post	X
dti-2347	123	7	hoc	hoc	X
dti-2347	123	8	test	test	NOUN
dti-2347	123	9	;	;	PUNCT
dti-2347	123	10	*	*	PUNCT
dti-2347	123	11	p<0.05	p<0.05	NOUN
dti-2347	123	12	vs.	vs.	ADP
dti-2347	123	13	healthy	healthy	ADJ
dti-2347	123	14	,	,	PUNCT
dti-2347	123	15	°	°	PROPN
dti-2347	123	16	p<0.01	p<0.01	PROPN
dti-2347	123	17	vs.	vs.	X
dti-2347	123	18	pre	pre	ADJ
dti-2347	123	19	-	-	ADJ
dti-2347	123	20	hex	hex	ADJ
dti-2347	123	21	.	.	PUNCT
dti-2347	123	22	macrophages	macrophage	NOUN
dti-2347	123	23	:	:	PUNCT
dti-2347	123	24	anova	anova	X
dti-2347	123	25	in	in	ADP
dti-2347	123	26	sacrifice	sacrifice	NOUN
dti-2347	123	27	6	6	NUM
dti-2347	123	28	h	h	NOUN
dti-2347	123	29	experiment	experiment	NOUN
dti-2347	123	30	p	p	X
dti-2347	123	31	=	=	PUNCT
dti-2347	123	32	ns	ns	PROPN
dti-2347	123	33	;	;	PUNCT
dti-2347	123	34	anova	anova	X
dti-2347	123	35	in	in	ADP
dti-2347	123	36	sacrifice	sacrifice	NOUN
dti-2347	123	37	24	24	NUM
dti-2347	123	38	h	h	NOUN
dti-2347	123	39	experiment	experiment	NOUN
dti-2347	123	40	p<0.01	p<0.01	PROPN
dti-2347	123	41	,	,	PUNCT
dti-2347	123	42	tukey	tukey	PROPN
dti-2347	123	43	post	post	X
dti-2347	123	44	hoc	hoc	X
dti-2347	123	45	test	test	NOUN
dti-2347	123	46	;	;	PUNCT
dti-2347	124	1	*	*	PUNCT
dti-2347	124	2	p	p	NOUN
dti-2347	124	3	=	=	NOUN
dti-2347	124	4	0.01	0.01	NUM
dti-2347	124	5	vs.	vs.	ADP
dti-2347	124	6	healthy	healthy	ADJ
dti-2347	124	7	,	,	PUNCT
dti-2347	124	8	°	°	PROPN
dti-2347	124	9	p<0.05	p<0.05	NOUN
dti-2347	124	10	vs.	vs.	ADP
dti-2347	124	11	pre	pre	ADJ
dti-2347	124	12	-	-	ADJ
dti-2347	124	13	hex	hex	ADJ
dti-2347	124	14	.	.	PUNCT
dti-2347	125	1	healthy	healthy	ADJ
dti-2347	125	2	:	:	PUNCT
dti-2347	126	1	no	no	DET
dti-2347	126	2	surgical	surgical	ADJ
dti-2347	126	3	interventions	intervention	NOUN
dti-2347	126	4	or	or	CCONJ
dti-2347	126	5	treatment	treatment	NOUN
dti-2347	126	6	(	(	PUNCT
dti-2347	126	7	n	n	NOUN
dti-2347	126	8	=	=	SYM
dti-2347	126	9	5	5	NUM
dti-2347	126	10	)	)	PUNCT
dti-2347	126	11	;	;	PUNCT
dti-2347	126	12	vehicle	vehicle	NOUN
dti-2347	126	13	:	:	PUNCT
dti-2347	126	14	hcl	hcl	PROPN
dti-2347	126	15	instillation	instillation	NOUN
dti-2347	126	16	+	+	CCONJ
dti-2347	126	17	vehicle	vehicle	NOUN
dti-2347	126	18	treatment	treatment	NOUN
dti-2347	126	19	(	(	PUNCT
dti-2347	126	20	n	n	NOUN
dti-2347	126	21	=	=	SYM
dti-2347	126	22	8)	8)	NUM
dti-2347	126	23	;	;	PUNCT
dti-2347	126	24	post	post	ADJ
dti-2347	126	25	-	-	ADJ
dti-2347	126	26	hex	hex	ADJ
dti-2347	126	27	:	:	PUNCT
dti-2347	126	28	hcl	hcl	PROPN
dti-2347	126	29	instillation	instillation	NOUN
dti-2347	126	30	+	+	CCONJ
dti-2347	126	31	hexarelin	hexarelin	PROPN
dti-2347	126	32	treatment	treatment	NOUN
dti-2347	126	33	(	(	PUNCT
dti-2347	126	34	n	n	NOUN
dti-2347	126	35	=	=	SYM
dti-2347	126	36	8)	8)	NUM
dti-2347	126	37	;	;	PUNCT
dti-2347	126	38	pre	pre	ADJ
dti-2347	126	39	-	-	ADJ
dti-2347	126	40	hex	hex	ADJ
dti-2347	126	41	:	:	PUNCT
dti-2347	126	42	hexarelin	hexarelin	PROPN
dti-2347	126	43	pretreatment	pretreatment	NOUN
dti-2347	126	44	+	+	CCONJ
dti-2347	126	45	hcl	hcl	PROPN
dti-2347	126	46	instillation	instillation	NOUN
dti-2347	126	47	(	(	PUNCT
dti-2347	126	48	n	n	NOUN
dti-2347	126	49	=	=	SYM
dti-2347	126	50	8)	8)	NUM
dti-2347	126	51	.	.	PUNCT
dti-2347	126	52	effects	effect	NOUN
dti-2347	126	53	of	of	ADP
dti-2347	126	54	hexarelin	hexarelin	PROPN
dti-2347	126	55	treatment	treatment	NOUN
dti-2347	126	56	on	on	ADP
dti-2347	126	57	acute	acute	ADJ
dti-2347	126	58	lung	lung	NOUN
dti-2347	126	59	injury30	injury30	NOUN
dti-2347	126	60	©	©	ADP
dti-2347	126	61	2021	2021	NUM
dti-2347	126	62	the	the	DET
dti-2347	126	63	authors	author	NOUN
dti-2347	126	64	.	.	PUNCT
dti-2347	127	1	drug	drug	NOUN
dti-2347	127	2	target	target	NOUN
dti-2347	127	3	insights	insight	NOUN
dti-2347	127	4	issn	issn	VERB
dti-2347	127	5	1177	1177	NUM
dti-2347	127	6	-	-	SYM
dti-2347	127	7	3928	3928	NUM
dti-2347	127	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	VERB
dti-2347	127	9	fourteen	fourteen	NUM
dti-2347	127	10	days	day	NOUN
dti-2347	127	11	post	post	ADJ
dti-2347	127	12	-	-	ADJ
dti-2347	127	13	instillation	instillation	ADJ
dti-2347	127	14	body	body	NOUN
dti-2347	127	15	weights	weight	NOUN
dti-2347	127	16	of	of	ADP
dti-2347	127	17	mice	mouse	NOUN
dti-2347	127	18	in	in	ADP
dti-2347	127	19	the	the	DET
dti-2347	127	20	vehicle	vehicle	NOUN
dti-2347	127	21	group	group	NOUN
dti-2347	127	22	were	be	AUX
dti-2347	127	23	significantly	significantly	ADV
dti-2347	127	24	(	(	PUNCT
dti-2347	127	25	p<0.05	p<0.05	NOUN
dti-2347	127	26	)	)	PUNCT
dti-2347	127	27	smaller	small	ADJ
dti-2347	127	28	than	than	ADP
dti-2347	127	29	those	those	PRON
dti-2347	127	30	of	of	ADP
dti-2347	127	31	healthy	healthy	ADJ
dti-2347	127	32	mice	mouse	NOUN
dti-2347	127	33	;	;	PUNCT
dti-2347	127	34	hexarelin	hexarelin	PROPN
dti-2347	127	35	treatment	treatment	NOUN
dti-2347	127	36	preserved	preserve	VERB
dti-2347	127	37	body	body	NOUN
dti-2347	127	38	weight	weight	NOUN
dti-2347	127	39	better	well	ADV
dti-2347	127	40	than	than	ADP
dti-2347	127	41	vehicle	vehicle	NOUN
dti-2347	127	42	treatment	treatment	NOUN
dti-2347	127	43	alone	alone	ADV
dti-2347	127	44	(	(	PUNCT
dti-2347	127	45	fig	fig	NOUN
dti-2347	127	46	.	.	PUNCT
dti-2347	128	1	3b	3b	NUM
dti-2347	128	2	)	)	PUNCT
dti-2347	128	3	.	.	PUNCT
dti-2347	129	1	pulmonary	pulmonary	ADJ
dti-2347	129	2	function	function	NOUN
dti-2347	129	3	by	by	ADP
dti-2347	129	4	14	14	NUM
dti-2347	129	5	days	day	NOUN
dti-2347	129	6	post	post	NOUN
dti-2347	129	7	-	-	NOUN
dti-2347	129	8	instillation	instillation	ADJ
dti-2347	129	9	,	,	PUNCT
dti-2347	129	10	respiratory	respiratory	ADJ
dti-2347	129	11	system	system	NOUN
dti-2347	129	12	static	static	ADJ
dti-2347	129	13	compliance	compliance	NOUN
dti-2347	129	14	did	do	AUX
dti-2347	129	15	not	not	PART
dti-2347	129	16	differ	differ	VERB
dti-2347	129	17	significantly	significantly	ADV
dti-2347	129	18	between	between	ADP
dti-2347	129	19	groups	group	NOUN
dti-2347	129	20	.	.	PUNCT
dti-2347	130	1	acidtreated	acidtreate	VERB
dti-2347	130	2	mice	mouse	NOUN
dti-2347	130	3	showed	show	VERB
dti-2347	130	4	no	no	DET
dti-2347	130	5	different	different	ADJ
dti-2347	130	6	(	(	PUNCT
dti-2347	130	7	anova	anova	PROPN
dti-2347	130	8	,	,	PUNCT
dti-2347	130	9	p	p	NOUN
dti-2347	130	10	=	=	SYM
dti-2347	130	11	ns	ns	ADJ
dti-2347	130	12	)	)	PUNCT
dti-2347	130	13	mechanical	mechanical	ADJ
dti-2347	130	14	properties	property	NOUN
dti-2347	130	15	(	(	PUNCT
dti-2347	130	16	51.6	51.6	NUM
dti-2347	130	17	±	±	NUM
dti-2347	130	18	3.0	3.0	NUM
dti-2347	130	19	and	and	CCONJ
dti-2347	130	20	51.0	51.0	NUM
dti-2347	130	21	±	±	NUM
dti-2347	130	22	3.4	3.4	NUM
dti-2347	130	23	µl	µl	NOUN
dti-2347	130	24	/	/	SYM
dti-2347	130	25	mm	mm	NOUN
dti-2347	130	26	hg	hg	NOUN
dti-2347	130	27	in	in	ADP
dti-2347	130	28	vehicle	vehicle	NOUN
dti-2347	130	29	and	and	CCONJ
dti-2347	130	30	hexarelin	hexarelin	PROPN
dti-2347	130	31	groups	group	NOUN
dti-2347	130	32	,	,	PUNCT
dti-2347	130	33	respectively	respectively	ADV
dti-2347	130	34	)	)	PUNCT
dti-2347	130	35	compared	compare	VERB
dti-2347	130	36	with	with	ADP
dti-2347	130	37	healthy	healthy	ADJ
dti-2347	130	38	mice	mouse	NOUN
dti-2347	130	39	(	(	PUNCT
dti-2347	130	40	58.0	58.0	NUM
dti-2347	130	41	±	±	NUM
dti-2347	130	42	4.5	4.5	NUM
dti-2347	130	43	µl	µl	NOUN
dti-2347	130	44	/	/	SYM
dti-2347	130	45	mm	mm	PROPN
dti-2347	130	46	hg	hg	NOUN
dti-2347	130	47	)	)	PUNCT
dti-2347	130	48	.	.	PUNCT
dti-2347	131	1	collagen	collagen	NOUN
dti-2347	131	2	deposition	deposition	NOUN
dti-2347	131	3	in	in	ADP
dti-2347	131	4	order	order	NOUN
dti-2347	131	5	to	to	PART
dti-2347	131	6	estimate	estimate	VERB
dti-2347	131	7	fibrosis	fibrosis	NOUN
dti-2347	131	8	development	development	NOUN
dti-2347	131	9	at	at	ADP
dti-2347	131	10	14	14	NUM
dti-2347	131	11	days	day	NOUN
dti-2347	131	12	postinstillation	postinstillation	NOUN
dti-2347	131	13	,	,	PUNCT
dti-2347	131	14	the	the	DET
dti-2347	131	15	collagen	collagen	NOUN
dti-2347	131	16	content	content	NOUN
dti-2347	131	17	of	of	ADP
dti-2347	131	18	each	each	DET
dti-2347	131	19	lung	lung	NOUN
dti-2347	131	20	was	be	AUX
dti-2347	131	21	measured	measure	VERB
dti-2347	131	22	indirectly	indirectly	ADV
dti-2347	131	23	with	with	ADP
dti-2347	131	24	the	the	DET
dti-2347	131	25	oh	oh	NOUN
dti-2347	131	26	-	-	PUNCT
dti-2347	131	27	pro	pro	NOUN
dti-2347	131	28	assay	assay	NOUN
dti-2347	131	29	.	.	PUNCT
dti-2347	132	1	the	the	DET
dti-2347	132	2	collagen	collagen	NOUN
dti-2347	132	3	contents	content	NOUN
dti-2347	132	4	of	of	ADP
dti-2347	132	5	both	both	CCONJ
dti-2347	132	6	right	right	ADJ
dti-2347	132	7	and	and	CCONJ
dti-2347	132	8	left	leave	VERB
dti-2347	132	9	lungs	lung	NOUN
dti-2347	132	10	of	of	ADP
dti-2347	132	11	the	the	DET
dti-2347	132	12	hexarelin	hexarelin	PROPN
dti-2347	132	13	-	-	PUNCT
dti-2347	132	14	treated	treat	VERB
dti-2347	132	15	group	group	NOUN
dti-2347	132	16	were	be	AUX
dti-2347	132	17	smaller	small	ADJ
dti-2347	132	18	compared	compare	VERB
dti-2347	132	19	with	with	ADP
dti-2347	132	20	those	those	PRON
dti-2347	132	21	in	in	ADP
dti-2347	132	22	the	the	DET
dti-2347	132	23	vehicle	vehicle	NOUN
dti-2347	132	24	-	-	PUNCT
dti-2347	132	25	treated	treat	VERB
dti-2347	132	26	group	group	NOUN
dti-2347	132	27	;	;	PUNCT
dti-2347	132	28	however	however	ADV
dti-2347	132	29	,	,	PUNCT
dti-2347	132	30	only	only	ADV
dti-2347	132	31	the	the	DET
dti-2347	132	32	right	right	ADJ
dti-2347	132	33	lungs	lung	NOUN
dti-2347	132	34	showed	show	VERB
dti-2347	132	35	a	a	DET
dti-2347	132	36	statistically	statistically	ADV
dti-2347	132	37	significant	significant	ADJ
dti-2347	132	38	difference	difference	NOUN
dti-2347	132	39	(	(	PUNCT
dti-2347	132	40	p<0.05	p<0.05	NOUN
dti-2347	132	41	)	)	PUNCT
dti-2347	132	42	between	between	ADP
dti-2347	132	43	the	the	DET
dti-2347	132	44	hexarelinand	hexarelinand	NOUN
dti-2347	132	45	vehicletreated	vehicletreate	VERB
dti-2347	132	46	groups	group	NOUN
dti-2347	132	47	(	(	PUNCT
dti-2347	132	48	fig	fig	NOUN
dti-2347	132	49	.	.	PUNCT
dti-2347	132	50	4a	4a	NUM
dti-2347	132	51	)	)	PUNCT
dti-2347	132	52	.	.	PUNCT
dti-2347	133	1	fig	fig	NOUN
dti-2347	133	2	.	.	PUNCT
dti-2347	134	1	3	3	NUM
dti-2347	134	2	body	body	NOUN
dti-2347	134	3	weight	weight	NOUN
dti-2347	134	4	increment	increment	NOUN
dti-2347	134	5	in	in	ADP
dti-2347	134	6	48	48	NUM
dti-2347	134	7	hours	hour	NOUN
dti-2347	134	8	(	(	PUNCT
dti-2347	134	9	panel	panel	NOUN
dti-2347	134	10	a	a	NOUN
dti-2347	134	11	)	)	PUNCT
dti-2347	134	12	and	and	CCONJ
dti-2347	134	13	in	in	ADP
dti-2347	134	14	14	14	NUM
dti-2347	134	15	days	day	NOUN
dti-2347	134	16	(	(	PUNCT
dti-2347	134	17	panel	panel	NOUN
dti-2347	134	18	b	b	NOUN
dti-2347	134	19	)	)	PUNCT
dti-2347	134	20	.	.	PUNCT
dti-2347	135	1	a	a	DET
dti-2347	135	2	)	)	PUNCT
dti-2347	135	3	analysis	analysis	NOUN
dti-2347	135	4	of	of	ADP
dti-2347	135	5	variance	variance	NOUN
dti-2347	135	6	(	(	PUNCT
dti-2347	135	7	anova	anova	PROPN
dti-2347	135	8	)	)	PUNCT
dti-2347	135	9	p<0.0001	p<0.0001	NOUN
dti-2347	135	10	,	,	PUNCT
dti-2347	135	11	tukey	tukey	PROPN
dti-2347	135	12	post	post	X
dti-2347	135	13	hoc	hoc	X
dti-2347	135	14	test	test	NOUN
dti-2347	135	15	;	;	PUNCT
dti-2347	135	16	*	*	PUNCT
dti-2347	135	17	p<0.01	p<0.01	PROPN
dti-2347	135	18	vs.	vs.	ADP
dti-2347	135	19	vehicle	vehicle	NOUN
dti-2347	135	20	and	and	CCONJ
dti-2347	135	21	hexarelin	hexarelin	PROPN
dti-2347	135	22	.	.	PUNCT
dti-2347	136	1	b	b	X
dti-2347	136	2	)	)	PUNCT
dti-2347	136	3	anova	anova	PROPN
dti-2347	137	1	p	p	X
dti-2347	137	2	=	=	PROPN
dti-2347	137	3	0.048	0.048	NUM
dti-2347	137	4	,	,	PUNCT
dti-2347	137	5	tukey	tukey	PROPN
dti-2347	137	6	post	post	X
dti-2347	137	7	hoc	hoc	X
dti-2347	137	8	test	test	NOUN
dti-2347	137	9	;	;	PUNCT
dti-2347	137	10	*	*	PUNCT
dti-2347	137	11	p<0.05	p<0.05	NOUN
dti-2347	137	12	vs.	vs.	ADP
dti-2347	137	13	healthy	healthy	ADJ
dti-2347	137	14	.	.	PUNCT
dti-2347	138	1	healthy	healthy	ADJ
dti-2347	138	2	:	:	PUNCT
dti-2347	138	3	no	no	DET
dti-2347	138	4	surgical	surgical	ADJ
dti-2347	138	5	interventions	intervention	NOUN
dti-2347	138	6	or	or	CCONJ
dti-2347	138	7	treatment	treatment	NOUN
dti-2347	138	8	(	(	PUNCT
dti-2347	138	9	n	n	NOUN
dti-2347	138	10	=	=	SYM
dti-2347	138	11	15	15	NUM
dti-2347	138	12	)	)	PUNCT
dti-2347	138	13	;	;	PUNCT
dti-2347	138	14	vehicle	vehicle	NOUN
dti-2347	138	15	:	:	PUNCT
dti-2347	138	16	hcl	hcl	PROPN
dti-2347	138	17	instillation	instillation	NOUN
dti-2347	138	18	+	+	CCONJ
dti-2347	138	19	vehicle	vehicle	NOUN
dti-2347	138	20	treatment	treatment	NOUN
dti-2347	138	21	(	(	PUNCT
dti-2347	138	22	n	n	NOUN
dti-2347	138	23	=	=	NUM
dti-2347	138	24	18	18	NUM
dti-2347	138	25	)	)	PUNCT
dti-2347	138	26	;	;	PUNCT
dti-2347	138	27	hexarelin	hexarelin	PROPN
dti-2347	138	28	:	:	PUNCT
dti-2347	138	29	hcl	hcl	PROPN
dti-2347	138	30	instillation	instillation	NOUN
dti-2347	138	31	+	+	CCONJ
dti-2347	138	32	hexarelin	hexarelin	PROPN
dti-2347	138	33	treatment	treatment	NOUN
dti-2347	138	34	(	(	PUNCT
dti-2347	138	35	n	n	NOUN
dti-2347	138	36	=	=	NUM
dti-2347	138	37	18	18	NUM
dti-2347	138	38	)	)	PUNCT
dti-2347	138	39	.	.	PUNCT
dti-2347	139	1	fig	fig	NOUN
dti-2347	139	2	.	.	PUNCT
dti-2347	140	1	4	4	NUM
dti-2347	140	2	lung	lung	NOUN
dti-2347	140	3	fibrosis	fibrosis	NOUN
dti-2347	140	4	:	:	PUNCT
dti-2347	140	5	oh	oh	NUM
dti-2347	140	6	-	-	PUNCT
dti-2347	140	7	proline	proline	NOUN
dti-2347	140	8	lung	lung	NOUN
dti-2347	140	9	content	content	NOUN
dti-2347	140	10	(	(	PUNCT
dti-2347	140	11	a	a	NOUN
dti-2347	140	12	)	)	PUNCT
dti-2347	140	13	and	and	CCONJ
dti-2347	140	14	effects	effect	NOUN
dti-2347	140	15	of	of	ADP
dti-2347	140	16	hexarelin	hexarelin	PROPN
dti-2347	140	17	on	on	ADP
dti-2347	140	18	lung	lung	NOUN
dti-2347	140	19	histology	histology	NOUN
dti-2347	140	20	(	(	PUNCT
dti-2347	140	21	b	b	NOUN
dti-2347	140	22	)	)	PUNCT
dti-2347	140	23	in	in	ADP
dti-2347	140	24	acid	acid	NOUN
dti-2347	140	25	-	-	PUNCT
dti-2347	140	26	injured	injure	VERB
dti-2347	140	27	mice	mouse	NOUN
dti-2347	140	28	14	14	NUM
dti-2347	140	29	days	day	NOUN
dti-2347	140	30	after	after	ADP
dti-2347	140	31	lung	lung	NOUN
dti-2347	140	32	injury	injury	NOUN
dti-2347	140	33	induction	induction	NOUN
dti-2347	140	34	.	.	PUNCT
dti-2347	141	1	the	the	DET
dti-2347	141	2	collagen	collagen	NOUN
dti-2347	141	3	deposition	deposition	NOUN
dti-2347	141	4	was	be	AUX
dti-2347	141	5	evaluated	evaluate	VERB
dti-2347	141	6	by	by	ADP
dti-2347	141	7	the	the	DET
dti-2347	141	8	assessment	assessment	NOUN
dti-2347	141	9	of	of	ADP
dti-2347	141	10	oh	oh	NUM
dti-2347	141	11	-	-	PUNCT
dti-2347	141	12	proline	proline	NOUN
dti-2347	141	13	content	content	NOUN
dti-2347	141	14	in	in	ADP
dti-2347	141	15	lung	lung	NOUN
dti-2347	141	16	-	-	PUNCT
dti-2347	141	17	homogenized	homogenize	VERB
dti-2347	141	18	tissue	tissue	NOUN
dti-2347	141	19	with	with	ADP
dti-2347	141	20	chloramine	chloramine	NOUN
dti-2347	141	21	t	t	PROPN
dti-2347	141	22	and	and	CCONJ
dti-2347	141	23	ehrlich	ehrlich	NOUN
dti-2347	141	24	’s	’s	PART
dti-2347	141	25	solutions	solution	NOUN
dti-2347	141	26	.	.	PUNCT
dti-2347	142	1	in	in	ADP
dti-2347	142	2	right	right	ADJ
dti-2347	142	3	lung	lung	NOUN
dti-2347	142	4	:	:	PUNCT
dti-2347	142	5	analysis	analysis	NOUN
dti-2347	142	6	of	of	ADP
dti-2347	142	7	variance	variance	NOUN
dti-2347	142	8	(	(	PUNCT
dti-2347	142	9	anova	anova	PROPN
dti-2347	142	10	)	)	PUNCT
dti-2347	142	11	p<0.05	p<0.05	NOUN
dti-2347	142	12	,	,	PUNCT
dti-2347	142	13	tukey	tukey	PROPN
dti-2347	142	14	post	post	X
dti-2347	142	15	hoc	hoc	X
dti-2347	142	16	;	;	PUNCT
dti-2347	142	17	*	*	PUNCT
dti-2347	142	18	p<0.05	p<0.05	NOUN
dti-2347	142	19	vs.	vs.	ADP
dti-2347	142	20	hexarelin	hexarelin	PROPN
dti-2347	142	21	,	,	PUNCT
dti-2347	142	22	°	°	PRON
dti-2347	142	23	p<0.05	p<0.05	NOUN
dti-2347	142	24	vs.	vs.	ADP
dti-2347	142	25	healthy	healthy	ADJ
dti-2347	142	26	.	.	PUNCT
dti-2347	143	1	in	in	ADP
dti-2347	143	2	left	left	ADJ
dti-2347	143	3	lung	lung	NOUN
dti-2347	143	4	:	:	PUNCT
dti-2347	143	5	anova	anova	PROPN
dti-2347	143	6	p	p	X
dti-2347	143	7	=	=	SYM
dti-2347	143	8	ns	ns	PROPN
dti-2347	143	9	.	.	PROPN
dti-2347	143	10	healthy	healthy	ADJ
dti-2347	143	11	:	:	PUNCT
dti-2347	143	12	no	no	DET
dti-2347	143	13	surgical	surgical	ADJ
dti-2347	143	14	interventions	intervention	NOUN
dti-2347	143	15	or	or	CCONJ
dti-2347	143	16	treatment	treatment	NOUN
dti-2347	143	17	(	(	PUNCT
dti-2347	143	18	n	n	NOUN
dti-2347	143	19	=	=	SYM
dti-2347	143	20	10	10	NUM
dti-2347	143	21	)	)	PUNCT
dti-2347	143	22	;	;	PUNCT
dti-2347	143	23	vehicle	vehicle	NOUN
dti-2347	143	24	:	:	PUNCT
dti-2347	143	25	hcl	hcl	PROPN
dti-2347	143	26	instillation	instillation	NOUN
dti-2347	143	27	+	+	CCONJ
dti-2347	143	28	vehicle	vehicle	NOUN
dti-2347	143	29	treatment	treatment	NOUN
dti-2347	143	30	(	(	PUNCT
dti-2347	143	31	n	n	NOUN
dti-2347	143	32	=	=	SYM
dti-2347	143	33	13	13	NUM
dti-2347	143	34	)	)	PUNCT
dti-2347	143	35	;	;	PUNCT
dti-2347	143	36	hexarelin	hexarelin	PROPN
dti-2347	143	37	:	:	PUNCT
dti-2347	143	38	hcl	hcl	PROPN
dti-2347	143	39	instillation	instillation	NOUN
dti-2347	143	40	+	+	CCONJ
dti-2347	143	41	hexarelin	hexarelin	PROPN
dti-2347	143	42	treatment	treatment	NOUN
dti-2347	143	43	(	(	PUNCT
dti-2347	143	44	n	n	NOUN
dti-2347	143	45	=	=	NOUN
dti-2347	143	46	13	13	NUM
dti-2347	143	47	)	)	PUNCT
dti-2347	143	48	.	.	PUNCT
dti-2347	144	1	histology	histology	NOUN
dti-2347	144	2	:	:	PUNCT
dti-2347	144	3	representative	representative	ADJ
dti-2347	144	4	images	image	NOUN
dti-2347	144	5	are	be	AUX
dti-2347	144	6	shown.tissues	shown.tissue	NOUN
dti-2347	144	7	were	be	AUX
dti-2347	144	8	prepared	prepare	VERB
dti-2347	144	9	for	for	SCONJ
dti-2347	144	10	masson	masson	PROPN
dti-2347	144	11	’s	’s	PART
dti-2347	144	12	trichrome	trichrome	NOUN
dti-2347	144	13	staining	stain	VERB
dti-2347	144	14	.	.	PUNCT
dti-2347	145	1	(	(	PUNCT
dti-2347	145	2	b	b	X
dti-2347	145	3	,	,	PUNCT
dti-2347	145	4	d	d	PROPN
dti-2347	145	5	,	,	PUNCT
dti-2347	145	6	f	f	NOUN
dti-2347	145	7	:	:	PUNCT
dti-2347	145	8	40×	40×	NUM
dti-2347	145	9	magnification	magnification	NOUN
dti-2347	145	10	;	;	PUNCT
dti-2347	145	11	c	c	X
dti-2347	145	12	,	,	PUNCT
dti-2347	145	13	e	e	NOUN
dti-2347	145	14	,	,	PUNCT
dti-2347	145	15	g	g	NOUN
dti-2347	145	16	:	:	PUNCT
dti-2347	145	17	400×	400×	PROPN
dti-2347	145	18	magnification	magnification	NOUN
dti-2347	145	19	.	.	PUNCT
dti-2347	145	20	)	)	PUNCT
dti-2347	146	1	(	(	PUNCT
dti-2347	146	2	b	b	X
dti-2347	146	3	,	,	PUNCT
dti-2347	146	4	c	c	NOUN
dti-2347	146	5	)	)	PUNCT
dti-2347	146	6	healthy	healthy	ADJ
dti-2347	146	7	:	:	PUNCT
dti-2347	146	8	no	no	DET
dti-2347	146	9	surgical	surgical	ADJ
dti-2347	146	10	interventions	intervention	NOUN
dti-2347	146	11	or	or	CCONJ
dti-2347	146	12	treatment	treatment	NOUN
dti-2347	146	13	(	(	PUNCT
dti-2347	146	14	n	n	NOUN
dti-2347	146	15	=	=	SYM
dti-2347	146	16	4	4	NUM
dti-2347	146	17	)	)	PUNCT
dti-2347	146	18	;	;	PUNCT
dti-2347	146	19	(	(	PUNCT
dti-2347	146	20	d	d	X
dti-2347	146	21	,	,	PUNCT
dti-2347	146	22	e	e	NOUN
dti-2347	146	23	)	)	PUNCT
dti-2347	146	24	vehicle	vehicle	NOUN
dti-2347	146	25	:	:	PUNCT
dti-2347	146	26	hcl	hcl	PROPN
dti-2347	146	27	instillation	instillation	NOUN
dti-2347	146	28	+	+	CCONJ
dti-2347	146	29	vehicle	vehicle	NOUN
dti-2347	146	30	treatment	treatment	NOUN
dti-2347	146	31	(	(	PUNCT
dti-2347	146	32	n	n	NOUN
dti-2347	146	33	=	=	SYM
dti-2347	146	34	3	3	NUM
dti-2347	146	35	)	)	PUNCT
dti-2347	146	36	;	;	PUNCT
dti-2347	146	37	and	and	CCONJ
dti-2347	146	38	(	(	PUNCT
dti-2347	146	39	f	f	X
dti-2347	146	40	,	,	PUNCT
dti-2347	146	41	g	g	NOUN
dti-2347	146	42	)	)	PUNCT
dti-2347	146	43	hexarelin	hexarelin	PROPN
dti-2347	146	44	:	:	PUNCT
dti-2347	146	45	hcl	hcl	PROPN
dti-2347	146	46	instillation	instillation	NOUN
dti-2347	146	47	+	+	CCONJ
dti-2347	146	48	hexarelin	hexarelin	PROPN
dti-2347	146	49	treatment	treatment	NOUN
dti-2347	146	50	(	(	PUNCT
dti-2347	146	51	n	n	NOUN
dti-2347	146	52	=	=	SYM
dti-2347	146	53	5	5	NUM
dti-2347	146	54	)	)	PUNCT
dti-2347	146	55	.	.	PUNCT
dti-2347	147	1	areas	area	NOUN
dti-2347	147	2	of	of	ADP
dti-2347	147	3	fibrosis	fibrosis	NOUN
dti-2347	147	4	(	(	PUNCT
dti-2347	147	5	stained	stain	VERB
dti-2347	147	6	in	in	ADP
dti-2347	147	7	green	green	NOUN
dti-2347	147	8	)	)	PUNCT
dti-2347	147	9	are	be	AUX
dti-2347	147	10	indicated	indicate	VERB
dti-2347	147	11	with	with	ADP
dti-2347	147	12	arrows	arrow	NOUN
dti-2347	147	13	;	;	PUNCT
dti-2347	147	14	boxes	box	NOUN
dti-2347	147	15	on	on	ADP
dti-2347	147	16	the	the	DET
dti-2347	147	17	40×	40×	NUM
dti-2347	147	18	images	image	NOUN
dti-2347	147	19	indicate	indicate	VERB
dti-2347	147	20	the	the	DET
dti-2347	147	21	locations	location	NOUN
dti-2347	147	22	of	of	ADP
dti-2347	147	23	the	the	DET
dti-2347	147	24	400×	400×	PROPN
dti-2347	147	25	images	image	NOUN
dti-2347	147	26	.	.	PUNCT
dti-2347	148	1	zambelli	zambelli	PROPN
dti-2347	148	2	et	et	PROPN
dti-2347	148	3	al	al	PROPN
dti-2347	148	4	drug	drug	PROPN
dti-2347	148	5	target	target	NOUN
dti-2347	148	6	insights	insight	NOUN
dti-2347	148	7	2021	2021	NUM
dti-2347	148	8	;	;	PUNCT
dti-2347	148	9	15	15	NUM
dti-2347	148	10	:	:	SYM
dti-2347	148	11	31	31	NUM
dti-2347	148	12	©	©	PROPN
dti-2347	148	13	2021	2021	NUM
dti-2347	148	14	the	the	DET
dti-2347	148	15	authors	author	NOUN
dti-2347	148	16	.	.	PUNCT
dti-2347	149	1	published	publish	VERB
dti-2347	149	2	by	by	ADP
dti-2347	149	3	aboutscience	aboutscience	NOUN
dti-2347	149	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2347	149	5	histological	histological	ADJ
dti-2347	149	6	examination	examination	NOUN
dti-2347	149	7	in	in	ADP
dti-2347	149	8	healthy	healthy	ADJ
dti-2347	149	9	mice	mouse	NOUN
dti-2347	149	10	,	,	PUNCT
dti-2347	149	11	lung	lung	NOUN
dti-2347	149	12	parenchyma	parenchyma	NOUN
dti-2347	149	13	was	be	AUX
dti-2347	149	14	substantially	substantially	ADV
dti-2347	149	15	preserved	preserve	VERB
dti-2347	149	16	with	with	ADP
dti-2347	149	17	normal	normal	ADJ
dti-2347	149	18	lobular	lobular	ADJ
dti-2347	149	19	structure	structure	NOUN
dti-2347	149	20	,	,	PUNCT
dti-2347	149	21	slight	slight	ADJ
dti-2347	149	22	bronchial	bronchial	ADJ
dti-2347	149	23	ectasia	ectasia	NOUN
dti-2347	149	24	,	,	PUNCT
dti-2347	149	25	normal	normal	ADJ
dti-2347	149	26	alveoli	alveolus	NOUN
dti-2347	149	27	,	,	PUNCT
dti-2347	149	28	and	and	CCONJ
dti-2347	149	29	alveolar	alveolar	ADJ
dti-2347	149	30	ducts	duct	NOUN
dti-2347	149	31	(	(	PUNCT
dti-2347	149	32	fig	fig	NOUN
dti-2347	149	33	.	.	PUNCT
dti-2347	150	1	4b	4b	PROPN
dti-2347	150	2	,	,	PUNCT
dti-2347	150	3	c	c	NOUN
dti-2347	150	4	)	)	PUNCT
dti-2347	150	5	.	.	PUNCT
dti-2347	151	1	in	in	ADP
dti-2347	151	2	the	the	DET
dti-2347	151	3	vehicle	vehicle	NOUN
dti-2347	151	4	-	-	PUNCT
dti-2347	151	5	treated	treat	VERB
dti-2347	151	6	group	group	NOUN
dti-2347	151	7	,	,	PUNCT
dti-2347	151	8	lung	lung	NOUN
dti-2347	151	9	tissue	tissue	NOUN
dti-2347	151	10	was	be	AUX
dti-2347	151	11	characterized	characterize	VERB
dti-2347	151	12	by	by	ADP
dti-2347	151	13	diffuse	diffuse	NOUN
dti-2347	151	14	areas	area	NOUN
dti-2347	151	15	of	of	ADP
dti-2347	151	16	fibrosis	fibrosis	NOUN
dti-2347	151	17	,	,	PUNCT
dti-2347	151	18	especially	especially	ADV
dti-2347	151	19	subpleural	subpleural	ADJ
dti-2347	151	20	with	with	ADP
dti-2347	151	21	centrilobular	centrilobular	ADJ
dti-2347	151	22	extension	extension	NOUN
dti-2347	151	23	.	.	PUNCT
dti-2347	152	1	this	this	DET
dti-2347	152	2	fibrosis	fibrosis	NOUN
dti-2347	152	3	was	be	AUX
dti-2347	152	4	of	of	ADP
dti-2347	152	5	a	a	DET
dti-2347	152	6	“	"	PUNCT
dti-2347	152	7	young	young	ADJ
dti-2347	152	8	”	"	PUNCT
dti-2347	152	9	type	type	NOUN
dti-2347	152	10	,	,	PUNCT
dti-2347	152	11	with	with	ADP
dti-2347	152	12	several	several	ADJ
dti-2347	152	13	fibroblastic	fibroblastic	ADJ
dti-2347	152	14	cells	cell	NOUN
dti-2347	152	15	in	in	ADP
dti-2347	152	16	deposits	deposit	NOUN
dti-2347	152	17	of	of	ADP
dti-2347	152	18	collagen	collagen	NOUN
dti-2347	152	19	and	and	CCONJ
dti-2347	152	20	with	with	ADP
dti-2347	152	21	large	large	ADJ
dti-2347	152	22	subpleural	subpleural	ADJ
dti-2347	152	23	nodules	nodule	NOUN
dti-2347	152	24	;	;	PUNCT
dti-2347	152	25	as	as	ADV
dti-2347	152	26	well	well	ADV
dti-2347	152	27	,	,	PUNCT
dti-2347	152	28	several	several	ADJ
dti-2347	152	29	small	small	ADJ
dti-2347	152	30	“	"	PUNCT
dti-2347	152	31	fibroblastic	fibroblastic	ADJ
dti-2347	152	32	foci	focus	NOUN
dti-2347	152	33	”	"	PUNCT
dti-2347	152	34	were	be	AUX
dti-2347	152	35	found	find	VERB
dti-2347	152	36	in	in	ADP
dti-2347	152	37	adjacent	adjacent	ADJ
dti-2347	152	38	parenchyma	parenchyma	NOUN
dti-2347	152	39	.	.	PUNCT
dti-2347	153	1	there	there	PRON
dti-2347	153	2	was	be	VERB
dti-2347	153	3	also	also	ADV
dti-2347	153	4	evidence	evidence	NOUN
dti-2347	153	5	of	of	ADP
dti-2347	153	6	architectural	architectural	ADJ
dti-2347	153	7	distortion	distortion	NOUN
dti-2347	153	8	with	with	ADP
dti-2347	153	9	marked	mark	VERB
dti-2347	153	10	bronchiolar	bronchiolar	ADJ
dti-2347	153	11	dilatation	dilatation	NOUN
dti-2347	153	12	forming	form	VERB
dti-2347	153	13	cystic	cystic	ADJ
dti-2347	153	14	spaces	space	NOUN
dti-2347	153	15	resembling	resemble	VERB
dti-2347	153	16	honeycombing	honeycomb	VERB
dti-2347	153	17	-	-	PUNCT
dti-2347	153	18	like	like	ADJ
dti-2347	153	19	features	feature	NOUN
dti-2347	153	20	(	(	PUNCT
dti-2347	153	21	fig	fig	NOUN
dti-2347	153	22	.	.	PUNCT
dti-2347	153	23	4d	4d	NUM
dti-2347	153	24	)	)	PUNCT
dti-2347	153	25	.	.	PUNCT
dti-2347	154	1	in	in	ADP
dti-2347	154	2	a	a	DET
dti-2347	154	3	vehicle	vehicle	NOUN
dti-2347	154	4	-	-	PUNCT
dti-2347	154	5	treated	treat	VERB
dti-2347	154	6	(	(	PUNCT
dti-2347	154	7	acid	acid	NOUN
dti-2347	154	8	-	-	PUNCT
dti-2347	154	9	instilled	instill	VERB
dti-2347	154	10	)	)	PUNCT
dti-2347	154	11	lung	lung	NOUN
dti-2347	154	12	there	there	PRON
dti-2347	154	13	was	be	VERB
dti-2347	154	14	evidence	evidence	NOUN
dti-2347	154	15	of	of	ADP
dti-2347	154	16	a	a	DET
dti-2347	154	17	slight	slight	ADJ
dti-2347	154	18	alveolar	alveolar	ADJ
dti-2347	154	19	distortion	distortion	NOUN
dti-2347	154	20	,	,	PUNCT
dti-2347	154	21	accompanied	accompany	VERB
dti-2347	154	22	by	by	ADP
dti-2347	154	23	many	many	ADJ
dti-2347	154	24	alveolar	alveolar	ADJ
dti-2347	154	25	macrophages	macrophage	NOUN
dti-2347	154	26	and	and	CCONJ
dti-2347	154	27	some	some	DET
dti-2347	154	28	pmn	pmn	NOUN
dti-2347	154	29	cells	cell	NOUN
dti-2347	154	30	(	(	PUNCT
dti-2347	154	31	fig	fig	NOUN
dti-2347	154	32	.	.	PUNCT
dti-2347	155	1	4e	4e	NOUN
dti-2347	155	2	)	)	PUNCT
dti-2347	155	3	.	.	PUNCT
dti-2347	156	1	in	in	ADP
dti-2347	156	2	hexarelin	hexarelin	PROPN
dti-2347	156	3	-	-	PUNCT
dti-2347	156	4	treated	treat	VERB
dti-2347	156	5	mice	mouse	NOUN
dti-2347	156	6	,	,	PUNCT
dti-2347	156	7	by	by	ADP
dti-2347	156	8	contrast	contrast	NOUN
dti-2347	156	9	,	,	PUNCT
dti-2347	156	10	fibrosis	fibrosis	NOUN
dti-2347	156	11	was	be	AUX
dti-2347	156	12	reduced	reduce	VERB
dti-2347	156	13	compared	compare	VERB
dti-2347	156	14	to	to	ADP
dti-2347	156	15	that	that	PRON
dti-2347	156	16	of	of	ADP
dti-2347	156	17	the	the	DET
dti-2347	156	18	vehicle	vehicle	NOUN
dti-2347	156	19	-	-	PUNCT
dti-2347	156	20	treated	treat	VERB
dti-2347	156	21	group	group	NOUN
dti-2347	156	22	;	;	PUNCT
dti-2347	156	23	fibrotic	fibrotic	ADJ
dti-2347	156	24	distribution	distribution	NOUN
dti-2347	156	25	was	be	AUX
dti-2347	156	26	patchy	patchy	ADJ
dti-2347	156	27	with	with	ADP
dti-2347	156	28	subpleural	subpleural	ADJ
dti-2347	156	29	localization	localization	NOUN
dti-2347	156	30	prevalent	prevalent	ADJ
dti-2347	156	31	.	.	PUNCT
dti-2347	157	1	this	this	DET
dti-2347	157	2	fibrotic	fibrotic	ADJ
dti-2347	157	3	tissue	tissue	NOUN
dti-2347	157	4	was	be	AUX
dti-2347	157	5	similar	similar	ADJ
dti-2347	157	6	to	to	ADP
dti-2347	157	7	that	that	PRON
dti-2347	157	8	previously	previously	ADV
dti-2347	157	9	described	describe	VERB
dti-2347	157	10	;	;	PUNCT
dti-2347	157	11	that	that	ADV
dti-2347	157	12	is	is	ADV
dti-2347	157	13	,	,	PUNCT
dti-2347	157	14	appearing	appear	VERB
dti-2347	157	15	young	young	ADJ
dti-2347	157	16	and	and	CCONJ
dti-2347	157	17	cellulated	cellulate	VERB
dti-2347	157	18	and	and	CCONJ
dti-2347	157	19	accompanied	accompany	VERB
dti-2347	157	20	by	by	ADP
dti-2347	157	21	evidence	evidence	NOUN
dti-2347	157	22	of	of	ADP
dti-2347	157	23	abrupt	abrupt	ADJ
dti-2347	157	24	transitions	transition	NOUN
dti-2347	157	25	from	from	ADP
dti-2347	157	26	remodeled	remodeled	ADJ
dti-2347	157	27	lung	lung	NOUN
dti-2347	157	28	parenchyma	parenchyma	NOUN
dti-2347	157	29	to	to	ADP
dti-2347	157	30	normal	normal	ADJ
dti-2347	157	31	alveolar	alveolar	ADJ
dti-2347	157	32	walls	wall	NOUN
dti-2347	157	33	.	.	PUNCT
dti-2347	158	1	at	at	ADP
dti-2347	158	2	the	the	DET
dti-2347	158	3	center	center	NOUN
dti-2347	158	4	of	of	ADP
dti-2347	158	5	a	a	DET
dti-2347	158	6	lobule	lobule	NOUN
dti-2347	158	7	,	,	PUNCT
dti-2347	158	8	the	the	DET
dti-2347	158	9	presence	presence	NOUN
dti-2347	158	10	of	of	ADP
dti-2347	158	11	a	a	DET
dti-2347	158	12	fibroblastic	fibroblastic	ADJ
dti-2347	158	13	focus	focus	NOUN
dti-2347	158	14	is	be	AUX
dti-2347	158	15	obvious	obvious	ADJ
dti-2347	158	16	(	(	PUNCT
dti-2347	158	17	fig	fig	NOUN
dti-2347	158	18	.	.	PUNCT
dti-2347	159	1	4f	4f	NUM
dti-2347	159	2	)	)	PUNCT
dti-2347	159	3	.	.	PUNCT
dti-2347	160	1	almost	almost	ADV
dti-2347	160	2	normal	normal	ADJ
dti-2347	160	3	alveolar	alveolar	ADJ
dti-2347	160	4	walls	wall	NOUN
dti-2347	160	5	and	and	CCONJ
dti-2347	160	6	only	only	ADV
dti-2347	160	7	some	some	DET
dti-2347	160	8	inflammatory	inflammatory	ADJ
dti-2347	160	9	cells	cell	NOUN
dti-2347	160	10	were	be	AUX
dti-2347	160	11	evident	evident	ADJ
dti-2347	160	12	in	in	ADP
dti-2347	160	13	lungs	lung	NOUN
dti-2347	160	14	from	from	ADP
dti-2347	160	15	hexarelin	hexarelin	PROPN
dti-2347	160	16	-	-	PUNCT
dti-2347	160	17	treated	treat	VERB
dti-2347	160	18	mice	mouse	NOUN
dti-2347	160	19	(	(	PUNCT
dti-2347	160	20	fig	fig	NOUN
dti-2347	160	21	.	.	PUNCT
dti-2347	161	1	4	4	NUM
dti-2347	161	2	g	g	NOUN
dti-2347	161	3	)	)	PUNCT
dti-2347	161	4	.	.	PUNCT
dti-2347	162	1	discussion	discussion	NOUN
dti-2347	162	2	in	in	ADP
dti-2347	162	3	this	this	DET
dti-2347	162	4	study	study	NOUN
dti-2347	162	5	,	,	PUNCT
dti-2347	162	6	we	we	PRON
dti-2347	162	7	demonstrate	demonstrate	VERB
dti-2347	162	8	protective	protective	ADJ
dti-2347	162	9	effects	effect	NOUN
dti-2347	162	10	of	of	ADP
dti-2347	162	11	hexarelin	hexarelin	PROPN
dti-2347	162	12	against	against	ADP
dti-2347	162	13	ards	ard	NOUN
dti-2347	162	14	in	in	ADP
dti-2347	162	15	a	a	DET
dti-2347	162	16	unilateral	unilateral	ADJ
dti-2347	162	17	acid	acid	NOUN
dti-2347	162	18	aspiration	aspiration	NOUN
dti-2347	162	19	lung	lung	NOUN
dti-2347	162	20	injury	injury	NOUN
dti-2347	162	21	model	model	NOUN
dti-2347	162	22	in	in	ADP
dti-2347	162	23	mice	mouse	NOUN
dti-2347	162	24	.	.	PUNCT
dti-2347	163	1	our	our	PRON
dti-2347	163	2	results	result	NOUN
dti-2347	163	3	show	show	VERB
dti-2347	163	4	that	that	SCONJ
dti-2347	163	5	hexarelin	hexarelin	PROPN
dti-2347	163	6	treatment	treatment	NOUN
dti-2347	163	7	significantly	significantly	ADV
dti-2347	163	8	(	(	PUNCT
dti-2347	163	9	i	i	NOUN
dti-2347	163	10	)	)	PUNCT
dti-2347	163	11	ameliorated	ameliorate	VERB
dti-2347	163	12	respiratory	respiratory	ADJ
dti-2347	163	13	system	system	NOUN
dti-2347	163	14	compliance	compliance	NOUN
dti-2347	163	15	,	,	PUNCT
dti-2347	163	16	(	(	PUNCT
dti-2347	163	17	ii	ii	NOUN
dti-2347	163	18	)	)	PUNCT
dti-2347	163	19	reduced	reduce	VERB
dti-2347	163	20	protein	protein	NOUN
dti-2347	163	21	levels	level	NOUN
dti-2347	163	22	in	in	ADP
dti-2347	163	23	the	the	DET
dti-2347	163	24	bal	bal	NOUN
dti-2347	163	25	,	,	PUNCT
dti-2347	163	26	and	and	CCONJ
dti-2347	163	27	(	(	PUNCT
dti-2347	163	28	iii	iii	NOUN
dti-2347	163	29	)	)	PUNCT
dti-2347	163	30	blunted	blunt	VERB
dti-2347	163	31	pmn	pmn	ADJ
dti-2347	163	32	infiltration	infiltration	NOUN
dti-2347	163	33	compared	compare	VERB
dti-2347	163	34	with	with	ADP
dti-2347	163	35	the	the	DET
dti-2347	163	36	vehicle	vehicle	NOUN
dti-2347	163	37	-	-	PUNCT
dti-2347	163	38	treated	treat	VERB
dti-2347	163	39	group	group	NOUN
dti-2347	163	40	;	;	PUNCT
dti-2347	163	41	these	these	DET
dti-2347	163	42	effects	effect	NOUN
dti-2347	163	43	eventually	eventually	ADV
dti-2347	163	44	attenuated	attenuate	VERB
dti-2347	163	45	lung	lung	NOUN
dti-2347	163	46	fibrosis	fibrosis	NOUN
dti-2347	163	47	and	and	CCONJ
dti-2347	163	48	collagen	collagen	NOUN
dti-2347	163	49	content	content	NOUN
dti-2347	163	50	.	.	PUNCT
dti-2347	164	1	to	to	ADP
dti-2347	164	2	the	the	DET
dti-2347	164	3	best	good	ADJ
dti-2347	164	4	of	of	ADP
dti-2347	164	5	our	our	PRON
dti-2347	164	6	knowledge	knowledge	NOUN
dti-2347	164	7	,	,	PUNCT
dti-2347	164	8	this	this	PRON
dti-2347	164	9	is	be	AUX
dti-2347	164	10	the	the	DET
dti-2347	164	11	first	first	ADJ
dti-2347	164	12	study	study	NOUN
dti-2347	164	13	to	to	PART
dti-2347	164	14	evaluate	evaluate	VERB
dti-2347	164	15	the	the	DET
dti-2347	164	16	effects	effect	NOUN
dti-2347	164	17	of	of	ADP
dti-2347	164	18	hexarelin	hexarelin	PROPN
dti-2347	164	19	on	on	ADP
dti-2347	164	20	ards	ard	NOUN
dti-2347	164	21	in	in	ADP
dti-2347	164	22	a	a	DET
dti-2347	164	23	mouse	mouse	NOUN
dti-2347	164	24	model	model	NOUN
dti-2347	164	25	of	of	ADP
dti-2347	164	26	unilateral	unilateral	ADJ
dti-2347	164	27	lung	lung	NOUN
dti-2347	164	28	acid	acid	NOUN
dti-2347	164	29	instillation	instillation	NOUN
dti-2347	164	30	.	.	PUNCT
dti-2347	165	1	hexarelin	hexarelin	PROPN
dti-2347	165	2	,	,	PUNCT
dti-2347	165	3	a	a	DET
dti-2347	165	4	synthetic	synthetic	ADJ
dti-2347	165	5	hexapeptide	hexapeptide	NOUN
dti-2347	165	6	,	,	PUNCT
dti-2347	165	7	is	be	AUX
dti-2347	165	8	a	a	DET
dti-2347	165	9	powerful	powerful	ADJ
dti-2347	165	10	agonist	agonist	NOUN
dti-2347	165	11	of	of	ADP
dti-2347	165	12	the	the	DET
dti-2347	165	13	ghrelin	ghrelin	NOUN
dti-2347	165	14	receptor	receptor	NOUN
dti-2347	165	15	and	and	CCONJ
dti-2347	165	16	,	,	PUNCT
dti-2347	165	17	consequently	consequently	ADV
dti-2347	165	18	,	,	PUNCT
dti-2347	165	19	manifests	manifest	NOUN
dti-2347	165	20	both	both	CCONJ
dti-2347	165	21	endocrine	endocrine	ADJ
dti-2347	165	22	and	and	CCONJ
dti-2347	165	23	extra	extra	ADJ
dti-2347	165	24	-	-	ADJ
dti-2347	165	25	endocrine	endocrine	ADJ
dti-2347	165	26	activities	activity	NOUN
dti-2347	165	27	.	.	PUNCT
dti-2347	166	1	these	these	DET
dti-2347	166	2	activities	activity	NOUN
dti-2347	166	3	include	include	VERB
dti-2347	166	4	positive	positive	ADJ
dti-2347	166	5	effects	effect	NOUN
dti-2347	166	6	on	on	ADP
dti-2347	166	7	gastrointestinal-	gastrointestinal-	PROPN
dti-2347	166	8	,	,	PUNCT
dti-2347	166	9	cardiovascular-	cardiovascular-	INTJ
dti-2347	166	10	,	,	PUNCT
dti-2347	166	11	muscular-	muscular-	ADJ
dti-2347	166	12	,	,	PUNCT
dti-2347	166	13	and	and	CCONJ
dti-2347	166	14	nervous	nervous	ADJ
dti-2347	166	15	systems	system	NOUN
dti-2347	166	16	,	,	PUNCT
dti-2347	166	17	as	as	ADV
dti-2347	166	18	well	well	ADV
dti-2347	166	19	as	as	ADP
dti-2347	166	20	participation	participation	NOUN
dti-2347	166	21	in	in	ADP
dti-2347	166	22	regulation	regulation	NOUN
dti-2347	166	23	of	of	ADP
dti-2347	166	24	energy	energy	NOUN
dti-2347	166	25	balance	balance	NOUN
dti-2347	166	26	(	(	PUNCT
dti-2347	166	27	7	7	NUM
dti-2347	166	28	-	-	SYM
dti-2347	166	29	11	11	NUM
dti-2347	166	30	)	)	PUNCT
dti-2347	166	31	.	.	PUNCT
dti-2347	167	1	in	in	ADP
dti-2347	167	2	humans	human	NOUN
dti-2347	167	3	,	,	PUNCT
dti-2347	167	4	hexarelin	hexarelin	PROPN
dti-2347	167	5	actions	action	NOUN
dti-2347	167	6	are	be	AUX
dti-2347	167	7	not	not	PART
dti-2347	167	8	restricted	restrict	VERB
dti-2347	167	9	to	to	ADP
dti-2347	167	10	stimulating	stimulate	VERB
dti-2347	167	11	gh	gh	PROPN
dti-2347	167	12	release	release	NOUN
dti-2347	167	13	;	;	PUNCT
dti-2347	167	14	to	to	PART
dti-2347	167	15	illustrate	illustrate	VERB
dti-2347	167	16	,	,	PUNCT
dti-2347	167	17	acute	acute	ADJ
dti-2347	167	18	hexarelin	hexarelin	PROPN
dti-2347	167	19	administration	administration	NOUN
dti-2347	167	20	markedly	markedly	ADV
dti-2347	167	21	increased	increase	VERB
dti-2347	167	22	left	leave	VERB
dti-2347	167	23	ventricular	ventricular	ADJ
dti-2347	167	24	function	function	NOUN
dti-2347	167	25	in	in	ADP
dti-2347	167	26	(	(	PUNCT
dti-2347	167	27	i	i	NOUN
dti-2347	167	28	)	)	PUNCT
dti-2347	167	29	normal	normal	ADJ
dti-2347	167	30	subjects	subject	NOUN
dti-2347	167	31	,	,	PUNCT
dti-2347	167	32	(	(	PUNCT
dti-2347	167	33	ii	ii	NOUN
dti-2347	167	34	)	)	PUNCT
dti-2347	167	35	in	in	ADP
dti-2347	167	36	patients	patient	NOUN
dti-2347	167	37	with	with	ADP
dti-2347	167	38	ischemic	ischemic	ADJ
dti-2347	167	39	cardiomyopathy	cardiomyopathy	ADJ
dti-2347	167	40	,	,	PUNCT
dti-2347	167	41	as	as	ADV
dti-2347	167	42	well	well	ADV
dti-2347	167	43	as	as	ADP
dti-2347	167	44	(	(	PUNCT
dti-2347	167	45	iii	iii	NOUN
dti-2347	167	46	)	)	PUNCT
dti-2347	167	47	in	in	ADP
dti-2347	167	48	patients	patient	NOUN
dti-2347	167	49	with	with	ADP
dti-2347	167	50	severe	severe	ADJ
dti-2347	167	51	gh	gh	PROPN
dti-2347	167	52	deficiency	deficiency	NOUN
dti-2347	167	53	(	(	PUNCT
dti-2347	167	54	20	20	NUM
dti-2347	167	55	)	)	PUNCT
dti-2347	167	56	.	.	PUNCT
dti-2347	168	1	hexarelin	hexarelin	PROPN
dti-2347	168	2	significantly	significantly	ADV
dti-2347	168	3	reduced	reduce	VERB
dti-2347	168	4	indices	index	NOUN
dti-2347	168	5	of	of	ADP
dti-2347	168	6	cardiac	cardiac	ADJ
dti-2347	168	7	fibrosis	fibrosis	NOUN
dti-2347	168	8	in	in	ADP
dti-2347	168	9	experimental	experimental	ADJ
dti-2347	168	10	models	model	NOUN
dti-2347	168	11	of	of	ADP
dti-2347	168	12	myocardial	myocardial	ADJ
dti-2347	168	13	infarction	infarction	NOUN
dti-2347	168	14	,	,	PUNCT
dti-2347	168	15	likely	likely	ADJ
dti-2347	168	16	through	through	ADP
dti-2347	168	17	an	an	DET
dti-2347	168	18	underlying	underlie	VERB
dti-2347	168	19	anti	anti	ADJ
dti-2347	168	20	-	-	ADJ
dti-2347	168	21	inflammatory	inflammatory	ADJ
dti-2347	168	22	mechanism	mechanism	NOUN
dti-2347	168	23	(	(	PUNCT
dti-2347	168	24	12	12	NUM
dti-2347	168	25	)	)	PUNCT
dti-2347	168	26	.	.	PUNCT
dti-2347	169	1	the	the	DET
dti-2347	169	2	effects	effect	NOUN
dti-2347	169	3	of	of	ADP
dti-2347	169	4	subacute	subacute	NOUN
dti-2347	169	5	hexarelin	hexarelin	PROPN
dti-2347	169	6	treatments	treatment	NOUN
dti-2347	169	7	in	in	ADP
dti-2347	169	8	rats	rat	NOUN
dti-2347	169	9	(	(	PUNCT
dti-2347	169	10	8)	8)	NUM
dti-2347	169	11	strongly	strongly	ADV
dti-2347	169	12	suggested	suggest	VERB
dti-2347	169	13	that	that	SCONJ
dti-2347	169	14	hexarelin	hexarelin	PROPN
dti-2347	169	15	could	could	AUX
dti-2347	169	16	interfere	interfere	VERB
dti-2347	169	17	with	with	ADP
dti-2347	169	18	the	the	DET
dti-2347	169	19	renin	renin	ADJ
dti-2347	169	20	-	-	PUNCT
dti-2347	169	21	angiotensin	angiotensin	NOUN
dti-2347	169	22	-	-	PUNCT
dti-2347	169	23	aldosterone	aldosterone	NOUN
dti-2347	169	24	system	system	NOUN
dti-2347	169	25	(	(	PUNCT
dti-2347	169	26	raas	raas	NOUN
dti-2347	169	27	)	)	PUNCT
dti-2347	169	28	.	.	PUNCT
dti-2347	170	1	we	we	PRON
dti-2347	170	2	provided	provide	VERB
dti-2347	170	3	evidence	evidence	NOUN
dti-2347	170	4	in	in	ADP
dti-2347	170	5	support	support	NOUN
dti-2347	170	6	of	of	ADP
dti-2347	170	7	that	that	DET
dti-2347	170	8	hypothesis	hypothesis	NOUN
dti-2347	170	9	by	by	ADP
dti-2347	170	10	showing	show	VERB
dti-2347	170	11	that	that	SCONJ
dti-2347	170	12	hexarelin	hexarelin	PROPN
dti-2347	170	13	and	and	CCONJ
dti-2347	170	14	other	other	ADJ
dti-2347	170	15	synthetic	synthetic	ADJ
dti-2347	170	16	ghs	gh	NOUN
dti-2347	170	17	inhibited	inhibit	VERB
dti-2347	170	18	the	the	DET
dti-2347	170	19	activity	activity	NOUN
dti-2347	170	20	of	of	ADP
dti-2347	170	21	ace	ace	NOUN
dti-2347	170	22	(	(	PUNCT
dti-2347	170	23	13	13	NUM
dti-2347	170	24	)	)	PUNCT
dti-2347	170	25	.	.	PUNCT
dti-2347	171	1	the	the	DET
dti-2347	171	2	somatic	somatic	ADJ
dti-2347	171	3	form	form	NOUN
dti-2347	171	4	of	of	ADP
dti-2347	171	5	ace	ace	NOUN
dti-2347	171	6	is	be	AUX
dti-2347	171	7	a	a	DET
dti-2347	171	8	type	type	NOUN
dti-2347	171	9	i	i	PRON
dti-2347	171	10	membrane	membrane	NOUN
dti-2347	171	11	-	-	PUNCT
dti-2347	171	12	anchored	anchor	VERB
dti-2347	171	13	dipeptidyl	dipeptidyl	NOUN
dti-2347	171	14	carboxypeptidase	carboxypeptidase	NOUN
dti-2347	171	15	consisting	consist	VERB
dti-2347	171	16	of	of	ADP
dti-2347	171	17	two	two	NUM
dti-2347	171	18	extracellular	extracellular	ADJ
dti-2347	171	19	catalytic	catalytic	ADJ
dti-2347	171	20	domains	domain	NOUN
dti-2347	171	21	:	:	PUNCT
dti-2347	171	22	the	the	DET
dti-2347	171	23	nand	nand	NOUN
dti-2347	171	24	c	c	NOUN
dti-2347	171	25	-	-	PUNCT
dti-2347	171	26	domains	domain	NOUN
dti-2347	171	27	specifically	specifically	ADV
dti-2347	171	28	catalyze	catalyze	NOUN
dti-2347	171	29	conversion	conversion	NOUN
dti-2347	171	30	of	of	ADP
dti-2347	171	31	angiotensin	angiotensin	NOUN
dti-2347	171	32	i	i	PRON
dti-2347	171	33	and	and	CCONJ
dti-2347	171	34	bradykinin	bradykinin	PROPN
dti-2347	171	35	,	,	PUNCT
dti-2347	171	36	respectively	respectively	ADV
dti-2347	171	37	(	(	PUNCT
dti-2347	171	38	21,22	21,22	NOUN
dti-2347	171	39	)	)	PUNCT
dti-2347	171	40	.	.	PUNCT
dti-2347	172	1	hexarelin	hexarelin	PROPN
dti-2347	172	2	and	and	CCONJ
dti-2347	172	3	synthetic	synthetic	ADJ
dti-2347	172	4	ghs	gh	NOUN
dti-2347	172	5	selectively	selectively	ADV
dti-2347	172	6	bind	bind	VERB
dti-2347	172	7	to	to	ADP
dti-2347	172	8	and	and	CCONJ
dti-2347	172	9	inhibit	inhibit	VERB
dti-2347	172	10	the	the	DET
dti-2347	172	11	activity	activity	NOUN
dti-2347	172	12	of	of	ADP
dti-2347	172	13	the	the	DET
dti-2347	172	14	c	c	NOUN
dti-2347	172	15	-	-	NOUN
dti-2347	172	16	domain	domain	NOUN
dti-2347	172	17	,	,	PUNCT
dti-2347	172	18	without	without	ADP
dti-2347	172	19	being	be	AUX
dti-2347	172	20	metabolized	metabolize	VERB
dti-2347	172	21	themselves	themselves	PRON
dti-2347	172	22	(	(	PUNCT
dti-2347	172	23	13	13	NUM
dti-2347	172	24	)	)	PUNCT
dti-2347	172	25	.	.	PUNCT
dti-2347	173	1	hexarelin	hexarelin	PROPN
dti-2347	173	2	inhibition	inhibition	NOUN
dti-2347	173	3	of	of	ADP
dti-2347	173	4	ace	ace	NOUN
dti-2347	173	5	may	may	AUX
dti-2347	173	6	account	account	VERB
dti-2347	173	7	,	,	PUNCT
dti-2347	173	8	in	in	ADP
dti-2347	173	9	part	part	NOUN
dti-2347	173	10	,	,	PUNCT
dti-2347	173	11	for	for	ADP
dti-2347	173	12	its	its	PRON
dti-2347	173	13	cardioprotective	cardioprotective	ADJ
dti-2347	173	14	effects	effect	NOUN
dti-2347	173	15	.	.	PUNCT
dti-2347	174	1	to	to	PART
dti-2347	174	2	illustrate	illustrate	VERB
dti-2347	174	3	,	,	PUNCT
dti-2347	174	4	binding	bind	VERB
dti-2347	174	5	sites	site	NOUN
dti-2347	174	6	for	for	ADP
dti-2347	174	7	ghs	gh	NOUN
dti-2347	174	8	are	be	AUX
dti-2347	174	9	expressed	express	VERB
dti-2347	174	10	in	in	ADP
dti-2347	174	11	the	the	DET
dti-2347	174	12	heart	heart	NOUN
dti-2347	174	13	;	;	PUNCT
dti-2347	174	14	moreover	moreover	ADV
dti-2347	174	15	,	,	PUNCT
dti-2347	174	16	mrna	mrna	PROPN
dti-2347	174	17	for	for	ADP
dti-2347	174	18	the	the	DET
dti-2347	174	19	specific	specific	ADJ
dti-2347	174	20	ghs	ghs	NOUN
dti-2347	174	21	receptor	receptor	NOUN
dti-2347	174	22	(	(	PUNCT
dti-2347	174	23	ghs	ghs	NOUN
dti-2347	174	24	-	-	PUNCT
dti-2347	174	25	r1a	r1a	NOUN
dti-2347	174	26	)	)	PUNCT
dti-2347	174	27	has	have	AUX
dti-2347	174	28	been	be	AUX
dti-2347	174	29	detected	detect	VERB
dti-2347	174	30	by	by	ADP
dti-2347	174	31	reverse	reverse	ADJ
dti-2347	174	32	transcriptase	transcriptase	NOUN
dti-2347	174	33	polymerase	polymerase	NOUN
dti-2347	174	34	chain	chain	NOUN
dti-2347	174	35	reaction	reaction	NOUN
dti-2347	174	36	(	(	PUNCT
dti-2347	174	37	rt	rt	NOUN
dti-2347	174	38	-	-	PUNCT
dti-2347	174	39	pcr	pcr	NOUN
dti-2347	174	40	)	)	PUNCT
dti-2347	174	41	in	in	ADP
dti-2347	174	42	the	the	DET
dti-2347	174	43	rat	rat	NOUN
dti-2347	174	44	aorta	aorta	NOUN
dti-2347	174	45	as	as	ADV
dti-2347	174	46	well	well	ADV
dti-2347	174	47	as	as	ADP
dti-2347	174	48	the	the	DET
dti-2347	174	49	left	left	ADJ
dti-2347	174	50	ventricle	ventricle	NOUN
dti-2347	174	51	and	and	CCONJ
dti-2347	174	52	left	leave	VERB
dti-2347	174	53	atrium	atrium	NOUN
dti-2347	174	54	(	(	PUNCT
dti-2347	174	55	23,24	23,24	NOUN
dti-2347	174	56	)	)	PUNCT
dti-2347	174	57	.	.	PUNCT
dti-2347	175	1	nonetheless	nonetheless	ADV
dti-2347	175	2	,	,	PUNCT
dti-2347	175	3	it	it	PRON
dti-2347	175	4	is	be	AUX
dti-2347	175	5	presumed	presume	VERB
dti-2347	175	6	that	that	SCONJ
dti-2347	175	7	the	the	DET
dti-2347	175	8	levels	level	NOUN
dti-2347	175	9	of	of	ADP
dti-2347	175	10	ghs	gh	NOUN
dti-2347	175	11	-	-	PUNCT
dti-2347	175	12	r1a	r1a	PRON
dti-2347	175	13	expressed	express	VERB
dti-2347	175	14	in	in	ADP
dti-2347	175	15	these	these	DET
dti-2347	175	16	tissues	tissue	NOUN
dti-2347	175	17	are	be	AUX
dti-2347	175	18	too	too	ADV
dti-2347	175	19	small	small	ADJ
dti-2347	175	20	to	to	PART
dti-2347	175	21	be	be	AUX
dti-2347	175	22	responsible	responsible	ADJ
dti-2347	175	23	for	for	ADP
dti-2347	175	24	ghs	gh	NOUN
dti-2347	175	25	cardioprotective	cardioprotective	ADJ
dti-2347	175	26	effects	effect	NOUN
dti-2347	175	27	.	.	PUNCT
dti-2347	176	1	ghs	ghs	PROPN
dti-2347	176	2	cardioprotective	cardioprotective	ADJ
dti-2347	176	3	effects	effect	NOUN
dti-2347	176	4	are	be	AUX
dti-2347	176	5	now	now	ADV
dti-2347	176	6	being	be	AUX
dti-2347	176	7	considered	consider	VERB
dti-2347	176	8	to	to	PART
dti-2347	176	9	be	be	AUX
dti-2347	176	10	more	more	ADV
dti-2347	176	11	related	related	ADJ
dti-2347	176	12	to	to	ADP
dti-2347	176	13	inhibition	inhibition	NOUN
dti-2347	176	14	of	of	ADP
dti-2347	176	15	angiotensin	angiotensin	NOUN
dti-2347	176	16	ii	ii	PROPN
dti-2347	176	17	(	(	PUNCT
dti-2347	176	18	aii	aii	PROPN
dti-2347	176	19	)	)	PUNCT
dti-2347	176	20	synthesis	synthesis	NOUN
dti-2347	176	21	and/or	and/or	CCONJ
dti-2347	176	22	the	the	DET
dti-2347	176	23	antagonism	antagonism	NOUN
dti-2347	176	24	of	of	ADP
dti-2347	176	25	its	its	PRON
dti-2347	176	26	receptor	receptor	NOUN
dti-2347	176	27	(	(	PUNCT
dti-2347	176	28	at1	at1	PROPN
dti-2347	176	29	)	)	PUNCT
dti-2347	176	30	.	.	PUNCT
dti-2347	177	1	ace	ace	VERB
dti-2347	177	2	synthesizes	synthesize	VERB
dti-2347	177	3	aii	aii	NOUN
dti-2347	177	4	,	,	PUNCT
dti-2347	177	5	which	which	PRON
dti-2347	177	6	acts	act	VERB
dti-2347	177	7	through	through	ADP
dti-2347	177	8	the	the	DET
dti-2347	177	9	at1	at1	PROPN
dti-2347	177	10	receptor	receptor	NOUN
dti-2347	177	11	to	to	PART
dti-2347	177	12	increase	increase	VERB
dti-2347	177	13	blood	blood	NOUN
dti-2347	177	14	pressure	pressure	NOUN
dti-2347	177	15	and	and	CCONJ
dti-2347	177	16	to	to	PART
dti-2347	177	17	promote	promote	VERB
dti-2347	177	18	fibrosis	fibrosis	NOUN
dti-2347	177	19	and	and	CCONJ
dti-2347	177	20	inflammation	inflammation	NOUN
dti-2347	177	21	.	.	PUNCT
dti-2347	178	1	the	the	DET
dti-2347	178	2	vulnerability	vulnerability	NOUN
dti-2347	178	3	of	of	ADP
dti-2347	178	4	aii	aii	NOUN
dti-2347	178	5	to	to	ADP
dti-2347	178	6	enzymatic	enzymatic	ADJ
dti-2347	178	7	conversion	conversion	NOUN
dti-2347	178	8	by	by	ADP
dti-2347	178	9	ace2	ace2	PROPN
dti-2347	178	10	leads	lead	VERB
dti-2347	178	11	to	to	ADP
dti-2347	178	12	reduction	reduction	NOUN
dti-2347	178	13	of	of	ADP
dti-2347	178	14	aii	aii	NOUN
dti-2347	178	15	levels	level	NOUN
dti-2347	178	16	and	and	CCONJ
dti-2347	178	17	production	production	NOUN
dti-2347	178	18	of	of	ADP
dti-2347	178	19	angiotensin	angiotensin	NOUN
dti-2347	178	20	(	(	PUNCT
dti-2347	178	21	1	1	NUM
dti-2347	178	22	-	-	SYM
dti-2347	178	23	7	7	NUM
dti-2347	178	24	)	)	PUNCT
dti-2347	178	25	which	which	PRON
dti-2347	178	26	selectively	selectively	ADV
dti-2347	178	27	binds	bind	VERB
dti-2347	178	28	to	to	ADP
dti-2347	178	29	the	the	DET
dti-2347	178	30	mas	mas	PROPN
dti-2347	178	31	receptor	receptor	NOUN
dti-2347	178	32	.	.	PUNCT
dti-2347	179	1	the	the	DET
dti-2347	179	2	beneficial	beneficial	ADJ
dti-2347	179	3	effects	effect	NOUN
dti-2347	179	4	of	of	ADP
dti-2347	179	5	ace2	ace2	NOUN
dti-2347	179	6	activity	activity	NOUN
dti-2347	179	7	may	may	AUX
dti-2347	179	8	be	be	AUX
dti-2347	179	9	both	both	ADV
dti-2347	179	10	systemic	systemic	ADJ
dti-2347	179	11	as	as	ADV
dti-2347	179	12	well	well	ADV
dti-2347	179	13	as	as	ADP
dti-2347	179	14	localized	localize	VERB
dti-2347	179	15	in	in	ADP
dti-2347	179	16	tissues	tissue	NOUN
dti-2347	179	17	,	,	PUNCT
dti-2347	179	18	such	such	ADJ
dti-2347	179	19	as	as	ADP
dti-2347	179	20	the	the	DET
dti-2347	179	21	heart	heart	NOUN
dti-2347	179	22	,	,	PUNCT
dti-2347	179	23	kidneys	kidney	NOUN
dti-2347	179	24	,	,	PUNCT
dti-2347	179	25	and	and	CCONJ
dti-2347	179	26	lungs	lung	NOUN
dti-2347	179	27	,	,	PUNCT
dti-2347	179	28	where	where	SCONJ
dti-2347	179	29	it	it	PRON
dti-2347	179	30	antagonizes	antagonize	VERB
dti-2347	179	31	pathological	pathological	ADJ
dti-2347	179	32	changes	change	NOUN
dti-2347	179	33	(	(	PUNCT
dti-2347	179	34	25	25	NUM
dti-2347	179	35	)	)	PUNCT
dti-2347	179	36	.	.	PUNCT
dti-2347	180	1	our	our	PRON
dti-2347	180	2	results	result	NOUN
dti-2347	180	3	that	that	PRON
dti-2347	180	4	demonstrate	demonstrate	VERB
dti-2347	180	5	hexarelin	hexarelin	PROPN
dti-2347	180	6	inhibition	inhibition	NOUN
dti-2347	180	7	of	of	ADP
dti-2347	180	8	lung	lung	NOUN
dti-2347	180	9	fibrosis	fibrosis	NOUN
dti-2347	180	10	in	in	ADP
dti-2347	180	11	acid	acid	NOUN
dti-2347	180	12	-	-	PUNCT
dti-2347	180	13	instilled	instill	VERB
dti-2347	180	14	mice	mouse	NOUN
dti-2347	180	15	are	be	AUX
dti-2347	180	16	in	in	ADP
dti-2347	180	17	agreement	agreement	NOUN
dti-2347	180	18	with	with	ADP
dti-2347	180	19	our	our	PRON
dti-2347	180	20	previous	previous	ADJ
dti-2347	180	21	results	result	NOUN
dti-2347	180	22	demonstrating	demonstrate	VERB
dti-2347	180	23	the	the	DET
dti-2347	180	24	cardioprotective	cardioprotective	ADJ
dti-2347	180	25	and	and	CCONJ
dti-2347	180	26	antiinflammatory	antiinflammatory	NOUN
dti-2347	180	27	effects	effect	NOUN
dti-2347	180	28	of	of	ADP
dti-2347	180	29	hexarelin	hexarelin	PROPN
dti-2347	180	30	(	(	PUNCT
dti-2347	180	31	8,26	8,26	NOUN
dti-2347	180	32	)	)	PUNCT
dti-2347	180	33	.	.	PUNCT
dti-2347	181	1	collectively	collectively	ADV
dti-2347	181	2	,	,	PUNCT
dti-2347	181	3	these	these	DET
dti-2347	181	4	findings	finding	NOUN
dti-2347	181	5	strongly	strongly	ADV
dti-2347	181	6	suggest	suggest	VERB
dti-2347	181	7	that	that	SCONJ
dti-2347	181	8	hexarelin	hexarelin	PROPN
dti-2347	181	9	may	may	AUX
dti-2347	181	10	inhibit	inhibit	VERB
dti-2347	181	11	the	the	DET
dti-2347	181	12	development	development	NOUN
dti-2347	181	13	of	of	ADP
dti-2347	181	14	pathological	pathological	ADJ
dti-2347	181	15	fibrosis	fibrosis	NOUN
dti-2347	181	16	in	in	ADP
dti-2347	181	17	both	both	DET
dti-2347	181	18	these	these	DET
dti-2347	181	19	organs	organ	NOUN
dti-2347	181	20	.	.	PUNCT
dti-2347	182	1	the	the	DET
dti-2347	182	2	lack	lack	NOUN
dti-2347	182	3	of	of	ADP
dti-2347	182	4	beneficial	beneficial	ADJ
dti-2347	182	5	effect	effect	NOUN
dti-2347	182	6	of	of	ADP
dti-2347	182	7	hexarelin	hexarelin	PROPN
dti-2347	182	8	on	on	ADP
dti-2347	182	9	oxygenation	oxygenation	NOUN
dti-2347	182	10	could	could	AUX
dti-2347	182	11	depend	depend	VERB
dti-2347	182	12	on	on	ADP
dti-2347	182	13	the	the	DET
dti-2347	182	14	short	short	ADJ
dti-2347	182	15	interval	interval	NOUN
dti-2347	182	16	after	after	ADP
dti-2347	182	17	treatment	treatment	NOUN
dti-2347	182	18	:	:	PUNCT
dti-2347	182	19	it	it	PRON
dti-2347	182	20	is	be	AUX
dti-2347	182	21	possible	possible	ADJ
dti-2347	182	22	that	that	SCONJ
dti-2347	182	23	24	24	NUM
dti-2347	182	24	hours	hour	NOUN
dti-2347	182	25	is	be	AUX
dti-2347	182	26	not	not	PART
dti-2347	182	27	enough	enough	ADJ
dti-2347	182	28	to	to	PART
dti-2347	182	29	affect	affect	VERB
dti-2347	182	30	oxygen	oxygen	NOUN
dti-2347	182	31	exchange	exchange	NOUN
dti-2347	182	32	.	.	PUNCT
dti-2347	183	1	an	an	DET
dti-2347	183	2	impaired	impaired	ADJ
dti-2347	183	3	perfusion	perfusion	NOUN
dti-2347	183	4	could	could	AUX
dti-2347	183	5	also	also	ADV
dti-2347	183	6	prevent	prevent	VERB
dti-2347	183	7	an	an	DET
dti-2347	183	8	increase	increase	NOUN
dti-2347	183	9	in	in	ADP
dti-2347	183	10	oxygenation	oxygenation	NOUN
dti-2347	183	11	.	.	PUNCT
dti-2347	184	1	the	the	DET
dti-2347	184	2	precise	precise	ADJ
dti-2347	184	3	pathogenesis	pathogenesis	NOUN
dti-2347	184	4	of	of	ADP
dti-2347	184	5	fibrotic	fibrotic	ADJ
dti-2347	184	6	pulmonary	pulmonary	ADJ
dti-2347	184	7	disorder	disorder	NOUN
dti-2347	184	8	is	be	AUX
dti-2347	184	9	still	still	ADV
dti-2347	184	10	unclear	unclear	ADJ
dti-2347	184	11	;	;	PUNCT
dti-2347	184	12	it	it	PRON
dti-2347	184	13	could	could	AUX
dti-2347	184	14	result	result	VERB
dti-2347	184	15	from	from	ADP
dti-2347	184	16	an	an	DET
dti-2347	184	17	excessive	excessive	ADJ
dti-2347	184	18	host	host	NOUN
dti-2347	184	19	inflammatory	inflammatory	ADJ
dti-2347	184	20	response	response	NOUN
dti-2347	184	21	of	of	ADP
dti-2347	184	22	the	the	DET
dti-2347	184	23	lung	lung	NOUN
dti-2347	184	24	to	to	ADP
dti-2347	184	25	an	an	DET
dti-2347	184	26	infectious	infectious	ADJ
dti-2347	184	27	or	or	CCONJ
dti-2347	184	28	noninfectious	noninfectious	ADJ
dti-2347	184	29	insult	insult	NOUN
dti-2347	184	30	.	.	PUNCT
dti-2347	185	1	a	a	DET
dti-2347	185	2	common	common	ADJ
dti-2347	185	3	feature	feature	NOUN
dti-2347	185	4	is	be	AUX
dti-2347	185	5	collagen	collagen	NOUN
dti-2347	185	6	accumulation	accumulation	NOUN
dti-2347	185	7	that	that	PRON
dti-2347	185	8	leads	lead	VERB
dti-2347	185	9	to	to	ADP
dti-2347	185	10	destruction	destruction	NOUN
dti-2347	185	11	of	of	ADP
dti-2347	185	12	alveolar	alveolar	ADJ
dti-2347	185	13	structures	structure	NOUN
dti-2347	185	14	and	and	CCONJ
dti-2347	185	15	promotes	promote	VERB
dti-2347	185	16	remodeling	remodeling	NOUN
dti-2347	185	17	.	.	PUNCT
dti-2347	186	1	this	this	DET
dti-2347	186	2	purported	purport	VERB
dti-2347	186	3	mechanism	mechanism	NOUN
dti-2347	186	4	has	have	AUX
dti-2347	186	5	been	be	AUX
dti-2347	186	6	proposed	propose	VERB
dti-2347	186	7	to	to	PART
dti-2347	186	8	play	play	VERB
dti-2347	186	9	a	a	DET
dti-2347	186	10	primary	primary	ADJ
dti-2347	186	11	role	role	NOUN
dti-2347	186	12	in	in	ADP
dti-2347	186	13	ards	ard	NOUN
dti-2347	186	14	(	(	PUNCT
dti-2347	186	15	27	27	NUM
dti-2347	186	16	)	)	PUNCT
dti-2347	186	17	.	.	PUNCT
dti-2347	187	1	in	in	ADP
dti-2347	187	2	the	the	DET
dti-2347	187	3	lung	lung	NOUN
dti-2347	187	4	and	and	CCONJ
dti-2347	187	5	other	other	ADJ
dti-2347	187	6	tissues	tissue	NOUN
dti-2347	187	7	,	,	PUNCT
dti-2347	187	8	inflammation	inflammation	NOUN
dti-2347	187	9	correlates	correlate	VERB
dti-2347	187	10	with	with	ADP
dti-2347	187	11	the	the	DET
dti-2347	187	12	presence	presence	NOUN
dti-2347	187	13	of	of	ADP
dti-2347	187	14	macrophages	macrophage	NOUN
dti-2347	187	15	and	and	CCONJ
dti-2347	187	16	other	other	ADJ
dti-2347	187	17	immune	immune	ADJ
dti-2347	187	18	cells	cell	NOUN
dti-2347	187	19	that	that	PRON
dti-2347	187	20	can	can	AUX
dti-2347	187	21	be	be	AUX
dti-2347	187	22	involved	involve	VERB
dti-2347	187	23	in	in	ADP
dti-2347	187	24	the	the	DET
dti-2347	187	25	inflammatory	inflammatory	ADJ
dti-2347	187	26	process	process	NOUN
dti-2347	187	27	and	and	CCONJ
dti-2347	187	28	thereafter	thereafter	ADV
dti-2347	187	29	its	its	PRON
dti-2347	187	30	resolution	resolution	NOUN
dti-2347	187	31	and	and	CCONJ
dti-2347	187	32	recovery	recovery	NOUN
dti-2347	187	33	from	from	ADP
dti-2347	187	34	ards	ard	NOUN
dti-2347	187	35	(	(	PUNCT
dti-2347	187	36	28	28	NUM
dti-2347	187	37	)	)	PUNCT
dti-2347	187	38	.	.	PUNCT
dti-2347	188	1	it	it	PRON
dti-2347	188	2	has	have	AUX
dti-2347	188	3	been	be	AUX
dti-2347	188	4	reported	report	VERB
dti-2347	188	5	that	that	SCONJ
dti-2347	188	6	ards	ard	NOUN
dti-2347	188	7	occurs	occur	VERB
dti-2347	188	8	in	in	ADP
dti-2347	188	9	some	some	DET
dti-2347	188	10	severe	severe	ADJ
dti-2347	188	11	acute	acute	ADJ
dti-2347	188	12	respiratory	respiratory	ADJ
dti-2347	188	13	syndrome	syndrome	NOUN
dti-2347	188	14	(	(	PUNCT
dti-2347	188	15	sars	sar	NOUN
dti-2347	188	16	)	)	PUNCT
dti-2347	188	17	patients	patient	NOUN
dti-2347	188	18	despite	despite	SCONJ
dti-2347	188	19	a	a	DET
dti-2347	188	20	diminishing	diminish	VERB
dti-2347	188	21	viral	viral	ADJ
dti-2347	188	22	load	load	NOUN
dti-2347	188	23	,	,	PUNCT
dti-2347	188	24	suggesting	suggest	VERB
dti-2347	188	25	that	that	SCONJ
dti-2347	188	26	the	the	DET
dti-2347	188	27	host	host	NOUN
dti-2347	188	28	immune	immune	ADJ
dti-2347	188	29	response	response	NOUN
dti-2347	188	30	rather	rather	ADV
dti-2347	188	31	than	than	ADP
dti-2347	188	32	viral	viral	ADJ
dti-2347	188	33	infection	infection	NOUN
dti-2347	188	34	itself	itself	PRON
dti-2347	188	35	could	could	AUX
dti-2347	188	36	be	be	AUX
dti-2347	188	37	responsible	responsible	ADJ
dti-2347	188	38	for	for	ADP
dti-2347	188	39	lung	lung	NOUN
dti-2347	188	40	damage	damage	NOUN
dti-2347	188	41	(	(	PUNCT
dti-2347	188	42	29	29	NUM
dti-2347	188	43	)	)	PUNCT
dti-2347	188	44	.	.	PUNCT
dti-2347	189	1	we	we	PRON
dti-2347	189	2	have	have	AUX
dti-2347	189	3	observed	observe	VERB
dti-2347	189	4	that	that	SCONJ
dti-2347	189	5	hexarelin	hexarelin	PROPN
dti-2347	189	6	reduced	reduce	VERB
dti-2347	189	7	the	the	DET
dti-2347	189	8	number	number	NOUN
dti-2347	189	9	of	of	ADP
dti-2347	189	10	immune	immune	ADJ
dti-2347	189	11	cells	cell	NOUN
dti-2347	189	12	in	in	ADP
dti-2347	189	13	the	the	DET
dti-2347	189	14	bal	bal	NOUN
dti-2347	189	15	,	,	PUNCT
dti-2347	189	16	in	in	ADP
dti-2347	189	17	particular	particular	ADJ
dti-2347	189	18	pmn	pmn	NOUN
dti-2347	189	19	,	,	PUNCT
dti-2347	189	20	suggesting	suggest	VERB
dti-2347	189	21	that	that	SCONJ
dti-2347	189	22	it	it	PRON
dti-2347	189	23	could	could	AUX
dti-2347	189	24	partially	partially	ADV
dti-2347	189	25	inhibit	inhibit	VERB
dti-2347	189	26	the	the	DET
dti-2347	189	27	recruitment	recruitment	NOUN
dti-2347	189	28	of	of	ADP
dti-2347	189	29	pmn	pmn	NOUN
dti-2347	189	30	into	into	ADP
dti-2347	189	31	the	the	DET
dti-2347	189	32	alveolar	alveolar	ADJ
dti-2347	189	33	space	space	NOUN
dti-2347	189	34	.	.	PUNCT
dti-2347	190	1	this	this	PRON
dti-2347	190	2	is	be	AUX
dti-2347	190	3	consistent	consistent	ADJ
dti-2347	190	4	with	with	ADP
dti-2347	190	5	the	the	DET
dti-2347	190	6	anti	anti	ADJ
dti-2347	190	7	-	-	ADJ
dti-2347	190	8	inflammatory	inflammatory	ADJ
dti-2347	190	9	and	and	CCONJ
dti-2347	190	10	antifibrotic	antifibrotic	ADJ
dti-2347	190	11	effects	effect	NOUN
dti-2347	190	12	reported	report	VERB
dti-2347	190	13	for	for	ADP
dti-2347	190	14	hexarelin	hexarelin	PROPN
dti-2347	190	15	in	in	ADP
dti-2347	190	16	the	the	DET
dti-2347	190	17	heart	heart	NOUN
dti-2347	190	18	(	(	PUNCT
dti-2347	190	19	12	12	NUM
dti-2347	190	20	)	)	PUNCT
dti-2347	190	21	.	.	PUNCT
dti-2347	191	1	in	in	ADP
dti-2347	191	2	this	this	DET
dti-2347	191	3	study	study	NOUN
dti-2347	191	4	,	,	PUNCT
dti-2347	191	5	we	we	PRON
dti-2347	191	6	observed	observe	VERB
dti-2347	191	7	that	that	SCONJ
dti-2347	191	8	hexarelin	hexarelin	PROPN
dti-2347	191	9	significantly	significantly	ADV
dti-2347	191	10	reduced	reduce	VERB
dti-2347	191	11	oh	oh	NUM
dti-2347	191	12	-	-	PUNCT
dti-2347	191	13	proline	proline	NOUN
dti-2347	191	14	levels	level	NOUN
dti-2347	191	15	,	,	PUNCT
dti-2347	191	16	a	a	DET
dti-2347	191	17	measure	measure	NOUN
dti-2347	191	18	of	of	ADP
dti-2347	191	19	collagen	collagen	NOUN
dti-2347	191	20	deposition	deposition	NOUN
dti-2347	191	21	,	,	PUNCT
dti-2347	191	22	in	in	ADP
dti-2347	191	23	the	the	DET
dti-2347	191	24	lung	lung	NOUN
dti-2347	191	25	treated	treat	VERB
dti-2347	191	26	with	with	ADP
dti-2347	191	27	acid	acid	NOUN
dti-2347	191	28	instillation	instillation	NOUN
dti-2347	191	29	.	.	PUNCT
dti-2347	192	1	this	this	DET
dti-2347	192	2	result	result	NOUN
dti-2347	192	3	is	be	AUX
dti-2347	192	4	effects	effect	NOUN
dti-2347	192	5	of	of	ADP
dti-2347	192	6	hexarelin	hexarelin	PROPN
dti-2347	192	7	treatment	treatment	NOUN
dti-2347	192	8	on	on	ADP
dti-2347	192	9	acute	acute	ADJ
dti-2347	192	10	lung	lung	NOUN
dti-2347	192	11	injury32	injury32	NOUN
dti-2347	193	1	©	©	ADP
dti-2347	193	2	2021	2021	NUM
dti-2347	193	3	the	the	DET
dti-2347	193	4	authors	author	NOUN
dti-2347	193	5	.	.	PUNCT
dti-2347	194	1	drug	drug	NOUN
dti-2347	194	2	target	target	NOUN
dti-2347	194	3	insights	insight	NOUN
dti-2347	194	4	issn	issn	VERB
dti-2347	194	5	1177	1177	NUM
dti-2347	194	6	-	-	SYM
dti-2347	194	7	3928	3928	NUM
dti-2347	194	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	VERB
dti-2347	194	9	consistent	consistent	ADJ
dti-2347	194	10	with	with	ADP
dti-2347	194	11	the	the	DET
dti-2347	194	12	ability	ability	NOUN
dti-2347	194	13	of	of	ADP
dti-2347	194	14	hexarelin	hexarelin	PROPN
dti-2347	194	15	to	to	PART
dti-2347	194	16	reduce	reduce	VERB
dti-2347	194	17	the	the	DET
dti-2347	194	18	fibrotic	fibrotic	ADJ
dti-2347	194	19	areas	area	NOUN
dti-2347	194	20	in	in	ADP
dti-2347	194	21	lung	lung	NOUN
dti-2347	194	22	histology	histology	NOUN
dti-2347	194	23	.	.	PUNCT
dti-2347	195	1	in	in	ADP
dti-2347	195	2	our	our	PRON
dti-2347	195	3	histological	histological	ADJ
dti-2347	195	4	observations	observation	NOUN
dti-2347	195	5	,	,	PUNCT
dti-2347	195	6	fibrosis	fibrosis	NOUN
dti-2347	195	7	features	feature	NOUN
dti-2347	195	8	were	be	AUX
dti-2347	195	9	similar	similar	ADJ
dti-2347	195	10	in	in	ADP
dti-2347	195	11	vehicleand	vehicleand	NOUN
dti-2347	195	12	hexarelin	hexarelin	PROPN
dti-2347	195	13	-	-	PUNCT
dti-2347	195	14	treated	treat	VERB
dti-2347	195	15	groups	group	NOUN
dti-2347	195	16	,	,	PUNCT
dti-2347	195	17	either	either	CCONJ
dti-2347	195	18	for	for	ADP
dti-2347	195	19	cellular	cellular	ADJ
dti-2347	195	20	type	type	NOUN
dti-2347	195	21	or	or	CCONJ
dti-2347	195	22	anatomical	anatomical	ADJ
dti-2347	195	23	location	location	NOUN
dti-2347	195	24	(	(	PUNCT
dti-2347	195	25	subpleural	subpleural	ADJ
dti-2347	195	26	origin	origin	NOUN
dti-2347	195	27	with	with	ADP
dti-2347	195	28	following	follow	VERB
dti-2347	195	29	centrilobular	centrilobular	ADJ
dti-2347	195	30	involvement	involvement	NOUN
dti-2347	195	31	,	,	PUNCT
dti-2347	195	32	like	like	ADP
dti-2347	195	33	usual	usual	ADJ
dti-2347	195	34	interstitial	interstitial	ADJ
dti-2347	195	35	pneumonia	pneumonia	NOUN
dti-2347	195	36	pattern	pattern	NOUN
dti-2347	195	37	)	)	PUNCT
dti-2347	195	38	(	(	PUNCT
dti-2347	195	39	30	30	NUM
dti-2347	195	40	)	)	PUNCT
dti-2347	195	41	.	.	PUNCT
dti-2347	196	1	the	the	DET
dti-2347	196	2	smaller	small	ADJ
dti-2347	196	3	amounts	amount	NOUN
dti-2347	196	4	of	of	ADP
dti-2347	196	5	fibrosis	fibrosis	NOUN
dti-2347	196	6	in	in	ADP
dti-2347	196	7	hexarelin	hexarelin	PROPN
dti-2347	196	8	-	-	PUNCT
dti-2347	196	9	treated	treat	VERB
dti-2347	196	10	mice	mouse	NOUN
dti-2347	196	11	could	could	AUX
dti-2347	196	12	be	be	AUX
dti-2347	196	13	related	relate	VERB
dti-2347	196	14	to	to	ADP
dti-2347	196	15	a	a	DET
dti-2347	196	16	lower	low	ADJ
dti-2347	196	17	collagen	collagen	NOUN
dti-2347	196	18	deposition	deposition	NOUN
dti-2347	196	19	,	,	PUNCT
dti-2347	196	20	consistent	consistent	ADJ
dti-2347	196	21	with	with	ADP
dti-2347	196	22	the	the	DET
dti-2347	196	23	reduced	reduce	VERB
dti-2347	196	24	presence	presence	NOUN
dti-2347	196	25	of	of	ADP
dti-2347	196	26	inflammatory	inflammatory	ADJ
dti-2347	196	27	cells	cell	NOUN
dti-2347	196	28	.	.	PUNCT
dti-2347	197	1	this	this	DET
dti-2347	197	2	study	study	NOUN
dti-2347	197	3	has	have	VERB
dti-2347	197	4	some	some	DET
dti-2347	197	5	limitations	limitation	NOUN
dti-2347	197	6	that	that	PRON
dti-2347	197	7	should	should	AUX
dti-2347	197	8	be	be	AUX
dti-2347	197	9	acknowledged	acknowledge	VERB
dti-2347	197	10	.	.	PUNCT
dti-2347	198	1	first	first	ADV
dti-2347	198	2	,	,	PUNCT
dti-2347	198	3	we	we	PRON
dti-2347	198	4	did	do	AUX
dti-2347	198	5	not	not	PART
dti-2347	198	6	confirm	confirm	VERB
dti-2347	198	7	the	the	DET
dti-2347	198	8	findings	finding	NOUN
dti-2347	198	9	in	in	ADP
dti-2347	198	10	a	a	DET
dti-2347	198	11	different	different	ADJ
dti-2347	198	12	model	model	NOUN
dti-2347	198	13	of	of	ADP
dti-2347	198	14	ards	ard	NOUN
dti-2347	198	15	.	.	PUNCT
dti-2347	199	1	second	second	ADJ
dti-2347	199	2	,	,	PUNCT
dti-2347	199	3	the	the	DET
dti-2347	199	4	possible	possible	ADJ
dti-2347	199	5	mechanisms	mechanism	NOUN
dti-2347	199	6	of	of	ADP
dti-2347	199	7	action	action	NOUN
dti-2347	199	8	of	of	ADP
dti-2347	199	9	hexarelin	hexarelin	PROPN
dti-2347	199	10	are	be	AUX
dti-2347	199	11	only	only	ADV
dti-2347	199	12	speculative	speculative	ADJ
dti-2347	199	13	.	.	PUNCT
dti-2347	200	1	third	third	ADJ
dti-2347	200	2	,	,	PUNCT
dti-2347	200	3	the	the	DET
dti-2347	200	4	levels	level	NOUN
dti-2347	200	5	of	of	ADP
dti-2347	200	6	inflammatory	inflammatory	ADJ
dti-2347	200	7	cytokines	cytokine	NOUN
dti-2347	200	8	were	be	AUX
dti-2347	200	9	not	not	PART
dti-2347	200	10	measured	measure	VERB
dti-2347	200	11	,	,	PUNCT
dti-2347	200	12	which	which	PRON
dti-2347	200	13	could	could	AUX
dti-2347	200	14	support	support	VERB
dti-2347	200	15	the	the	DET
dti-2347	200	16	results	result	NOUN
dti-2347	200	17	on	on	ADP
dti-2347	200	18	inflammation	inflammation	NOUN
dti-2347	200	19	obtained	obtain	VERB
dti-2347	200	20	for	for	ADP
dti-2347	200	21	local	local	ADJ
dti-2347	200	22	and	and	CCONJ
dti-2347	200	23	peripheral	peripheral	ADJ
dti-2347	200	24	inflammatory	inflammatory	ADJ
dti-2347	200	25	cell	cell	NOUN
dti-2347	200	26	count	count	NOUN
dti-2347	200	27	.	.	PUNCT
dti-2347	201	1	fourth	fourth	ADJ
dti-2347	201	2	,	,	PUNCT
dti-2347	201	3	as	as	ADP
dti-2347	201	4	index	index	NOUN
dti-2347	201	5	of	of	ADP
dti-2347	201	6	lung	lung	NOUN
dti-2347	201	7	,	,	PUNCT
dti-2347	201	8	edema	edema	NOUN
dti-2347	201	9	,	,	PUNCT
dti-2347	201	10	septal	septal	ADJ
dti-2347	201	11	thickening	thickening	NOUN
dti-2347	201	12	,	,	PUNCT
dti-2347	201	13	and	and	CCONJ
dti-2347	201	14	hemorrhage	hemorrhage	NOUN
dti-2347	201	15	were	be	AUX
dti-2347	201	16	not	not	PART
dti-2347	201	17	assessed	assess	VERB
dti-2347	201	18	in	in	ADP
dti-2347	201	19	this	this	DET
dti-2347	201	20	study	study	NOUN
dti-2347	201	21	.	.	PUNCT
dti-2347	202	1	in	in	ADP
dti-2347	202	2	conclusion	conclusion	NOUN
dti-2347	202	3	,	,	PUNCT
dti-2347	202	4	our	our	PRON
dti-2347	202	5	results	result	NOUN
dti-2347	202	6	suggest	suggest	VERB
dti-2347	202	7	that	that	SCONJ
dti-2347	202	8	hexarelin	hexarelin	PROPN
dti-2347	202	9	can	can	AUX
dti-2347	202	10	ameliorate	ameliorate	VERB
dti-2347	202	11	the	the	DET
dti-2347	202	12	static	static	ADJ
dti-2347	202	13	compliance	compliance	NOUN
dti-2347	202	14	of	of	ADP
dti-2347	202	15	acid	acid	NOUN
dti-2347	202	16	-	-	PUNCT
dti-2347	202	17	injured	injure	VERB
dti-2347	202	18	lungs	lung	NOUN
dti-2347	202	19	in	in	ADP
dti-2347	202	20	mice	mouse	NOUN
dti-2347	202	21	,	,	PUNCT
dti-2347	202	22	an	an	DET
dti-2347	202	23	experimental	experimental	ADJ
dti-2347	202	24	model	model	NOUN
dti-2347	202	25	of	of	ADP
dti-2347	202	26	ards	ard	NOUN
dti-2347	202	27	.	.	PUNCT
dti-2347	203	1	our	our	PRON
dti-2347	203	2	results	result	NOUN
dti-2347	203	3	also	also	ADV
dti-2347	203	4	show	show	VERB
dti-2347	203	5	that	that	SCONJ
dti-2347	203	6	hexarelin	hexarelin	PROPN
dti-2347	203	7	can	can	AUX
dti-2347	203	8	reduce	reduce	VERB
dti-2347	203	9	lung	lung	NOUN
dti-2347	203	10	fibrosis	fibrosis	NOUN
dti-2347	203	11	,	,	PUNCT
dti-2347	203	12	a	a	DET
dti-2347	203	13	complication	complication	NOUN
dti-2347	203	14	often	often	ADV
dti-2347	203	15	reported	report	VERB
dti-2347	203	16	in	in	ADP
dti-2347	203	17	patients	patient	NOUN
dti-2347	203	18	with	with	ADP
dti-2347	203	19	classical	classical	ADJ
dti-2347	203	20	and	and	CCONJ
dti-2347	203	21	covid-19	covid-19	PROPN
dti-2347	203	22	ards	ard	NOUN
dti-2347	203	23	.	.	PUNCT
dti-2347	204	1	collectively	collectively	ADV
dti-2347	204	2	,	,	PUNCT
dti-2347	204	3	these	these	DET
dti-2347	204	4	findings	finding	NOUN
dti-2347	204	5	suggest	suggest	VERB
dti-2347	204	6	that	that	SCONJ
dti-2347	204	7	hexarelin	hexarelin	PROPN
dti-2347	204	8	and	and	CCONJ
dti-2347	204	9	other	other	ADJ
dti-2347	204	10	synthetic	synthetic	ADJ
dti-2347	204	11	ghs	gh	NOUN
dti-2347	204	12	may	may	AUX
dti-2347	204	13	be	be	AUX
dti-2347	204	14	successfully	successfully	ADV
dti-2347	204	15	co	co	VERB
dti-2347	204	16	-	-	VERB
dti-2347	204	17	opted	opt	VERB
dti-2347	204	18	for	for	ADP
dti-2347	204	19	use	use	NOUN
dti-2347	204	20	in	in	ADP
dti-2347	204	21	antagonizing	antagonize	VERB
dti-2347	204	22	lung	lung	NOUN
dti-2347	204	23	and	and	CCONJ
dti-2347	204	24	cardiac	cardiac	ADJ
dti-2347	204	25	fibrosis	fibrosis	NOUN
dti-2347	204	26	.	.	PUNCT
dti-2347	205	1	acknowledgments	acknowledgment	NOUN
dti-2347	205	2	conflict	conflict	NOUN
dti-2347	205	3	of	of	ADP
dti-2347	205	4	interest	interest	NOUN
dti-2347	205	5	:	:	PUNCT
dti-2347	205	6	the	the	DET
dti-2347	205	7	authors	author	NOUN
dti-2347	205	8	declare	declare	VERB
dti-2347	205	9	that	that	SCONJ
dti-2347	205	10	the	the	DET
dti-2347	205	11	research	research	NOUN
dti-2347	205	12	was	be	AUX
dti-2347	205	13	conducted	conduct	VERB
dti-2347	205	14	in	in	ADP
dti-2347	205	15	the	the	DET
dti-2347	205	16	absence	absence	NOUN
dti-2347	205	17	of	of	ADP
dti-2347	205	18	any	any	DET
dti-2347	205	19	commercial	commercial	ADJ
dti-2347	205	20	or	or	CCONJ
dti-2347	205	21	financial	financial	ADJ
dti-2347	205	22	relationships	relationship	NOUN
dti-2347	205	23	that	that	PRON
dti-2347	205	24	could	could	AUX
dti-2347	205	25	be	be	AUX
dti-2347	205	26	construed	construe	VERB
dti-2347	205	27	as	as	ADP
dti-2347	205	28	a	a	DET
dti-2347	205	29	potential	potential	ADJ
dti-2347	205	30	conflict	conflict	NOUN
dti-2347	205	31	of	of	ADP
dti-2347	205	32	interest	interest	NOUN
dti-2347	205	33	.	.	PUNCT
dti-2347	206	1	funding	funding	NOUN
dti-2347	206	2	/	/	SYM
dti-2347	206	3	support	support	NOUN
dti-2347	206	4	:	:	PUNCT
dti-2347	206	5	we	we	PRON
dti-2347	206	6	acknowledge	acknowledge	VERB
dti-2347	206	7	that	that	SCONJ
dti-2347	206	8	this	this	DET
dti-2347	206	9	research	research	NOUN
dti-2347	206	10	was	be	AUX
dti-2347	206	11	partially	partially	ADV
dti-2347	206	12	supported	support	VERB
dti-2347	206	13	by	by	ADP
dti-2347	206	14	the	the	DET
dti-2347	206	15	italian	italian	PROPN
dti-2347	206	16	ministry	ministry	PROPN
dti-2347	206	17	of	of	ADP
dti-2347	206	18	university	university	PROPN
dti-2347	206	19	and	and	CCONJ
dti-2347	206	20	research	research	NOUN
dti-2347	206	21	(	(	PUNCT
dti-2347	206	22	miur	miur	NOUN
dti-2347	206	23	)	)	PUNCT
dti-2347	206	24	,	,	PUNCT
dti-2347	206	25	department	department	NOUN
dti-2347	206	26	of	of	ADP
dti-2347	206	27	excellence	excellence	PROPN
dti-2347	206	28	project	project	PROPN
dti-2347	206	29	premia	premia	PROPN
dti-2347	206	30	(	(	PUNCT
dti-2347	206	31	precision	precision	NOUN
dti-2347	206	32	medicine	medicine	NOUN
dti-2347	206	33	approach	approach	NOUN
dti-2347	206	34	:	:	PUNCT
dti-2347	206	35	bringing	bring	VERB
dti-2347	206	36	biomarker	biomarker	NOUN
dti-2347	206	37	research	research	NOUN
dti-2347	206	38	to	to	ADP
dti-2347	206	39	clinic	clinic	NOUN
dti-2347	206	40	)	)	PUNCT
dti-2347	206	41	.	.	PUNCT
dti-2347	207	1	dr	dr	PROPN
dti-2347	207	2	.	.	PROPN
dti-2347	207	3	emanuele	emanuele	PROPN
dti-2347	207	4	rezoagli	rezoagli	PROPN
dti-2347	207	5	was	be	AUX
dti-2347	207	6	supported	support	VERB
dti-2347	207	7	by	by	ADP
dti-2347	207	8	the	the	DET
dti-2347	207	9	international	international	ADJ
dti-2347	207	10	young	young	ADJ
dti-2347	207	11	investigator	investigator	NOUN
dti-2347	207	12	award	award	PROPN
dti-2347	207	13	2018	2018	NUM
dti-2347	207	14	from	from	ADP
dti-2347	207	15	the	the	DET
dti-2347	207	16	european	european	PROPN
dti-2347	207	17	society	society	NOUN
dti-2347	207	18	of	of	ADP
dti-2347	207	19	intensive	intensive	ADJ
dti-2347	207	20	care	care	NOUN
dti-2347	207	21	medicine	medicine	NOUN
dti-2347	207	22	(	(	PUNCT
dti-2347	207	23	esicm	esicm	NOUN
dti-2347	207	24	)	)	PUNCT
dti-2347	207	25	with	with	ADP
dti-2347	207	26	the	the	DET
dti-2347	207	27	project	project	NOUN
dti-2347	207	28	titled	title	VERB
dti-2347	207	29	:	:	PUNCT
dti-2347	207	30	“	"	PUNCT
dti-2347	207	31	role	role	NOUN
dti-2347	207	32	of	of	ADP
dti-2347	207	33	the	the	DET
dti-2347	207	34	exhaled	exhale	VERB
dti-2347	207	35	breath	breath	NOUN
dti-2347	207	36	condensate	condensate	NOUN
dti-2347	207	37	as	as	ADP
dti-2347	207	38	non	non	ADJ
dti-2347	207	39	-	-	ADJ
dti-2347	207	40	invasive	invasive	ADJ
dti-2347	207	41	monitoring	monitoring	NOUN
dti-2347	207	42	of	of	ADP
dti-2347	207	43	the	the	DET
dti-2347	207	44	lung	lung	NOUN
dti-2347	207	45	inflammation	inflammation	NOUN
dti-2347	207	46	during	during	ADP
dti-2347	207	47	ards	ard	NOUN
dti-2347	207	48	:	:	PUNCT
dti-2347	207	49	a	a	DET
dti-2347	207	50	prospective	prospective	ADJ
dti-2347	207	51	cohort	cohort	NOUN
dti-2347	207	52	study	study	NOUN
dti-2347	207	53	”	"	PUNCT
dti-2347	207	54	and	and	CCONJ
dti-2347	207	55	by	by	ADP
dti-2347	207	56	the	the	DET
dti-2347	207	57	national	national	PROPN
dti-2347	207	58	merck	merck	PROPN
dti-2347	207	59	sharp	sharp	PROPN
dti-2347	207	60	&	&	CCONJ
dti-2347	207	61	dohme	dohme	PROPN
dti-2347	207	62	corporation	corporation	PROPN
dti-2347	207	63	research	research	PROPN
dti-2347	207	64	award	award	PROPN
dti-2347	207	65	2017	2017	NUM
dti-2347	207	66	from	from	ADP
dti-2347	207	67	the	the	DET
dti-2347	207	68	società	società	ADJ
dti-2347	207	69	italiana	italiana	PROPN
dti-2347	207	70	di	di	PROPN
dti-2347	207	71	anestesia	anestesia	PROPN
dti-2347	207	72	analgesia	analgesia	PROPN
dti-2347	207	73	rianimazione	rianimazione	PROPN
dti-2347	207	74	e	e	PROPN
dti-2347	207	75	terapia	terapia	PROPN
dti-2347	207	76	intensiva	intensiva	PROPN
dti-2347	207	77	(	(	PUNCT
dti-2347	207	78	siaarti	siaarti	PROPN
dti-2347	207	79	)	)	PUNCT
dti-2347	207	80	with	with	ADP
dti-2347	207	81	the	the	DET
dti-2347	207	82	project	project	NOUN
dti-2347	207	83	titled	title	VERB
dti-2347	207	84	:	:	PUNCT
dti-2347	207	85	“	"	PUNCT
dti-2347	207	86	studio	studio	NOUN
dti-2347	207	87	della	della	NOUN
dti-2347	207	88	concentrazione	concentrazione	NOUN
dti-2347	207	89	di	di	NOUN
dti-2347	207	90	ossido	ossido	PROPN
dti-2347	207	91	nitrico	nitrico	NOUN
dti-2347	207	92	nell’esalato	nell’esalato	PROPN
dti-2347	207	93	espiratorio	espiratorio	NOUN
dti-2347	207	94	come	come	VERB
dti-2347	207	95	marcatore	marcatore	PROPN
dti-2347	207	96	di	di	PROPN
dti-2347	207	97	danno	danno	PROPN
dti-2347	207	98	polmonare	polmonare	PROPN
dti-2347	207	99	acuto	acuto	PROPN
dti-2347	207	100	in	in	ADP
dti-2347	207	101	pazienti	pazienti	PROPN
dti-2347	207	102	adulti	adulti	PROPN
dti-2347	207	103	con	con	PROPN
dti-2347	207	104	ards	ards	PROPN
dti-2347	207	105	sottoposti	sottoposti	VERB
dti-2347	207	106	a	a	DET
dti-2347	207	107	ventilazione	ventilazione	NOUN
dti-2347	207	108	meccanica	meccanica	PROPN
dti-2347	207	109	.	.	PUNCT
dti-2347	207	110	”	"	PUNCT
dti-2347	208	1	references	reference	NOUN
dti-2347	208	2	1	1	NUM
dti-2347	208	3	.	.	PUNCT
dti-2347	208	4	bellani	bellani	PROPN
dti-2347	208	5	g	g	PROPN
dti-2347	208	6	,	,	PUNCT
dti-2347	208	7	laffey	laffey	PROPN
dti-2347	208	8	jg	jg	PROPN
dti-2347	208	9	,	,	PUNCT
dti-2347	208	10	pham	pham	PROPN
dti-2347	208	11	t	t	PROPN
dti-2347	208	12	,	,	PUNCT
dti-2347	208	13	et	et	PROPN
dti-2347	208	14	al	al	PROPN
dti-2347	208	15	;	;	PUNCT
dti-2347	208	16	lung	lung	NOUN
dti-2347	208	17	safe	safe	ADJ
dti-2347	208	18	investigators	investigator	NOUN
dti-2347	208	19	;	;	PUNCT
dti-2347	208	20	esicm	esicm	ADJ
dti-2347	208	21	trials	trial	NOUN
dti-2347	208	22	group	group	NOUN
dti-2347	208	23	.	.	PUNCT
dti-2347	209	1	epidemiology	epidemiology	NOUN
dti-2347	209	2	,	,	PUNCT
dti-2347	209	3	patterns	pattern	NOUN
dti-2347	209	4	of	of	ADP
dti-2347	209	5	care	care	NOUN
dti-2347	209	6	,	,	PUNCT
dti-2347	209	7	and	and	CCONJ
dti-2347	209	8	mortality	mortality	NOUN
dti-2347	209	9	for	for	ADP
dti-2347	209	10	patients	patient	NOUN
dti-2347	209	11	with	with	ADP
dti-2347	209	12	acute	acute	ADJ
dti-2347	209	13	respiratory	respiratory	ADJ
dti-2347	209	14	distress	distress	NOUN
dti-2347	209	15	syndrome	syndrome	NOUN
dti-2347	209	16	in	in	ADP
dti-2347	209	17	intensive	intensive	ADJ
dti-2347	209	18	care	care	NOUN
dti-2347	209	19	units	unit	NOUN
dti-2347	209	20	in	in	ADP
dti-2347	209	21	50	50	NUM
dti-2347	209	22	countries	country	NOUN
dti-2347	209	23	.	.	PUNCT
dti-2347	210	1	jama	jama	PROPN
dti-2347	210	2	.	.	PUNCT
dti-2347	211	1	2016;315(8):788800	2016;315(8):788800	NUM
dti-2347	211	2	.	.	PUNCT
dti-2347	212	1	crossref	crossref	PROPN
dti-2347	212	2	pubmed	pubmed	PROPN
dti-2347	212	3	2	2	PROPN
dti-2347	212	4	.	.	PUNCT
dti-2347	212	5	mcnicholas	mcnicholas	PROPN
dti-2347	212	6	ba	ba	PROPN
dti-2347	212	7	,	,	PUNCT
dti-2347	212	8	rooney	rooney	PROPN
dti-2347	212	9	gm	gm	PROPN
dti-2347	212	10	,	,	PUNCT
dti-2347	212	11	laffey	laffey	PROPN
dti-2347	212	12	jg	jg	PROPN
dti-2347	212	13	.	.	PUNCT
dti-2347	213	1	lessons	lesson	NOUN
dti-2347	213	2	to	to	PART
dti-2347	213	3	learn	learn	VERB
dti-2347	213	4	from	from	ADP
dti-2347	213	5	epidemiologic	epidemiologic	ADJ
dti-2347	213	6	studies	study	NOUN
dti-2347	213	7	in	in	ADP
dti-2347	213	8	ards	ard	NOUN
dti-2347	213	9	.	.	PUNCT
dti-2347	214	1	curr	curr	PROPN
dti-2347	214	2	opin	opin	PROPN
dti-2347	214	3	crit	crit	NOUN
dti-2347	214	4	care	care	NOUN
dti-2347	214	5	.	.	PUNCT
dti-2347	215	1	2018;24(1	2018;24(1	NUM
dti-2347	215	2	):	):	PUNCT
dti-2347	215	3	41	41	NUM
dti-2347	215	4	-	-	SYM
dti-2347	215	5	48	48	NUM
dti-2347	215	6	.	.	PUNCT
dti-2347	216	1	crossref	crossref	PROPN
dti-2347	216	2	pubmed	pubmed	PROPN
dti-2347	216	3	3	3	PROPN
dti-2347	216	4	.	.	PUNCT
dti-2347	216	5	heymann	heymann	PROPN
dti-2347	216	6	dl	dl	PROPN
dti-2347	216	7	,	,	PUNCT
dti-2347	216	8	shindo	shindo	PROPN
dti-2347	216	9	n	n	CCONJ
dti-2347	216	10	;	;	PUNCT
dti-2347	216	11	who	who	PRON
dti-2347	216	12	scientific	scientific	ADJ
dti-2347	216	13	and	and	CCONJ
dti-2347	216	14	technical	technical	ADJ
dti-2347	216	15	advisory	advisory	ADJ
dti-2347	216	16	group	group	NOUN
dti-2347	216	17	for	for	ADP
dti-2347	216	18	infectious	infectious	ADJ
dti-2347	216	19	hazards	hazard	NOUN
dti-2347	216	20	.	.	PUNCT
dti-2347	217	1	covid-19	covid-19	PROPN
dti-2347	217	2	:	:	PUNCT
dti-2347	217	3	what	what	PRON
dti-2347	217	4	is	be	AUX
dti-2347	217	5	next	next	ADJ
dti-2347	217	6	for	for	ADP
dti-2347	217	7	public	public	ADJ
dti-2347	217	8	health	health	NOUN
dti-2347	217	9	?	?	PUNCT
dti-2347	218	1	lancet	lancet	NOUN
dti-2347	218	2	.	.	PUNCT
dti-2347	219	1	2020;395(10224):542	2020;395(10224):542	NUM
dti-2347	219	2	-	-	SYM
dti-2347	219	3	545	545	NUM
dti-2347	219	4	.	.	PUNCT
dti-2347	220	1	crossref	crossref	PROPN
dti-2347	220	2	pubmed	pubmed	PROPN
dti-2347	220	3	4	4	PROPN
dti-2347	220	4	.	.	PUNCT
dti-2347	221	1	ranieri	ranieri	PROPN
dti-2347	221	2	vm	vm	PROPN
dti-2347	221	3	,	,	PUNCT
dti-2347	221	4	rubenfeld	rubenfeld	VERB
dti-2347	221	5	gd	gd	PROPN
dti-2347	221	6	,	,	PUNCT
dti-2347	221	7	thompson	thompson	PROPN
dti-2347	221	8	bt	bt	PROPN
dti-2347	221	9	,	,	PUNCT
dti-2347	221	10	et	et	PROPN
dti-2347	221	11	al	al	PROPN
dti-2347	221	12	;	;	PUNCT
dti-2347	221	13	ards	ard	VERB
dti-2347	221	14	definition	definition	NOUN
dti-2347	221	15	task	task	NOUN
dti-2347	221	16	force	force	NOUN
dti-2347	221	17	.	.	PUNCT
dti-2347	222	1	acute	acute	ADJ
dti-2347	222	2	respiratory	respiratory	ADJ
dti-2347	222	3	distress	distress	NOUN
dti-2347	222	4	syndrome	syndrome	NOUN
dti-2347	222	5	:	:	PUNCT
dti-2347	222	6	the	the	DET
dti-2347	222	7	berlin	berlin	PROPN
dti-2347	222	8	definition	definition	NOUN
dti-2347	222	9	.	.	PUNCT
dti-2347	223	1	jama	jama	PROPN
dti-2347	223	2	.	.	PUNCT
dti-2347	224	1	2012;307(23):2526	2012;307(23):2526	NUM
dti-2347	224	2	-	-	SYM
dti-2347	224	3	2533	2533	NUM
dti-2347	224	4	.	.	PUNCT
dti-2347	225	1	pubmed	pubmed	PROPN
dti-2347	225	2	5	5	NUM
dti-2347	225	3	.	.	PUNCT
dti-2347	226	1	ware	ware	VERB
dti-2347	226	2	lb	lb	PROPN
dti-2347	226	3	,	,	PUNCT
dti-2347	226	4	matthay	matthay	PROPN
dti-2347	226	5	ma	ma	PROPN
dti-2347	226	6	.	.	PUNCT
dti-2347	227	1	the	the	DET
dti-2347	227	2	acute	acute	ADJ
dti-2347	227	3	respiratory	respiratory	ADJ
dti-2347	227	4	distress	distress	NOUN
dti-2347	227	5	syndrome	syndrome	NOUN
dti-2347	227	6	.	.	PUNCT
dti-2347	228	1	n	n	PROPN
dti-2347	228	2	engl	engl	PROPN
dti-2347	228	3	j	j	PROPN
dti-2347	228	4	med	med	PROPN
dti-2347	228	5	.	.	PUNCT
dti-2347	229	1	2000;342(18):1334	2000;342(18):1334	NUM
dti-2347	229	2	-	-	SYM
dti-2347	229	3	1349	1349	NUM
dti-2347	229	4	.	.	PUNCT
dti-2347	230	1	crossref	crossref	PROPN
dti-2347	230	2	pubmed	pubmed	PROPN
dti-2347	230	3	6	6	NUM
dti-2347	230	4	.	.	PUNCT
dti-2347	231	1	bachofen	bachofen	PROPN
dti-2347	231	2	m	m	PROPN
dti-2347	231	3	,	,	PUNCT
dti-2347	231	4	weibel	weibel	NOUN
dti-2347	231	5	er	er	INTJ
dti-2347	231	6	.	.	PUNCT
dti-2347	231	7	structural	structural	ADJ
dti-2347	231	8	alterations	alteration	NOUN
dti-2347	231	9	of	of	ADP
dti-2347	231	10	lung	lung	NOUN
dti-2347	231	11	parenchyma	parenchyma	NOUN
dti-2347	231	12	in	in	ADP
dti-2347	231	13	the	the	DET
dti-2347	231	14	adult	adult	NOUN
dti-2347	231	15	respiratory	respiratory	ADJ
dti-2347	231	16	distress	distress	NOUN
dti-2347	231	17	syndrome	syndrome	NOUN
dti-2347	231	18	.	.	PUNCT
dti-2347	232	1	clin	clin	PROPN
dti-2347	232	2	chest	chest	PROPN
dti-2347	232	3	med	me	VERB
dti-2347	232	4	.	.	PUNCT
dti-2347	233	1	1982;3(1):35	1982;3(1):35	NUM
dti-2347	233	2	-	-	SYM
dti-2347	233	3	56	56	NUM
dti-2347	233	4	.	.	PUNCT
dti-2347	234	1	crossref	crossref	PROPN
dti-2347	234	2	pubmed	pubmed	PROPN
dti-2347	234	3	7	7	PROPN
dti-2347	234	4	.	.	PROPN
dti-2347	234	5	sibilia	sibilia	PROPN
dti-2347	234	6	v	v	PROPN
dti-2347	234	7	,	,	PUNCT
dti-2347	234	8	torsello	torsello	NOUN
dti-2347	234	9	a	a	PRON
dti-2347	234	10	,	,	PUNCT
dti-2347	234	11	pagani	pagani	PROPN
dti-2347	234	12	f	f	PROPN
dti-2347	234	13	,	,	PUNCT
dti-2347	234	14	et	et	PROPN
dti-2347	234	15	al	al	PROPN
dti-2347	234	16	.	.	PUNCT
dti-2347	235	1	effects	effect	NOUN
dti-2347	235	2	of	of	ADP
dti-2347	235	3	hexarelin	hexarelin	PROPN
dti-2347	235	4	against	against	ADP
dti-2347	235	5	acid	acid	NOUN
dti-2347	235	6	-	-	PUNCT
dti-2347	235	7	independent	independent	ADJ
dti-2347	235	8	and	and	CCONJ
dti-2347	235	9	acid	acid	NOUN
dti-2347	235	10	-	-	PUNCT
dti-2347	235	11	dependent	dependent	ADJ
dti-2347	235	12	ulcerogens	ulcerogen	NOUN
dti-2347	235	13	in	in	ADP
dti-2347	235	14	the	the	DET
dti-2347	235	15	rat	rat	NOUN
dti-2347	235	16	.	.	PUNCT
dti-2347	235	17	peptides	peptide	NOUN
dti-2347	235	18	.	.	PUNCT
dti-2347	236	1	2004;25(12):2163	2004;25(12):2163	NUM
dti-2347	236	2	-	-	SYM
dti-2347	236	3	2170	2170	NUM
dti-2347	236	4	.	.	PUNCT
dti-2347	237	1	crossref	crossref	PROPN
dti-2347	237	2	pubmed	pubmed	PROPN
dti-2347	237	3	8	8	PROPN
dti-2347	237	4	.	.	PUNCT
dti-2347	238	1	locatelli	locatelli	PROPN
dti-2347	238	2	v	v	PROPN
dti-2347	238	3	,	,	PUNCT
dti-2347	238	4	rossoni	rossoni	VERB
dti-2347	238	5	g	g	NOUN
dti-2347	238	6	,	,	PUNCT
dti-2347	238	7	schweiger	schweiger	PROPN
dti-2347	238	8	f	f	PROPN
dti-2347	238	9	,	,	PUNCT
dti-2347	238	10	et	et	PROPN
dti-2347	238	11	al	al	PROPN
dti-2347	238	12	.	.	PROPN
dti-2347	238	13	growth	growth	PROPN
dti-2347	238	14	hormoneindependent	hormoneindependent	PROPN
dti-2347	238	15	cardioprotective	cardioprotective	ADJ
dti-2347	238	16	effects	effect	NOUN
dti-2347	238	17	of	of	ADP
dti-2347	238	18	hexarelin	hexarelin	PROPN
dti-2347	238	19	in	in	ADP
dti-2347	238	20	the	the	DET
dti-2347	238	21	rat	rat	NOUN
dti-2347	238	22	.	.	PROPN
dti-2347	238	23	endocrinology	endocrinology	NOUN
dti-2347	238	24	.	.	PUNCT
dti-2347	239	1	1999;140(9):4024	1999;140(9):4024	NUM
dti-2347	239	2	-	-	SYM
dti-2347	239	3	4031	4031	NUM
dti-2347	239	4	.	.	PUNCT
dti-2347	240	1	crossref	crossref	PROPN
dti-2347	240	2	pubmed	pubmed	PROPN
dti-2347	240	3	9	9	PROPN
dti-2347	240	4	.	.	PUNCT
dti-2347	240	5	biagini	biagini	PROPN
dti-2347	240	6	g	g	PROPN
dti-2347	240	7	,	,	PUNCT
dti-2347	240	8	torsello	torsello	PROPN
dti-2347	240	9	a	a	X
dti-2347	240	10	,	,	PUNCT
dti-2347	240	11	marinelli	marinelli	PROPN
dti-2347	240	12	c	c	AUX
dti-2347	240	13	,	,	PUNCT
dti-2347	240	14	et	et	PROPN
dti-2347	240	15	al	al	PROPN
dti-2347	240	16	.	.	PROPN
dti-2347	241	1	beneficial	beneficial	ADJ
dti-2347	241	2	effects	effect	NOUN
dti-2347	241	3	of	of	ADP
dti-2347	241	4	desacyl	desacyl	NOUN
dti-2347	241	5	-	-	PUNCT
dti-2347	241	6	ghrelin	ghrelin	NOUN
dti-2347	241	7	,	,	PUNCT
dti-2347	241	8	hexarelin	hexarelin	PROPN
dti-2347	241	9	and	and	CCONJ
dti-2347	241	10	ep-80317	ep-80317	NOUN
dti-2347	241	11	in	in	ADP
dti-2347	241	12	models	model	NOUN
dti-2347	241	13	of	of	ADP
dti-2347	241	14	status	status	NOUN
dti-2347	241	15	epilepticus	epilepticus	NOUN
dti-2347	241	16	.	.	PUNCT
dti-2347	242	1	eur	eur	PROPN
dti-2347	242	2	j	j	PROPN
dti-2347	242	3	pharmacol	pharmacol	PROPN
dti-2347	242	4	.	.	PUNCT
dti-2347	243	1	2011;670(1):130	2011;670(1):130	NUM
dti-2347	243	2	-	-	SYM
dti-2347	243	3	136	136	NUM
dti-2347	243	4	.	.	PUNCT
dti-2347	244	1	crossref	crossref	PROPN
dti-2347	244	2	pubmed	pubmed	PROPN
dti-2347	244	3	10	10	PROPN
dti-2347	244	4	.	.	PUNCT
dti-2347	245	1	conte	conte	PROPN
dti-2347	245	2	e	e	PROPN
dti-2347	245	3	,	,	PUNCT
dti-2347	245	4	camerino	camerino	PROPN
dti-2347	245	5	gm	gm	PROPN
dti-2347	245	6	,	,	PUNCT
dti-2347	245	7	mele	mele	PROPN
dti-2347	245	8	a	a	PROPN
dti-2347	245	9	,	,	PUNCT
dti-2347	245	10	et	et	PROPN
dti-2347	245	11	al	al	PROPN
dti-2347	245	12	.	.	PUNCT
dti-2347	246	1	growth	growth	NOUN
dti-2347	246	2	hormone	hormone	NOUN
dti-2347	246	3	secretagogues	secretagogue	NOUN
dti-2347	246	4	prevent	prevent	VERB
dti-2347	246	5	dysregulation	dysregulation	NOUN
dti-2347	246	6	of	of	ADP
dti-2347	246	7	skeletal	skeletal	ADJ
dti-2347	246	8	muscle	muscle	NOUN
dti-2347	246	9	calcium	calcium	NOUN
dti-2347	246	10	homeostasis	homeostasis	NOUN
dti-2347	246	11	in	in	ADP
dti-2347	246	12	a	a	DET
dti-2347	246	13	rat	rat	NOUN
dti-2347	246	14	model	model	NOUN
dti-2347	246	15	of	of	ADP
dti-2347	246	16	cisplatin	cisplatin	NOUN
dti-2347	246	17	-	-	PUNCT
dti-2347	246	18	induced	induce	VERB
dti-2347	246	19	cachexia	cachexia	NOUN
dti-2347	246	20	.	.	PUNCT
dti-2347	247	1	j	j	PROPN
dti-2347	247	2	cachexia	cachexia	PROPN
dti-2347	247	3	sarcopenia	sarcopenia	PROPN
dti-2347	247	4	muscle	muscle	PROPN
dti-2347	247	5	.	.	PUNCT
dti-2347	248	1	2017;8(3):386	2017;8(3):386	NUM
dti-2347	248	2	-	-	PUNCT
dti-2347	248	3	404	404	NUM
dti-2347	248	4	.	.	PUNCT
dti-2347	249	1	crossref	crossref	PROPN
dti-2347	249	2	pubmed	pubmed	PROPN
dti-2347	249	3	11	11	NUM
dti-2347	249	4	.	.	PUNCT
dti-2347	250	1	bresciani	bresciani	PROPN
dti-2347	250	2	e	e	PROPN
dti-2347	250	3	,	,	PUNCT
dti-2347	250	4	pitsikas	pitsikas	PROPN
dti-2347	250	5	n	n	CCONJ
dti-2347	250	6	,	,	PUNCT
dti-2347	250	7	tamiazzo	tamiazzo	PROPN
dti-2347	250	8	l	l	NOUN
dti-2347	250	9	,	,	PUNCT
dti-2347	250	10	et	et	PROPN
dti-2347	250	11	al	al	PROPN
dti-2347	250	12	.	.	PUNCT
dti-2347	251	1	feeding	feed	VERB
dti-2347	251	2	behavior	behavior	NOUN
dti-2347	251	3	during	during	ADP
dti-2347	251	4	long	long	ADJ
dti-2347	251	5	-	-	PUNCT
dti-2347	251	6	term	term	NOUN
dti-2347	251	7	hexarelin	hexarelin	PROPN
dti-2347	251	8	administration	administration	NOUN
dti-2347	251	9	in	in	ADP
dti-2347	251	10	young	young	ADJ
dti-2347	251	11	and	and	CCONJ
dti-2347	251	12	old	old	ADJ
dti-2347	251	13	rats	rat	NOUN
dti-2347	251	14	.	.	PUNCT
dti-2347	252	1	j	j	PROPN
dti-2347	252	2	endocrinol	endocrinol	NOUN
dti-2347	252	3	invest	inv	ADJ
dti-2347	252	4	.	.	PUNCT
dti-2347	253	1	2008;31(7):647	2008;31(7):647	NUM
dti-2347	253	2	-	-	PUNCT
dti-2347	253	3	652	652	NUM
dti-2347	253	4	.	.	PUNCT
dti-2347	254	1	crossref	crossref	PROPN
dti-2347	254	2	pubmed	pubmed	PROPN
dti-2347	254	3	12	12	NUM
dti-2347	254	4	.	.	PUNCT
dti-2347	255	1	mao	mao	PROPN
dti-2347	256	1	y	y	PROPN
dti-2347	256	2	,	,	PUNCT
dti-2347	256	3	tokudome	tokudome	PROPN
dti-2347	256	4	t	t	PROPN
dti-2347	256	5	,	,	PUNCT
dti-2347	256	6	kishimoto	kishimoto	PROPN
dti-2347	256	7	i.	i.	PROPN
dti-2347	256	8	the	the	DET
dti-2347	256	9	cardiovascular	cardiovascular	ADJ
dti-2347	256	10	action	action	NOUN
dti-2347	256	11	of	of	ADP
dti-2347	256	12	hexarelin	hexarelin	PROPN
dti-2347	256	13	.	.	PUNCT
dti-2347	257	1	j	j	PROPN
dti-2347	257	2	geriatr	geriatr	PROPN
dti-2347	257	3	cardiol	cardiol	NOUN
dti-2347	257	4	.	.	PUNCT
dti-2347	258	1	2014;11(3):253	2014;11(3):253	NUM
dti-2347	258	2	-	-	SYM
dti-2347	258	3	258	258	NUM
dti-2347	258	4	.	.	PUNCT
dti-2347	259	1	pubmed	pubmed	PROPN
dti-2347	259	2	13	13	PROPN
dti-2347	259	3	.	.	PUNCT
dti-2347	260	1	torsello	torsello	PROPN
dti-2347	260	2	a	a	PRON
dti-2347	260	3	,	,	PUNCT
dti-2347	260	4	bresciani	bresciani	ADJ
dti-2347	260	5	e	e	NOUN
dti-2347	260	6	,	,	PUNCT
dti-2347	260	7	ravelli	ravelli	PROPN
dti-2347	260	8	m	m	PROPN
dti-2347	260	9	,	,	PUNCT
dti-2347	260	10	et	et	PROPN
dti-2347	260	11	al	al	PROPN
dti-2347	260	12	.	.	PROPN
dti-2347	260	13	novel	novel	PROPN
dti-2347	260	14	domain	domain	NOUN
dti-2347	260	15	-	-	PUNCT
dti-2347	260	16	selective	selective	ADJ
dti-2347	260	17	ace	ace	NOUN
dti-2347	260	18	-	-	PUNCT
dti-2347	260	19	inhibiting	inhibit	VERB
dti-2347	260	20	activity	activity	NOUN
dti-2347	260	21	of	of	ADP
dti-2347	260	22	synthetic	synthetic	ADJ
dti-2347	260	23	growth	growth	NOUN
dti-2347	260	24	hormone	hormone	NOUN
dti-2347	260	25	secretagogues	secretagogue	NOUN
dti-2347	260	26	.	.	PUNCT
dti-2347	261	1	pharmacol	pharmacol	NOUN
dti-2347	261	2	res	re	NOUN
dti-2347	261	3	.	.	PUNCT
dti-2347	262	1	2012;66(4):317	2012;66(4):317	NOUN
dti-2347	262	2	-	-	SYM
dti-2347	262	3	324	324	NUM
dti-2347	262	4	.	.	PUNCT
dti-2347	263	1	crossref	crossref	PROPN
dti-2347	263	2	pubmed	pubmed	PROPN
dti-2347	263	3	14	14	PROPN
dti-2347	263	4	.	.	PUNCT
dti-2347	264	1	deng	deng	PROPN
dti-2347	264	2	w	w	PROPN
dti-2347	264	3	,	,	PUNCT
dti-2347	264	4	deng	deng	PROPN
dti-2347	264	5	y	y	PROPN
dti-2347	264	6	,	,	PUNCT
dti-2347	264	7	deng	deng	PROPN
dti-2347	264	8	j	j	PROPN
dti-2347	264	9	,	,	PUNCT
dti-2347	264	10	et	et	PROPN
dti-2347	264	11	al	al	PROPN
dti-2347	264	12	.	.	PROPN
dti-2347	265	1	losartan	losartan	PROPN
dti-2347	265	2	attenuated	attenuate	VERB
dti-2347	265	3	lipopolysaccharide	lipopolysaccharide	ADV
dti-2347	265	4	-	-	PUNCT
dti-2347	265	5	induced	induce	VERB
dti-2347	265	6	lung	lung	NOUN
dti-2347	265	7	injury	injury	NOUN
dti-2347	265	8	by	by	ADP
dti-2347	265	9	suppression	suppression	NOUN
dti-2347	265	10	of	of	ADP
dti-2347	265	11	lectin	lectin	NOUN
dti-2347	265	12	-	-	PUNCT
dti-2347	265	13	like	like	ADJ
dti-2347	265	14	oxidized	oxidize	VERB
dti-2347	265	15	low	low	ADJ
dti-2347	265	16	-	-	PUNCT
dti-2347	265	17	density	density	NOUN
dti-2347	265	18	lipoprotein	lipoprotein	ADJ
dti-2347	265	19	receptor-1	receptor-1	NOUN
dti-2347	265	20	.	.	PUNCT
dti-2347	266	1	int	int	PROPN
dti-2347	267	1	j	j	PROPN
dti-2347	267	2	clin	clin	PROPN
dti-2347	267	3	exp	exp	NOUN
dti-2347	267	4	pathol	pathol	NOUN
dti-2347	267	5	.	.	PUNCT
dti-2347	268	1	2015;8(12):15670	2015;8(12):15670	NUM
dti-2347	268	2	-	-	SYM
dti-2347	268	3	6	6	NUM
dti-2347	268	4	.	.	PUNCT
dti-2347	269	1	pubmed	pubmed	PROPN
dti-2347	269	2	15	15	PROPN
dti-2347	269	3	.	.	PUNCT
dti-2347	270	1	torsello	torsello	PROPN
dti-2347	270	2	a	a	PRON
dti-2347	270	3	,	,	PUNCT
dti-2347	270	4	bresciani	bresciani	ADJ
dti-2347	270	5	e	e	NOUN
dti-2347	270	6	,	,	PUNCT
dti-2347	270	7	rossoni	rossoni	VERB
dti-2347	270	8	g	g	PROPN
dti-2347	270	9	,	,	PUNCT
dti-2347	270	10	et	et	PROPN
dti-2347	270	11	al	al	PROPN
dti-2347	270	12	.	.	PROPN
dti-2347	270	13	ghrelin	ghrelin	NOUN
dti-2347	270	14	plays	play	VERB
dti-2347	270	15	a	a	DET
dti-2347	270	16	minor	minor	ADJ
dti-2347	270	17	role	role	NOUN
dti-2347	270	18	in	in	ADP
dti-2347	270	19	the	the	DET
dti-2347	270	20	physiological	physiological	ADJ
dti-2347	270	21	control	control	NOUN
dti-2347	270	22	of	of	ADP
dti-2347	270	23	cardiac	cardiac	ADJ
dti-2347	270	24	function	function	NOUN
dti-2347	270	25	in	in	ADP
dti-2347	270	26	the	the	DET
dti-2347	270	27	rat	rat	NOUN
dti-2347	270	28	.	.	PROPN
dti-2347	270	29	endocrinology	endocrinology	NOUN
dti-2347	270	30	.	.	PUNCT
dti-2347	271	1	2003;144(5):1787	2003;144(5):1787	NUM
dti-2347	271	2	-	-	SYM
dti-2347	271	3	1792	1792	NUM
dti-2347	271	4	.	.	PUNCT
dti-2347	272	1	crossref	crossref	PROPN
dti-2347	272	2	pubmed	pubmed	PROPN
dti-2347	272	3	16	16	NUM
dti-2347	272	4	.	.	PUNCT
dti-2347	273	1	amigoni	amigoni	PROPN
dti-2347	273	2	m	m	PROPN
dti-2347	273	3	,	,	PUNCT
dti-2347	273	4	bellani	bellani	ADV
dti-2347	273	5	g	g	NOUN
dti-2347	273	6	,	,	PUNCT
dti-2347	273	7	scanziani	scanziani	PROPN
dti-2347	273	8	m	m	PROPN
dti-2347	273	9	,	,	PUNCT
dti-2347	273	10	et	et	PROPN
dti-2347	273	11	al	al	PROPN
dti-2347	273	12	.	.	PUNCT
dti-2347	273	13	lung	lung	PROPN
dti-2347	273	14	injury	injury	NOUN
dti-2347	273	15	and	and	CCONJ
dti-2347	273	16	recovery	recovery	NOUN
dti-2347	273	17	in	in	ADP
dti-2347	273	18	a	a	DET
dti-2347	273	19	murine	murine	ADJ
dti-2347	273	20	model	model	NOUN
dti-2347	273	21	of	of	ADP
dti-2347	273	22	unilateral	unilateral	ADJ
dti-2347	273	23	acid	acid	NOUN
dti-2347	273	24	aspiration	aspiration	NOUN
dti-2347	273	25	:	:	PUNCT
dti-2347	273	26	functional	functional	ADJ
dti-2347	273	27	,	,	PUNCT
dti-2347	273	28	biochemical	biochemical	ADJ
dti-2347	273	29	,	,	PUNCT
dti-2347	273	30	and	and	CCONJ
dti-2347	273	31	morphologic	morphologic	ADJ
dti-2347	273	32	characterization	characterization	NOUN
dti-2347	273	33	.	.	PUNCT
dti-2347	274	1	anesthesiology	anesthesiology	NOUN
dti-2347	274	2	.	.	PUNCT
dti-2347	275	1	2008;108(6):1037	2008;108(6):1037	NUM
dti-2347	275	2	-	-	SYM
dti-2347	275	3	1046	1046	NUM
dti-2347	275	4	.	.	PUNCT
dti-2347	276	1	crossref	crossref	PROPN
dti-2347	276	2	pubmed	pubmed	PROPN
dti-2347	276	3	17	17	NUM
dti-2347	276	4	.	.	PUNCT
dti-2347	277	1	amigoni	amigoni	PROPN
dti-2347	277	2	m	m	PROPN
dti-2347	277	3	,	,	PUNCT
dti-2347	277	4	bellani	bellani	ADV
dti-2347	277	5	g	g	PROPN
dti-2347	277	6	,	,	PUNCT
dti-2347	277	7	zambelli	zambelli	PROPN
dti-2347	277	8	v	v	PROPN
dti-2347	277	9	,	,	PUNCT
dti-2347	277	10	et	et	PROPN
dti-2347	277	11	al	al	PROPN
dti-2347	277	12	.	.	PROPN
dti-2347	277	13	unilateral	unilateral	ADJ
dti-2347	277	14	acid	acid	NOUN
dti-2347	277	15	aspiration	aspiration	NOUN
dti-2347	277	16	augments	augment	VERB
dti-2347	277	17	the	the	DET
dti-2347	277	18	effects	effect	NOUN
dti-2347	277	19	of	of	ADP
dti-2347	277	20	ventilator	ventilator	NOUN
dti-2347	277	21	lung	lung	NOUN
dti-2347	277	22	injury	injury	NOUN
dti-2347	277	23	in	in	ADP
dti-2347	277	24	the	the	DET
dti-2347	277	25	contralateral	contralateral	ADJ
dti-2347	277	26	lung	lung	NOUN
dti-2347	277	27	.	.	PUNCT
dti-2347	278	1	anesthesiology	anesthesiology	NOUN
dti-2347	278	2	.	.	PUNCT
dti-2347	279	1	2013;119(3):642	2013;119(3):642	NUM
dti-2347	279	2	-	-	SYM
dti-2347	279	3	651	651	NUM
dti-2347	279	4	.	.	PUNCT
dti-2347	280	1	crossref	crossref	PROPN
dti-2347	280	2	pubmed	pubmed	PROPN
dti-2347	280	3	18	18	NUM
dti-2347	280	4	.	.	PUNCT
dti-2347	281	1	zambelli	zambelli	PROPN
dti-2347	281	2	v	v	PROPN
dti-2347	281	3	,	,	PUNCT
dti-2347	281	4	bellani	bellani	ADV
dti-2347	281	5	g	g	PROPN
dti-2347	281	6	,	,	PUNCT
dti-2347	281	7	borsa	borsa	PROPN
dti-2347	281	8	r	r	PROPN
dti-2347	281	9	,	,	PUNCT
dti-2347	281	10	et	et	PROPN
dti-2347	281	11	al	al	PROPN
dti-2347	281	12	.	.	PUNCT
dti-2347	282	1	angiotensin-(1	angiotensin-(1	PROPN
dti-2347	282	2	-	-	PUNCT
dti-2347	282	3	7	7	NUM
dti-2347	282	4	)	)	PUNCT
dti-2347	282	5	improves	improve	VERB
dti-2347	282	6	oxygenation	oxygenation	NOUN
dti-2347	282	7	,	,	PUNCT
dti-2347	282	8	while	while	SCONJ
dti-2347	282	9	reducing	reduce	VERB
dti-2347	282	10	cellular	cellular	ADJ
dti-2347	282	11	infiltrate	infiltrate	NOUN
dti-2347	282	12	and	and	CCONJ
dti-2347	282	13	fibrosis	fibrosis	NOUN
dti-2347	282	14	in	in	ADP
dti-2347	282	15	experimental	experimental	ADJ
dti-2347	282	16	acute	acute	ADJ
dti-2347	282	17	respiratory	respiratory	ADJ
dti-2347	282	18	distress	distress	NOUN
dti-2347	282	19	syndrome	syndrome	NOUN
dti-2347	282	20	.	.	PUNCT
dti-2347	283	1	intensive	intensive	ADJ
dti-2347	283	2	care	care	NOUN
dti-2347	283	3	med	me	VERB
dti-2347	283	4	exp	exp	NOUN
dti-2347	283	5	.	.	PUNCT
dti-2347	284	1	2015;3(1):44	2015;3(1):44	NUM
dti-2347	284	2	.	.	PUNCT
dti-2347	284	3	crossref	crossref	PROPN
dti-2347	284	4	pubmed	pubmed	PROPN
dti-2347	284	5	19	19	NUM
dti-2347	284	6	.	.	PUNCT
dti-2347	285	1	tager	tager	NOUN
dti-2347	285	2	am	be	AUX
dti-2347	285	3	,	,	PUNCT
dti-2347	285	4	kradin	kradin	VERB
dti-2347	285	5	rl	rl	SYM
dti-2347	285	6	,	,	PUNCT
dti-2347	285	7	lacamera	lacamera	NOUN
dti-2347	285	8	p	p	NOUN
dti-2347	285	9	,	,	PUNCT
dti-2347	285	10	et	et	PROPN
dti-2347	285	11	al	al	PROPN
dti-2347	285	12	.	.	PROPN
dti-2347	285	13	inhibition	inhibition	NOUN
dti-2347	285	14	of	of	ADP
dti-2347	285	15	pulmonary	pulmonary	ADJ
dti-2347	285	16	fibrosis	fibrosis	NOUN
dti-2347	285	17	by	by	ADP
dti-2347	285	18	the	the	DET
dti-2347	285	19	chemokine	chemokine	ADJ
dti-2347	285	20	ip-10	ip-10	NOUN
dti-2347	285	21	/	/	SYM
dti-2347	285	22	cxcl10	cxcl10	NOUN
dti-2347	285	23	.	.	PUNCT
dti-2347	286	1	am	be	AUX
dti-2347	286	2	j	j	PROPN
dti-2347	286	3	respir	respir	NOUN
dti-2347	286	4	cell	cell	NOUN
dti-2347	286	5	mol	mol	ADP
dti-2347	286	6	biol	biol	NOUN
dti-2347	286	7	.	.	PUNCT
dti-2347	287	1	2004;31(4):395	2004;31(4):395	NUM
dti-2347	287	2	-	-	PUNCT
dti-2347	287	3	404	404	NUM
dti-2347	287	4	.	.	PUNCT
dti-2347	288	1	crossref	crossref	PROPN
dti-2347	288	2	pubmed	pubmed	PROPN
dti-2347	288	3	20	20	NUM
dti-2347	288	4	.	.	PUNCT
dti-2347	289	1	broglio	broglio	PROPN
dti-2347	289	2	f	f	PROPN
dti-2347	289	3	,	,	PUNCT
dti-2347	289	4	benso	benso	PROPN
dti-2347	289	5	a	a	PRON
dti-2347	289	6	,	,	PUNCT
dti-2347	289	7	valetto	valetto	PROPN
dti-2347	289	8	mr	mr	PROPN
dti-2347	289	9	,	,	PUNCT
dti-2347	289	10	et	et	PROPN
dti-2347	289	11	al	al	PROPN
dti-2347	289	12	.	.	PUNCT
dti-2347	290	1	growth	growth	NOUN
dti-2347	290	2	hormone	hormone	NOUN
dti-2347	290	3	-	-	PUNCT
dti-2347	290	4	independent	independent	ADJ
dti-2347	290	5	cardiotropic	cardiotropic	NOUN
dti-2347	290	6	activities	activity	NOUN
dti-2347	290	7	of	of	ADP
dti-2347	290	8	growth	growth	NOUN
dti-2347	290	9	hormone	hormone	NOUN
dti-2347	290	10	-	-	PUNCT
dti-2347	290	11	releasing	release	VERB
dti-2347	290	12	peptides	peptide	NOUN
dti-2347	290	13	in	in	ADP
dti-2347	290	14	normal	normal	ADJ
dti-2347	290	15	subjects	subject	NOUN
dti-2347	290	16	,	,	PUNCT
dti-2347	290	17	in	in	ADP
dti-2347	290	18	patients	patient	NOUN
dti-2347	290	19	with	with	ADP
dti-2347	290	20	growth	growth	NOUN
dti-2347	290	21	hormone	hormone	NOUN
dti-2347	290	22	deficiency	deficiency	NOUN
dti-2347	290	23	,	,	PUNCT
dti-2347	290	24	and	and	CCONJ
dti-2347	290	25	in	in	ADP
dti-2347	290	26	patients	patient	NOUN
dti-2347	290	27	with	with	ADP
dti-2347	290	28	idiopathic	idiopathic	ADJ
dti-2347	290	29	or	or	CCONJ
dti-2347	290	30	ischemic	ischemic	ADJ
dti-2347	290	31	dilated	dilated	ADJ
dti-2347	290	32	cardiomyopathy	cardiomyopathy	ADJ
dti-2347	290	33	.	.	PUNCT
dti-2347	291	1	endocrine	endocrine	NOUN
dti-2347	291	2	.	.	PUNCT
dti-2347	292	1	2001;14(1):105	2001;14(1):105	NUM
dti-2347	292	2	-	-	PUNCT
dti-2347	292	3	108	108	NUM
dti-2347	292	4	.	.	PUNCT
dti-2347	293	1	crossref	crossref	PROPN
dti-2347	293	2	pubmed	pubmed	PROPN
dti-2347	293	3	21	21	NUM
dti-2347	293	4	.	.	PUNCT
dti-2347	294	1	soubrier	soubrier	PROPN
dti-2347	294	2	f	f	PROPN
dti-2347	294	3	,	,	PUNCT
dti-2347	294	4	alhenc	alhenc	NOUN
dti-2347	294	5	-	-	PUNCT
dti-2347	294	6	gelas	gela	NOUN
dti-2347	294	7	f	f	PROPN
dti-2347	294	8	,	,	PUNCT
dti-2347	294	9	hubert	hubert	PROPN
dti-2347	294	10	c	c	PROPN
dti-2347	294	11	,	,	PUNCT
dti-2347	294	12	et	et	PROPN
dti-2347	294	13	al	al	PROPN
dti-2347	294	14	.	.	PROPN
dti-2347	295	1	two	two	NUM
dti-2347	295	2	putative	putative	ADJ
dti-2347	295	3	active	active	ADJ
dti-2347	295	4	centers	center	NOUN
dti-2347	295	5	in	in	ADP
dti-2347	295	6	human	human	ADJ
dti-2347	295	7	angiotensin	angiotensin	NOUN
dti-2347	295	8	i	i	PRON
dti-2347	295	9	-	-	PUNCT
dti-2347	295	10	converting	convert	VERB
dti-2347	295	11	enzyme	enzyme	NOUN
dti-2347	295	12	revealed	reveal	VERB
dti-2347	295	13	by	by	ADP
dti-2347	295	14	molecular	molecular	ADJ
dti-2347	295	15	cloning	cloning	NOUN
dti-2347	295	16	.	.	PUNCT
dti-2347	296	1	proc	proc	PROPN
dti-2347	296	2	natl	natl	PROPN
dti-2347	296	3	acad	acad	PROPN
dti-2347	296	4	sci	sci	PROPN
dti-2347	296	5	usa	usa	PROPN
dti-2347	296	6	.	.	PROPN
dti-2347	296	7	1988;85(24):93869390	1988;85(24):93869390	PROPN
dti-2347	296	8	.	.	PUNCT
dti-2347	297	1	crossref	crossref	PROPN
dti-2347	297	2	pubmed	pubmed	PROPN
dti-2347	297	3	22	22	NUM
dti-2347	297	4	.	.	PUNCT
dti-2347	298	1	georgiadis	georgiadis	PROPN
dti-2347	298	2	d	d	PROPN
dti-2347	298	3	,	,	PUNCT
dti-2347	298	4	beau	beau	PROPN
dti-2347	298	5	f	f	PROPN
dti-2347	298	6	,	,	PUNCT
dti-2347	298	7	czarny	czarny	PROPN
dti-2347	298	8	b	b	PROPN
dti-2347	298	9	,	,	PUNCT
dti-2347	298	10	cotton	cotton	PROPN
dti-2347	298	11	j	j	PROPN
dti-2347	298	12	,	,	PUNCT
dti-2347	298	13	yiotakis	yiotakis	PROPN
dti-2347	298	14	a	a	X
dti-2347	298	15	,	,	PUNCT
dti-2347	298	16	dive	dive	NOUN
dti-2347	298	17	v.	v.	ADP
dti-2347	298	18	roles	role	NOUN
dti-2347	298	19	of	of	ADP
dti-2347	298	20	the	the	DET
dti-2347	298	21	two	two	NUM
dti-2347	298	22	active	active	ADJ
dti-2347	298	23	sites	site	NOUN
dti-2347	298	24	of	of	ADP
dti-2347	298	25	somatic	somatic	ADJ
dti-2347	298	26	angiotensin	angiotensin	NOUN
dti-2347	298	27	-	-	PUNCT
dti-2347	298	28	converting	convert	VERB
dti-2347	298	29	https://doi.org/10.1001/jama.2016.0291	https://doi.org/10.1001/jama.2016.0291	PROPN
dti-2347	298	30	https://pubmed.ncbi.nlm.nih.gov/26903337	https://pubmed.ncbi.nlm.nih.gov/26903337	PROPN
dti-2347	298	31	https://doi.org/10.1097/mcc.0000000000000473	https://doi.org/10.1097/mcc.0000000000000473	ADJ
dti-2347	298	32	https://pubmed.ncbi.nlm.nih.gov/29135617	https://pubmed.ncbi.nlm.nih.gov/29135617	NOUN
dti-2347	298	33	https://doi.org/10.1016/s0140-6736(20)30374-3	https://doi.org/10.1016/s0140-6736(20)30374-3	NOUN
dti-2347	298	34	https://pubmed.ncbi.nlm.nih.gov/32061313	https://pubmed.ncbi.nlm.nih.gov/32061313	VERB
dti-2347	298	35	https://pubmed.ncbi.nlm.nih.gov/22797452	https://pubmed.ncbi.nlm.nih.gov/22797452	NOUN
dti-2347	298	36	https://doi.org/10.1056/nejm200005043421806	https://doi.org/10.1056/nejm200005043421806	NOUN
dti-2347	298	37	https://pubmed.ncbi.nlm.nih.gov/10793167	https://pubmed.ncbi.nlm.nih.gov/10793167	PROPN
dti-2347	298	38	https://doi.org/10.1016/s0272-5231(21)00143-x	https://doi.org/10.1016/s0272-5231(21)00143-x	PROPN
dti-2347	298	39	https://pubmed.ncbi.nlm.nih.gov/7075161	https://pubmed.ncbi.nlm.nih.gov/7075161	ADJ
dti-2347	298	40	https://doi.org/10.1016/j.peptides.2004.08.001	https://doi.org/10.1016/j.peptides.2004.08.001	NOUN
dti-2347	298	41	https://pubmed.ncbi.nlm.nih.gov/15572206	https://pubmed.ncbi.nlm.nih.gov/15572206	PROPN
dti-2347	298	42	https://doi.org/10.1210/endo.140.9.6948	https://doi.org/10.1210/endo.140.9.6948	PROPN
dti-2347	298	43	https://pubmed.ncbi.nlm.nih.gov/10465272	https://pubmed.ncbi.nlm.nih.gov/10465272	PROPN
dti-2347	298	44	https://doi.org/10.1016/j.ejphar.2011.08.020	https://doi.org/10.1016/j.ejphar.2011.08.020	NOUN
dti-2347	298	45	https://pubmed.ncbi.nlm.nih.gov/21914437	https://pubmed.ncbi.nlm.nih.gov/21914437	NOUN
dti-2347	298	46	https://doi.org/10.1002/jcsm.12185	https://doi.org/10.1002/jcsm.12185	NOUN
dti-2347	298	47	https://pubmed.ncbi.nlm.nih.gov/28294567	https://pubmed.ncbi.nlm.nih.gov/28294567	NOUN
dti-2347	298	48	https://doi.org/10.1007/bf03345618	https://doi.org/10.1007/bf03345618	NOUN
dti-2347	298	49	https://pubmed.ncbi.nlm.nih.gov/18787385	https://pubmed.ncbi.nlm.nih.gov/18787385	PROPN
dti-2347	298	50	https://pubmed.ncbi.nlm.nih.gov/25278975	https://pubmed.ncbi.nlm.nih.gov/25278975	PROPN
dti-2347	298	51	https://doi.org/10.1016/j.phrs.2012.06.006	https://doi.org/10.1016/j.phrs.2012.06.006	ADJ
dti-2347	298	52	https://pubmed.ncbi.nlm.nih.gov/22732396	https://pubmed.ncbi.nlm.nih.gov/22732396	PROPN
dti-2347	298	53	https://pubmed.ncbi.nlm.nih.gov/26884836	https://pubmed.ncbi.nlm.nih.gov/26884836	PROPN
dti-2347	298	54	https://doi.org/10.1210/en.2002-221048	https://doi.org/10.1210/en.2002-221048	ADJ
dti-2347	298	55	https://pubmed.ncbi.nlm.nih.gov/12697684	https://pubmed.ncbi.nlm.nih.gov/12697684	PROPN
dti-2347	298	56	https://doi.org/10.1097/aln.0b013e318173f64f	https://doi.org/10.1097/aln.0b013e318173f64f	NOUN
dti-2347	298	57	https://pubmed.ncbi.nlm.nih.gov/18497604	https://pubmed.ncbi.nlm.nih.gov/18497604	ADP
dti-2347	298	58	https://doi.org/10.1097/aln.0b013e318297d487	https://doi.org/10.1097/aln.0b013e318297d487	PROPN
dti-2347	298	59	https://pubmed.ncbi.nlm.nih.gov/23681142	https://pubmed.ncbi.nlm.nih.gov/23681142	PROPN
dti-2347	298	60	https://doi.org/10.1186/s40635-015-0044-3	https://doi.org/10.1186/s40635-015-0044-3	NUM
dti-2347	298	61	https://pubmed.ncbi.nlm.nih.gov/26215809	https://pubmed.ncbi.nlm.nih.gov/26215809	PROPN
dti-2347	298	62	https://doi.org/10.1165/rcmb.2004-0175oc	https://doi.org/10.1165/rcmb.2004-0175oc	PUNCT
dti-2347	298	63	https://pubmed.ncbi.nlm.nih.gov/15205180	https://pubmed.ncbi.nlm.nih.gov/15205180	NOUN
dti-2347	298	64	https://doi.org/10.1385/endo:14:1:105	https://doi.org/10.1385/endo:14:1:105	PROPN
dti-2347	298	65	https://pubmed.ncbi.nlm.nih.gov/11322491	https://pubmed.ncbi.nlm.nih.gov/11322491	NOUN
dti-2347	298	66	https://doi.org/10.1073/pnas.85.24.9386	https://doi.org/10.1073/pnas.85.24.9386	NOUN
dti-2347	299	1	https://pubmed.ncbi.nlm.nih.gov/2849100	https://pubmed.ncbi.nlm.nih.gov/2849100	ADJ
dti-2347	299	2	zambelli	zambelli	PROPN
dti-2347	299	3	et	et	PROPN
dti-2347	299	4	al	al	PROPN
dti-2347	299	5	drug	drug	PROPN
dti-2347	299	6	target	target	NOUN
dti-2347	299	7	insights	insight	NOUN
dti-2347	299	8	2021	2021	NUM
dti-2347	299	9	;	;	PUNCT
dti-2347	299	10	15	15	NUM
dti-2347	299	11	:	:	SYM
dti-2347	299	12	33	33	NUM
dti-2347	299	13	©	©	PROPN
dti-2347	299	14	2021	2021	NUM
dti-2347	299	15	the	the	DET
dti-2347	299	16	authors	author	NOUN
dti-2347	299	17	.	.	PUNCT
dti-2347	300	1	published	publish	VERB
dti-2347	300	2	by	by	ADP
dti-2347	300	3	aboutscience	aboutscience	NOUN
dti-2347	300	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2347	300	5	enzyme	enzyme	NOUN
dti-2347	300	6	in	in	ADP
dti-2347	300	7	the	the	DET
dti-2347	300	8	cleavage	cleavage	NOUN
dti-2347	300	9	of	of	ADP
dti-2347	300	10	angiotensin	angiotensin	NOUN
dti-2347	300	11	i	i	PRON
dti-2347	300	12	and	and	CCONJ
dti-2347	300	13	bradykinin	bradykinin	PROPN
dti-2347	300	14	:	:	PUNCT
dti-2347	300	15	insights	insight	NOUN
dti-2347	300	16	from	from	ADP
dti-2347	300	17	selective	selective	ADJ
dti-2347	300	18	inhibitors	inhibitor	NOUN
dti-2347	300	19	.	.	PUNCT
dti-2347	301	1	circ	circ	PROPN
dti-2347	301	2	res	re	NOUN
dti-2347	301	3	.	.	PUNCT
dti-2347	302	1	2003;93(2):148154	2003;93(2):148154	NUM
dti-2347	302	2	.	.	PUNCT
dti-2347	303	1	crossref	crossref	PROPN
dti-2347	303	2	pubmed	pubmed	PROPN
dti-2347	303	3	23	23	NUM
dti-2347	303	4	.	.	PUNCT
dti-2347	304	1	katugampola	katugampola	PROPN
dti-2347	304	2	sd	sd	PROPN
dti-2347	304	3	,	,	PUNCT
dti-2347	304	4	pallikaros	pallikaros	PROPN
dti-2347	304	5	z	z	PROPN
dti-2347	304	6	,	,	PUNCT
dti-2347	304	7	davenport	davenport	PROPN
dti-2347	304	8	ap	ap	PROPN
dti-2347	304	9	.	.	PUNCT
dti-2347	305	1	[	[	X
dti-2347	305	2	125i	125i	NOUN
dti-2347	305	3	-	-	PUNCT
dti-2347	305	4	his(9)]ghrelin	his(9)]ghrelin	PROPN
dti-2347	305	5	,	,	PUNCT
dti-2347	305	6	a	a	DET
dti-2347	305	7	novel	novel	ADJ
dti-2347	305	8	radioligand	radioligand	NOUN
dti-2347	305	9	for	for	ADP
dti-2347	305	10	localizing	localize	VERB
dti-2347	305	11	ghs	ghs	ADJ
dti-2347	305	12	orphan	orphan	NOUN
dti-2347	305	13	receptors	receptor	NOUN
dti-2347	305	14	in	in	ADP
dti-2347	305	15	human	human	ADJ
dti-2347	305	16	and	and	CCONJ
dti-2347	305	17	rat	rat	NOUN
dti-2347	305	18	tissue	tissue	NOUN
dti-2347	305	19	:	:	PUNCT
dti-2347	305	20	up	up	ADP
dti-2347	305	21	-	-	PUNCT
dti-2347	305	22	regulation	regulation	NOUN
dti-2347	305	23	of	of	ADP
dti-2347	305	24	receptors	receptor	NOUN
dti-2347	305	25	with	with	ADP
dti-2347	305	26	athersclerosis	athersclerosis	NOUN
dti-2347	305	27	.	.	PUNCT
dti-2347	306	1	br	br	PROPN
dti-2347	306	2	j	j	PROPN
dti-2347	306	3	pharmacol	pharmacol	PROPN
dti-2347	306	4	.	.	PUNCT
dti-2347	307	1	2001;134(1):143	2001;134(1):143	NUM
dti-2347	307	2	-	-	SYM
dti-2347	307	3	149	149	NUM
dti-2347	307	4	.	.	PUNCT
dti-2347	308	1	crossref	crossref	PROPN
dti-2347	308	2	pubmed	pubmed	PROPN
dti-2347	308	3	24	24	NUM
dti-2347	308	4	.	.	PUNCT
dti-2347	309	1	nagaya	nagaya	PROPN
dti-2347	309	2	n	n	CCONJ
dti-2347	309	3	,	,	PUNCT
dti-2347	309	4	miyatake	miyatake	PROPN
dti-2347	309	5	k	k	PROPN
dti-2347	309	6	,	,	PUNCT
dti-2347	309	7	uematsu	uematsu	PROPN
dti-2347	309	8	m	m	PROPN
dti-2347	309	9	,	,	PUNCT
dti-2347	309	10	et	et	PROPN
dti-2347	309	11	al	al	PROPN
dti-2347	309	12	.	.	PROPN
dti-2347	309	13	hemodynamic	hemodynamic	ADJ
dti-2347	309	14	,	,	PUNCT
dti-2347	309	15	renal	renal	ADJ
dti-2347	309	16	,	,	PUNCT
dti-2347	309	17	and	and	CCONJ
dti-2347	309	18	hormonal	hormonal	ADJ
dti-2347	309	19	effects	effect	NOUN
dti-2347	309	20	of	of	ADP
dti-2347	309	21	ghrelin	ghrelin	NOUN
dti-2347	309	22	infusion	infusion	NOUN
dti-2347	309	23	in	in	ADP
dti-2347	309	24	patients	patient	NOUN
dti-2347	309	25	with	with	ADP
dti-2347	309	26	chronic	chronic	ADJ
dti-2347	309	27	heart	heart	NOUN
dti-2347	309	28	failure	failure	NOUN
dti-2347	309	29	.	.	PUNCT
dti-2347	310	1	j	j	PROPN
dti-2347	310	2	clin	clin	PROPN
dti-2347	310	3	endocrinol	endocrinol	PROPN
dti-2347	310	4	metab	metab	NOUN
dti-2347	310	5	.	.	PUNCT
dti-2347	311	1	2001;86(12):5854	2001;86(12):5854	NUM
dti-2347	311	2	-	-	SYM
dti-2347	311	3	5859	5859	NUM
dti-2347	311	4	.	.	PUNCT
dti-2347	312	1	crossref	crossref	PROPN
dti-2347	312	2	pubmed	pubmed	PROPN
dti-2347	312	3	25	25	NUM
dti-2347	312	4	.	.	PUNCT
dti-2347	313	1	kuba	kuba	PROPN
dti-2347	313	2	k	k	PROPN
dti-2347	313	3	,	,	PUNCT
dti-2347	313	4	imai	imai	PROPN
dti-2347	313	5	y	y	PROPN
dti-2347	313	6	,	,	PUNCT
dti-2347	313	7	ohto	ohto	NOUN
dti-2347	313	8	-	-	PROPN
dti-2347	313	9	nakanishi	nakanishi	PROPN
dti-2347	313	10	t	t	PROPN
dti-2347	313	11	,	,	PUNCT
dti-2347	313	12	penninger	penninger	PROPN
dti-2347	313	13	jm	jm	PROPN
dti-2347	313	14	.	.	PROPN
dti-2347	313	15	trilogy	trilogy	NOUN
dti-2347	313	16	of	of	ADP
dti-2347	313	17	ace2	ace2	PROPN
dti-2347	313	18	:	:	PUNCT
dti-2347	313	19	a	a	DET
dti-2347	313	20	peptidase	peptidase	NOUN
dti-2347	313	21	in	in	ADP
dti-2347	313	22	the	the	DET
dti-2347	313	23	renin	renin	ADJ
dti-2347	313	24	-	-	PUNCT
dti-2347	313	25	angiotensin	angiotensin	NOUN
dti-2347	313	26	system	system	NOUN
dti-2347	313	27	,	,	PUNCT
dti-2347	313	28	a	a	DET
dti-2347	313	29	sars	sars	NOUN
dti-2347	313	30	receptor	receptor	NOUN
dti-2347	313	31	,	,	PUNCT
dti-2347	313	32	and	and	CCONJ
dti-2347	313	33	a	a	DET
dti-2347	313	34	partner	partner	NOUN
dti-2347	313	35	for	for	ADP
dti-2347	313	36	amino	amino	NOUN
dti-2347	313	37	acid	acid	NOUN
dti-2347	313	38	transporters	transporter	NOUN
dti-2347	313	39	.	.	PUNCT
dti-2347	314	1	pharmacol	pharmacol	VERB
dti-2347	314	2	ther	ther	ADV
dti-2347	314	3	.	.	PUNCT
dti-2347	315	1	2010	2010	NUM
dti-2347	315	2	;	;	PUNCT
dti-2347	315	3	128(1):119	128(1):119	NUM
dti-2347	315	4	-	-	SYM
dti-2347	315	5	128	128	NUM
dti-2347	315	6	.	.	PUNCT
dti-2347	316	1	crossref	crossref	PROPN
dti-2347	316	2	pubmed	pubmed	PROPN
dti-2347	316	3	26	26	NUM
dti-2347	316	4	.	.	PUNCT
dti-2347	317	1	bulgarelli	bulgarelli	PROPN
dti-2347	318	1	i	i	PRON
dti-2347	318	2	,	,	PUNCT
dti-2347	318	3	tamiazzo	tamiazzo	PROPN
dti-2347	318	4	l	l	NOUN
dti-2347	318	5	,	,	PUNCT
dti-2347	318	6	bresciani	bresciani	PROPN
dti-2347	318	7	e	e	NOUN
dti-2347	318	8	,	,	PUNCT
dti-2347	318	9	et	et	PROPN
dti-2347	318	10	al	al	PROPN
dti-2347	318	11	.	.	PROPN
dti-2347	318	12	desacyl	desacyl	NOUN
dti-2347	318	13	-	-	PUNCT
dti-2347	318	14	ghrelin	ghrelin	NOUN
dti-2347	318	15	and	and	CCONJ
dti-2347	318	16	synthetic	synthetic	ADJ
dti-2347	318	17	gh	gh	PROPN
dti-2347	318	18	-	-	PUNCT
dti-2347	318	19	secretagogues	secretagogue	NOUN
dti-2347	318	20	modulate	modulate	VERB
dti-2347	318	21	the	the	DET
dti-2347	318	22	production	production	NOUN
dti-2347	318	23	of	of	ADP
dti-2347	318	24	inflammatory	inflammatory	ADJ
dti-2347	318	25	cytokines	cytokine	NOUN
dti-2347	318	26	in	in	ADP
dti-2347	318	27	mouse	mouse	NOUN
dti-2347	318	28	microglia	microglia	ADJ
dti-2347	318	29	cells	cell	NOUN
dti-2347	318	30	stimulated	stimulate	VERB
dti-2347	318	31	by	by	ADP
dti-2347	318	32	beta	beta	NOUN
dti-2347	318	33	-	-	PUNCT
dti-2347	318	34	amyloid	amyloid	NOUN
dti-2347	318	35	fibrils	fibril	NOUN
dti-2347	318	36	.	.	PUNCT
dti-2347	319	1	j	j	PROPN
dti-2347	319	2	neurosci	neurosci	PROPN
dti-2347	319	3	res	re	NOUN
dti-2347	319	4	.	.	PUNCT
dti-2347	320	1	2009;87(12):2718	2009;87(12):2718	NUM
dti-2347	320	2	-	-	SYM
dti-2347	320	3	2727	2727	NUM
dti-2347	320	4	.	.	PUNCT
dti-2347	321	1	crossref	crossref	PROPN
dti-2347	321	2	pubmed	pubmed	PROPN
dti-2347	321	3	27	27	NUM
dti-2347	321	4	.	.	PUNCT
dti-2347	322	1	fukuda	fukuda	PROPN
dti-2347	322	2	y	y	PROPN
dti-2347	322	3	,	,	PUNCT
dti-2347	322	4	ishizaki	ishizaki	PROPN
dti-2347	322	5	m	m	PROPN
dti-2347	322	6	,	,	PUNCT
dti-2347	322	7	masuda	masuda	PROPN
dti-2347	322	8	y	y	PROPN
dti-2347	322	9	,	,	PUNCT
dti-2347	322	10	kimura	kimura	NOUN
dti-2347	322	11	g	g	NOUN
dti-2347	322	12	,	,	PUNCT
dti-2347	322	13	kawanami	kawanami	NOUN
dti-2347	322	14	o	o	PROPN
dti-2347	322	15	,	,	PUNCT
dti-2347	322	16	masugi	masugi	PROPN
dti-2347	322	17	y.	y.	PROPN
dti-2347	322	18	the	the	DET
dti-2347	322	19	role	role	NOUN
dti-2347	322	20	of	of	ADP
dti-2347	322	21	intraalveolar	intraalveolar	ADJ
dti-2347	322	22	fibrosis	fibrosis	NOUN
dti-2347	322	23	in	in	ADP
dti-2347	322	24	the	the	DET
dti-2347	322	25	process	process	NOUN
dti-2347	322	26	of	of	ADP
dti-2347	322	27	pulmonary	pulmonary	ADJ
dti-2347	322	28	structural	structural	ADJ
dti-2347	322	29	remodeling	remodeling	NOUN
dti-2347	322	30	in	in	ADP
dti-2347	322	31	patients	patient	NOUN
dti-2347	322	32	with	with	ADP
dti-2347	322	33	diffuse	diffuse	ADJ
dti-2347	322	34	alveolar	alveolar	ADJ
dti-2347	322	35	damage	damage	NOUN
dti-2347	322	36	.	.	PUNCT
dti-2347	323	1	am	be	AUX
dti-2347	323	2	j	j	PROPN
dti-2347	323	3	pathol	pathol	NOUN
dti-2347	323	4	.	.	PUNCT
dti-2347	324	1	1987;126(1):171	1987;126(1):171	NUM
dti-2347	324	2	-	-	SYM
dti-2347	324	3	182	182	NUM
dti-2347	324	4	.	.	PUNCT
dti-2347	325	1	pubmed	pubmed	PROPN
dti-2347	325	2	28	28	PROPN
dti-2347	325	3	.	.	PUNCT
dti-2347	326	1	aggarwal	aggarwal	PROPN
dti-2347	326	2	nr	nr	PROPN
dti-2347	326	3	,	,	PUNCT
dti-2347	326	4	king	king	NOUN
dti-2347	326	5	ls	ls	PROPN
dti-2347	326	6	,	,	PUNCT
dti-2347	326	7	d’alessio	d’alessio	PROPN
dti-2347	326	8	fr	fr	NOUN
dti-2347	326	9	.	.	PUNCT
dti-2347	327	1	diverse	diverse	ADJ
dti-2347	327	2	macrophage	macrophage	ADJ
dti-2347	327	3	populations	population	NOUN
dti-2347	327	4	mediate	mediate	VERB
dti-2347	327	5	acute	acute	ADJ
dti-2347	327	6	lung	lung	NOUN
dti-2347	327	7	inflammation	inflammation	NOUN
dti-2347	327	8	and	and	CCONJ
dti-2347	327	9	resolution	resolution	NOUN
dti-2347	327	10	.	.	PUNCT
dti-2347	328	1	am	be	AUX
dti-2347	328	2	j	j	PROPN
dti-2347	328	3	physiol	physiol	PROPN
dti-2347	328	4	lung	lung	PROPN
dti-2347	328	5	cell	cell	NOUN
dti-2347	328	6	mol	mol	ADP
dti-2347	328	7	physiol	physiol	PROPN
dti-2347	328	8	.	.	PUNCT
dti-2347	329	1	2014;306(8):l709	2014;306(8):l709	NUM
dti-2347	329	2	-	-	PUNCT
dti-2347	329	3	l725	l725	PROPN
dti-2347	329	4	.	.	PUNCT
dti-2347	330	1	crossref	crossref	PROPN
dti-2347	330	2	pubmed	pubmed	PROPN
dti-2347	330	3	29	29	NUM
dti-2347	330	4	.	.	PUNCT
dti-2347	331	1	peiris	peiris	PROPN
dti-2347	331	2	js	js	PROPN
dti-2347	331	3	,	,	PUNCT
dti-2347	331	4	yuen	yuen	PROPN
dti-2347	331	5	ky	ky	PROPN
dti-2347	331	6	,	,	PUNCT
dti-2347	331	7	osterhaus	osterhaus	PROPN
dti-2347	331	8	ad	ad	NOUN
dti-2347	331	9	,	,	PUNCT
dti-2347	331	10	stöhr	stöhr	PROPN
dti-2347	331	11	k.	k.	PROPN
dti-2347	332	1	the	the	DET
dti-2347	332	2	severe	severe	ADJ
dti-2347	332	3	acute	acute	ADJ
dti-2347	332	4	respiratory	respiratory	ADJ
dti-2347	332	5	syndrome	syndrome	NOUN
dti-2347	332	6	.	.	PUNCT
dti-2347	333	1	n	n	PROPN
dti-2347	333	2	engl	engl	PROPN
dti-2347	333	3	j	j	PROPN
dti-2347	333	4	med	med	PROPN
dti-2347	333	5	.	.	PUNCT
dti-2347	334	1	2003;349(25):2431	2003;349(25):2431	X
dti-2347	334	2	-	-	SYM
dti-2347	334	3	2441	2441	NUM
dti-2347	334	4	.	.	PUNCT
dti-2347	335	1	crossref	crossref	PROPN
dti-2347	335	2	pubmed	pubmed	PROPN
dti-2347	335	3	30	30	PROPN
dti-2347	335	4	.	.	PUNCT
dti-2347	336	1	blackwell	blackwell	PROPN
dti-2347	336	2	ts	ts	PROPN
dti-2347	336	3	,	,	PUNCT
dti-2347	336	4	tager	tager	NOUN
dti-2347	336	5	am	be	AUX
dti-2347	336	6	,	,	PUNCT
dti-2347	336	7	borok	borok	PROPN
dti-2347	336	8	z	z	NOUN
dti-2347	336	9	,	,	PUNCT
dti-2347	336	10	et	et	PROPN
dti-2347	336	11	al	al	PROPN
dti-2347	336	12	.	.	PUNCT
dti-2347	337	1	future	future	ADJ
dti-2347	337	2	directions	direction	NOUN
dti-2347	337	3	in	in	ADP
dti-2347	337	4	idiopathic	idiopathic	ADJ
dti-2347	337	5	pulmonary	pulmonary	ADJ
dti-2347	337	6	fibrosis	fibrosis	NOUN
dti-2347	337	7	research	research	NOUN
dti-2347	337	8	.	.	PUNCT
dti-2347	338	1	an	an	DET
dti-2347	338	2	nhlbi	nhlbi	PROPN
dti-2347	338	3	workshop	workshop	NOUN
dti-2347	338	4	report	report	NOUN
dti-2347	338	5	.	.	PUNCT
dti-2347	339	1	am	be	AUX
dti-2347	339	2	j	j	PROPN
dti-2347	339	3	respir	respir	NOUN
dti-2347	339	4	crit	crit	PROPN
dti-2347	339	5	care	care	NOUN
dti-2347	339	6	med	me	VERB
dti-2347	339	7	.	.	PUNCT
dti-2347	340	1	2014;189(2):214	2014;189(2):214	NUM
dti-2347	340	2	-	-	SYM
dti-2347	340	3	222	222	NUM
dti-2347	340	4	.	.	PUNCT
dti-2347	341	1	crossref	crossref	PROPN
dti-2347	341	2	pubmed	pubmed	PROPN
dti-2347	341	3	https://doi.org/10.1161/01.res.0000081593.33848.fc	https://doi.org/10.1161/01.res.0000081593.33848.fc	PROPN
dti-2347	342	1	https://pubmed.ncbi.nlm.nih.gov/12805239	https://pubmed.ncbi.nlm.nih.gov/12805239	PROPN
dti-2347	342	2	https://doi.org/10.1038/sj.bjp.0704228	https://doi.org/10.1038/sj.bjp.0704228	PROPN
dti-2347	342	3	https://pubmed.ncbi.nlm.nih.gov/11522606	https://pubmed.ncbi.nlm.nih.gov/11522606	PROPN
dti-2347	342	4	https://doi.org/10.1210/jcem.86.12.8115	https://doi.org/10.1210/jcem.86.12.8115	PRON
dti-2347	343	1	https://pubmed.ncbi.nlm.nih.gov/11739451	https://pubmed.ncbi.nlm.nih.gov/11739451	NOUN
dti-2347	343	2	https://doi.org/10.1016/j.pharmthera.2010.06.003	https://doi.org/10.1016/j.pharmthera.2010.06.003	PROPN
dti-2347	343	3	https://pubmed.ncbi.nlm.nih.gov/20599443	https://pubmed.ncbi.nlm.nih.gov/20599443	ADV
dti-2347	343	4	https://doi.org/10.1002/jnr.22088	https://doi.org/10.1002/jnr.22088	INTJ
dti-2347	343	5	https://pubmed.ncbi.nlm.nih.gov/19382238	https://pubmed.ncbi.nlm.nih.gov/19382238	VERB
dti-2347	343	6	https://pubmed.ncbi.nlm.nih.gov/3812636	https://pubmed.ncbi.nlm.nih.gov/3812636	NOUN
dti-2347	343	7	https://doi.org/10.1152/ajplung.00341.2013	https://doi.org/10.1152/ajplung.00341.2013	PROPN
dti-2347	343	8	https://pubmed.ncbi.nlm.nih.gov/24508730	https://pubmed.ncbi.nlm.nih.gov/24508730	ADV
dti-2347	343	9	https://doi.org/10.1056/nejmra032498	https://doi.org/10.1056/nejmra032498	ADJ
dti-2347	343	10	https://pubmed.ncbi.nlm.nih.gov/14681510	https://pubmed.ncbi.nlm.nih.gov/14681510	ADJ
dti-2347	343	11	https://doi.org/10.1164/rccm.201306-1141ws	https://doi.org/10.1164/rccm.201306-1141ws	PROPN
dti-2347	343	12	https://pubmed.ncbi.nlm.nih.gov/24160862	https://pubmed.ncbi.nlm.nih.gov/24160862	VERB